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General introduction
The number of people living with cancer is increasing
Cancer incidence and mortality are rapidly growing worldwide due to ageing and 
population growth. This phenomenon is referred to as double ageing: people both live 
longer and the relative proportion of people aged 65 and over increases.[1] Moreover, 
changes in the prevalence and distribution of the main risk factors for cancer are 
expected.[2] It is predicted that the incidence of all-cancer cases will increase from 12.7 
million new cases in 2008 to 22.2 million by 2030.[3]
Cancer patients suffer from psychological distress
It is recommended that all patients with cancer and all cancer survivors are evaluated 
for symptoms of psychological distress. Psychological distress is defined by the National 
Comprehensive Cancer Network (NCCN) as “a multi-factorial unpleasant emotional 
experience of a psychological (i.e. cognitive, behavioural, emotional), social, and/or 
spiritual nature that may interfere with the ability to cope effectively with cancer, its physical 
symptoms, and its treatment. Distress extends along a continuum, ranging from common 
normal feelings of vulnerability, sadness and fears to problems that can become disabling, 
such as depression, anxiety, panic, social isolation, and existential and spiritual crisis".[4]
Thus, psychological distress can be conceptualised both as a dimensional measure 
ranging on a continuum or as a dichotomous outcome measure in terms of presence or 
absence of psychiatric disorder.
Several self-report questionnaires are available to measure psychological distress on 
a dimensional scale.[5] These questionnaires are estimated to take one quarter of the 
time and cost one third as much as conducting psychiatric assessments by means of 
a clinical interview.[6] In clinical practice, screening outcomes are often dichotomized 
by use of cut-offs for clinically relevant levels of psychological distress to screen for 
presence of psychiatric disorder.[7] One study assessing clinical levels of psychological 
distress in a large sample of 4496 cancer patients using the Brief Symptom Inventory 
found clinically levels of psychological distress in 35%.[8] Another study in a multicentre 
epidemiological sample of 3724 cancer patients with different types of cancer used the 
Distress Thermometer and found clinically levels of psychological distress in 52%.[9] The 
authors listed a slight bias towards younger age as one of the possible reasons of higher 
prevalence. In all, prevalence estimates of clinically significant levels of psychological 
distress as measured by self-report screening measures seem to vary somewhere 
between one third and one out of two cancer patients.
Differences in abovementioned psychological distress prevalence estimates are for a 
large part caused by different questionnaires used to screen for psychological distress.[9] 
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Moreover, demographic and clinical variables such as younger age [10, 11] and advanced 
stage of disease [9] are known to be associated with higher levels of psychological 
distress. The association between younger age and higher levels psychological distress 
also implies that the number of distressed cancer patients is not expected to increase 
proportionally with the increase in people living with cancer mentioned above, as the 
prevalence of patients living with cancer is expected to increase because of an ageing 
population.
Outcomes of screening for psychological distress can be used as needs assessment and 
as a source of information to determine whether referral to psychological or psychiatric 
services is necessary.[4] However, screening alone is not enough: it is suggested that 
the one-dimensional concern with intensity of distress should be broadened to include 
more information about the context of the distress.[5] Positive screens for psychological 
distress warrant follow-up with further assessment of specific needs and appropriate 
referral and treatment.[12] Not all distressed cancer patients wish for psychological 
treatment: some patients might for example have sufficient support from family and 
friends or prefer not to talk about their problems.[13] What responses should follow a 
positive screen, remains a topic of research in itself.[5]
In contrast, determining presence or absence of psychiatric disorder by psychiatric 
assessment in a clinical interview is still considered to be gold standard in terms of 
prognostic value, as a means of contextual assessment of functional impairments and 
as needs assessment for additional psychiatric or psychological treatment in cancer 
patients in general.[9] In a meta-analysis of 94 studies with almost 15000 participants 
in oncological, haematological and palliative-care settings it was concluded that some 
combination of mood disorders occurs in 30–40% of cancer patients. Combination 
diagnoses were common: all types of depression occurred in 21% of patients, depression 
or adjustment disorder in 32%, and any mood disorder in 38%. There was no significant 
difference in prevalence between palliative-care and non-palliative-care settings.[14]
Whether or not cancer patients suffer from a higher level of psychological distress or 
psychiatric disorder compared to healthy controls on the long term is unclear. In a 
systematic review and meta-analysis of depression and anxiety in long-term cancer 
survivors compared with spouses and healthy controls it was found that after 2 years or 
more, cancer patients had much the same prevalence of depression as did spouses and 
healthy controls (12 vs. 10%). However, the prevalence of anxiety was higher in cancer 
patients than in healthy controls (18 vs. 14%). This suggests that anxiety, rather than 
depression, is most likely to be a problem in long-term cancer survivors and spouses 
compared with healthy controls.[15]
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Consequences of psychological distress in cancer are profound
On the shorter term, addressing the psychological distress of cancer patients is 
important because it has profound consequences for the individual patient and for 
society as a whole. Psychological co-morbidity in cancer is associated with reduced 
quality of life, decreased compliance with medical care, prolonged duration of hospital 
stay and increased (inappropriate) healthcare use.[16-18] For example, it was previously 
demonstrated that psychological distress was associated with increased use of 
outpatient and inpatient hospital healthcare, emergency healthcare and prescription 
medication in a large cross-sectional sample of 4326 heterogeneous-cancer survivors.
[18] Providing psychosocial care to cancer patients may thus lead to cost savings in the 
long-term as cancer patients benefitting from psychosocial care make less use of other 
healthcare services.[19] This phenomenon is referred to as cost-offset: increased mental 
well-being is supposed to lead to increased adherence with anticancer treatment and 
supportive lifestyle changes (for example to quit smoking). In addition, productivity 
losses among the working cancer population may be reduced.[19]
Improved cancer survival rates: the emergence of psycho-oncology
The need for psychological treatment for cancer patients might seem self-evident 
nowadays, although the recognition of psychological needs of cancer patients by the 
establishment of psychosocial oncology as a dedicated sub-discipline of oncology is a 
relatively recent development.[20] The increased recognition of psychological needs of 
the cancer patient is perhaps best understood within the context of drastically improved 
survival rates for cancer patients.[20]
In the 1800s, effective treatments for cancer patients were not available. By the mid-19th 
century the establishment of anaesthesia led to first attempts to remove tumours. Early 
in the 20th century the possibility of cure emerged with further innovations, the role of 
radiotherapy as a treatment for cancer opened up hopes for cure, or at least extended life 
expectancy, later followed by chemotherapy as another alternative and, more recently, 
targeted therapies.[20] As a result, cancer survival rates drastically improved. In England 
and Wales, the overall index of net survival increased substantially during the 40-year 
period of 1971-2011. For patients diagnosed in 1971-72, the index of net survival was 
50% at 1 year after diagnosis. Forty years later, the same value of 50% was predicted 
at 10 years after diagnosis.[21] Progress has been most rapid for hematopoietic and 
lymphoid malignancies due to improvements in treatment protocols. For example, 
comparing patients diagnosed in the mid-1970s with those diagnosed during 2006 
to 2012, the 5-year relative survival rate has increased from 41% to 71% for acute 
lymphocytic leukaemia and from 22% to 66% for chronic myeloid leukaemia.[22]
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In the 1950s, the first studies on psychological reactions to cancer began to emerge. 
New psychiatric units at Memorial Sloan-Kettering Cancer Center in New York and 
Massachusetts General Hospital in Boston were established.
Subsequently, patient advocacy groups in the 1960s and 1970s placed the cancer 
agenda into the public arena.[20] With more people living longer with the consequences 
of cancer, cancer survivorship in terms of psychological well-being and quality of life has 
received an increasing amount of attention.[23] In 2013 the NCCN released guidelines 
for the provision of general survivorship care and management of long-term or late 
effects of cancer that survivors might experience, with screening for psychological 
morbidities and psychiatric assessment.[24]
Although the need for regaining psychological well-being increased with the growing 
length of cancer survivorship, attention for quality of life and well-being in cancer 
patients lagged behind due to a predominantly technologically based focus on fighting 
the disease. As a consequence, mental health professionals began to advocate for: “The 
need for person-oriented medicine and the importance of clinical skills involving knowing 
and understanding the patient in front of you as a person, not a collection of cells, and doing 
this well enough to have insight into their problems, concerns, and emotions”[20, 23], for 
example through founding professional societies (the British Psychosocial Oncology 
Society in 1982, and the American Psycho-Oncology Society and International Psycho-
Oncology Society in 1984).[25]
Evidence-based psychological treatments for cancer patients
In the past 30 years evidence-based psychological treatments for cancer patients 
increasingly became available. In a meta-analysis of 198 studies including 22238 cancer 
patients small-to-medium effects of psycho-oncological interventions on emotional 
distress, anxiety, depression, and health-related quality-of-life (QoL) were found. These 
effects were mostly sustained in the medium term and even long term.[26]
But does psycho-oncological treatment also provide value for money? In a healthcare 
system with increasingly scarce resources, data on the cost-effectiveness of psychological 
treatments is ever more important. In cost-effectiveness studies, the difference in 
total costs between alternative interventions are weighted against the differences in 
effectiveness, often expressed as improvement in quality-adjusted life-year (QALY). The 
QALY is a composite outcome multiplying the life expectancy by the quality of these 
remaining life-years.[27] A review of 11 cost-effectiveness studies of psycho-oncological 
interventions including collaborative care interventions (n=4), group interventions 
(n=4), individual psychological support (n=2), and individual psycho-education (n=1) 
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concluded that psycho-oncological care is likely to be cost-effective depending on how 
much society is willing to pay for gain in QALYs in cancer patients.[28] Moreover, since 
psychological distress levels are higher in people of young age [9] who still have a whole 
working life in front of them, there is great potential economical impact of early and 
effective psychological interventions in terms of reducing productivity losses for many 
years to come.
Despite established effectiveness and cost-effectiveness, evidence-based psychological 
treatments are not always accessible for cancer patients due to known patient-reported 
barriers to engaging in face-to-face psychological treatment, stigma, reluctance 
to return to the hospital, and indirect costs such as travel- and time investment.[29] 
Therefore, these interventions are increasingly delivered via Internet. Internet-based 
interventions are easily accessible, save travelling time and can be as effective as their 
face-to-face counterparts.[30, 31]
Of all evidence-based psychological treatments in psycho-oncology, weaker evidence 
exists for counselling, support-based and narrative therapy interventions.[32] The 
strongest evidence base for new psychological intervention research in cancer consists 
for cognitive behavioural therapy (CBT) and mindfulness-based interventions (MBIs).
[32]
Cognitive behavioural therapy
Cognitive behavioural therapy (CBT) has been considered the gold-standard of 
treatment for psychopathology in general[33] and for psychopathology in cancer 
patients in particular.[32] CBT focuses on identifying and challenging irrational 
negative automatic thoughts in order to change them into more realistic or helpful 
ones. It also aims at altering maladaptive behaviour.[34] The quality of evidence for 
CBT interventions had improved over the years.[35] A 2015 Cochrane review focusing 
on psychological interventions in non-metastatic breast cancer patients including 24 
RCTs on CBT concluded that women who received CBT showed important reductions 
in anxiety, depression and mood disturbance.[36] Other studies indicate effectiveness 
of CBT compared to patient education in reducing psychological distress with small 
to medium effect sizes in other tumour types e.g. gynaecological[37] and head/neck 
cancers.[38] Although this evidence is promising, much of it derives from trials under 
‘ideal’ conditions. Few pragmatic trials have been conducted, and it remains unclear 
how well CBT works in ‘real world’ settings in patients with complex co-morbidity.[32]
Two studies specifically focused on the cost-effectiveness of CBT in cancer patients. One 
study found (nonsignificant) lower costs in the CBT group compared to the supportive-
18
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experiential group therapy while effectiveness was almost identical.[39] In highly-
distressed cancer patients treated with CBT total costs were on average lower and more 
QALYs were gained than in those offered a nurse-led self-management intervention, 
although both findings were statistically not significant. In less-distressed patients, 
lower effect sizes were found.[40]
Moreover, evidence for the efficacy of internet-delivered CBT in cancer patients is 
accumulating. Guided Internet-based cognitive behavioural therapy has shown 
to improve generic psychological outcomes with small effect sizes (17-.21) with 
occasionally larger effects for disease-related impact outcomes (.17-1.11). Internet-
based CBT with a longer treatment duration (>6 weeks) led to more consistent effects 
on depression.[41] Moreover, CBT-based online interventions for cancer survivors 
without therapist guidance, or unguided interventions, were found effective in reducing 
psychological distress and fatigue [42-44], improving QoL [43], improving emotional 
and social functioning [44], and self‐efficacy skills.[45] However, it must be noted that 
adherence to unguided interventions is often lower than intended [46] and evidence 
for the effectiveness of self-guided interventions in cancer patients is still limited.[47]
Mindfulness-based interventions
In addition to CBT, a minority of intervention research in psycho-oncology has involved 
mindfulness-based Interventions (MBIs) such as Mindfulness-based Stress Reduction 
(MBSR) [48] and Mindfulness-based Cognitive Therapy (MBCT).[49] These are increasingly 
being applied in oncology. Mindfulness is often defined as:“Paying attention, on purpose, 
in the present moment and non-judgmentally”.[48] Whilst CBT focuses on identifying and 
challenging irrational thoughts and behaviour, many of cancer-related thoughts and 
cognitions are not irrational. Anxiety for cancer recurrence, once having been treated for 
cancer, is all but irrational – it may even trigger positive health behaviours.[50] Instead, 
becoming aware of how you relate to difficult thoughts, emotions or painful bodily 
sensations may be more helpful than focusing on the specific contents of thoughts, 
emotions and bodily sensations.
This is where mindfulness comes into play: the practice of mindfulness enables 
participants to make a radical shift in how they relate to their thoughts, feelings, and 
body sensations, as well as to outer circumstances. They recognize habitual, conditioned 
modes of reacting, and learn to disengage from them.[49] As such, MBIs focus on 
growing the capacity to embrace the unequivocal reality of living with cancer, and the 
ability of paying kind attention and of choosing freely and deliberately how you want to 
go about dealing with these thoughts, emotions, and bodily sensations, without having 
to get rid of them.
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Evidence for the effectiveness of MBIs in oncology has rapidly increased in the last two 
decades. A meta-analysis of 29 RCTs with a total of 3439 patients[51] report reduction 
of psychological distress in cancer patients with a small to medium effect size (Hedges’g 
= .30). MBIs have beneficial effects on depression, anxiety, fear of cancer recurrence and 
fatigue.
Although first results indicate that MBIs are cost-effective in cancer care[52, 53], cost-
effectiveness evaluations of MBIs are scarce.[54] A study in 129 breast cancer patients 
suffering from persistent pain explored cost-effectiveness of MBCT compared to wait-
list control. At a Willingness to Pay (WTP) for a Quality adjusted life year (QALY) gained of 
€0, MBCT was cost-effective with a probability of 85% and remained cost-effective with 
a probability of 70% to 82% when smaller effects and higher MBCT costs were assumed.
[52] Another study in 104 breast cancer patients compared the cost-effectiveness of 
Mindfulness-Based Stress Reduction (MBSR) to wait-list controls and concluded that 
MBSR was more expensive, but also slightly more effective than a waitlist control group.
[53] Another study in 191 breast cancer patients investigated the cost-effectiveness 
of an adapted MBI with a different focus: Mindfulness-Based Art Therapy (MBAT). 
MBAT was compared to an active support group intervention employing a healthcare 
perspective. MBAT demonstrated the potential to achieve an equal trade-off between 
costs and effects with the support group intervention if some intervention-related costs 
were reduced.[55]
MBIs are also being delivered via Internet, but research on Internet-based MBIs (eMBIs) 
mostly focus on the efficacy of eMBIs in the general public. A recent review of 15 RCTs 
on eMBIs for the general public demonstrated a small but significant beneficial impact 
on depression, anxiety, well-being and mindfulness. The largest effect was found for 
stress, with a moderate effect size (Hedges’ g=0.51).[56] For stress and mindfulness, 
exploratory subgroup analyses indicated that guided eMBIs had higher effect sizes than 
unguided eMBI, which are MBIs delivered through technological platforms without 
a therapist. Nevertheless, a review of 10 studies on unguided eMBIs provided initial 
support for unguided eMBIs in the general public as well.[57]
Studies focusing on the efficacy of eMBIs in cancer patients are scarce. One single 
controlled study (n=62) demonstrated feasibility of adapted Internet-based MBSR for 
cancer patients.[58] Another pilot study confirmed that MBSR delivered via an iPad may 
be feasible and acceptable for breast cancer patients.[59] In addition, an uncontrolled 
cohort of 257 fatigued patients showed significant improvements in fatigue and 
psychological distress after individual eMBCT.[60]
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Although MBIs have previously demonstrated their potential as an alternative 
psychological treatment for cancer patients, a well-designed RCT comparing both 
individual Internet-based MBCT and group-based MBCT for cancer patients has never 
been conducted.
THESIS OUTLINE
This thesis focuses on an eMBI which already existed in clinical practice, which is an 
achievement on the account of the Helen Dowling Institute. The Helen Dowling Institute 
(HDI) is the oldest mental healthcare institute for cancer patients and their partners in 
The Netherlands. In order to improve patient-friendliness and accessibility of MBIs in 
cancer patients, the Helen Dowling Institute started to provide individual Internet-based 
MBCT (eMBCT) for cancer patients in clinical practice over ten years ago. In addition, the 
Radboud University Medical Centre for Mindfulness has gained experience in providing 
patient care and conducting research projects on MBIs in several patient groups, 
including cancer patients, since 2008. In 2012, the HDI and the Centre for Mindfulness 
combined forces and engaged in a collaborative research project comparing clinical 
and cost-effectiveness of both group-based MBCT and Internet-based MBCT (eMBCT) 
compared to Treatment as Usual (TAU). This thesis aims at researching these two 
interventions on clinical and cost-effectiveness outcomes compared to TAU.
Chapter 2 illustrates how psychiatric disorder and psychological distress are related 
to healthcare utilization in cancer patients. The research question in this chapter is: 
“Are psychiatric disorder and psychological distress associated with increased healthcare 
utilization and increased healthcare costs?” To answer this question, patients were 
assessed with Structured Clinical Interview for DSM-IV-TR Axis I Disorders (SCID-I) for 
depressive, anxiety, and/or adjustment disorder. The Hospital Anxiety and Depression 
Scale-questionnaire measured psychological distress. Retrospective self-reported 
healthcare utilization over the past 3 months was collected and associations between 
psychiatric disorder, psychological distress and healthcare utilization and costs per 
healthcare utilization category (mental, primary, somatic, and complementary) were 
assessed.
Chapter 3 describes the design and protocol of the BeMind study. The BeMind study 
examines the effectiveness of both group-based and Internet-based MBCT compared 
to TAU in reducing psychological distress by conducting a multicentre randomized 
controlled trial in a sample of 245 (mildly) distressed cancer patients. We reported 
detailed information on the methodological aspects of the trial, including its design, 
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eligibility criteria, study procedure, outcome measures, sample size calculation 
and statistical analyses. The research question of the BeMind study is: “What is the 
effectiveness of both group-based and Internet-based MBCT compared to TAU in distressed 
cancer patients?”
Chapter 4 describes the results of the BeMind study. In total, 245 cancer patients were 
randomly assigned to MBCT (n=77), eMBCT (n=90) or TAU (n=78). The effectiveness 
of both interventions compared to TAU was evaluated at post-treatment in terms of 
the primary outcome psychological distress and secondary outcomes fear of cancer 
recurrence, rumination, health-related quality of life, mindfulness skills and positive 
mental health.
Chapter 5 aims to determine how cancer patients and their mindfulness therapists 
experience participating in Internet-based MBCT. Therefore, the chapter describes 
the results of individual post-treatment interviews with 31 patients and a focus group 
interview with 8 therapists on experienced facilitators and barriers during Internet-
based MBCT. The research question was “What facilitators and barriers do patients and 
therapists experience in individual asynchronous therapist-assisted Internet-based MBCT?”
Chapter 6 describes the results of the cost-effectiveness evaluation of both group-
based and Internet-based MBCT compared to TAU. The research question is: “Are both 
group-based and Internet-based MBCT cost-effective treatments from a societal perspective 
compared to TAU?” Therefore, we conducted a cost-utility trial from the societal 
perspective along-side the three-armed clinical RCT.
Chapter 7 gives a summary of the main findings followed by a general discussion of 
the results in the light of the current literature, strengths and limitations of the research 
project, directions for future research and a reflection on the implementation of MBCT 
for cancer patients in regular healthcare.
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ABSTRACT
Objective
The mental burden of cancer might elicit additional healthcare utilization. However, 
it is unclear how psychiatric disorder and psychological distress relate to healthcare 
utilization. Therefore, this study explores associations between psychiatric disorder, 
psychological distress and healthcare utilization. It was hypothesized that presence 
of psychiatric disorder and psychological distress were associated with increased 
healthcare utilization and costs.
Methods
The current study consisted of secondary analyses of baseline data of a larger randomized 
controlled trial. 245 mixed-cancer patients with at least mild symptoms of psychological 
distress (Hospital Anxiety and Depression Scale (HADS-T) ≥11) were mainly recruited 
via online media, participating centres and patient associations. Patients were assessed 
with SCID-I for depressive, anxiety and/or adjustment disorder. Psychological distress 
was measured by the HADS. Retrospective self-reported healthcare utilization in the 
past three months was collected. Associations between predictors and healthcare 
utilization in terms of incidence rate ratios and costs per category (mental, primary, 
somatic, complementary) were assessed by negative binomial, logistic and gamma 
regression.
Results
Eighty-nine (36.3%) patients suffered from psychiatric disorder, which was associated 
with mental healthcare utilization (IRR=1.63) and costs (OR=3.11). We observed a 
nonsignificant trend of somatic healthcare utilization in patients with psychiatric 
disorder. Psychological distress was associated with mental healthcare utilization 
(IRR=1.09) and costs (OR=1.09). Psychological distress was also associated with 
complementary healthcare utilization (IRR=1.03).
Conclusion
Psychiatric disorder and psychological distress were associated with mental healthcare 
use and costs. Psychological distress was associated with complementary healthcare 
use. Adequate assessment and referral to mental healthcare might prevent unnecessary 
healthcare utilization.
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BACKGROUND
In 2025 and beyond, each year 20 million people worldwide will be diagnosed with 
cancer.[1] Many cancer patients suffer from cancer-related mental burden, or even 
psychiatric disorder. A meta-analysis of psychiatric disorder in oncological and 
hematological settings yielded a prevalence of 30 to 40%.[2] Major depressive disorders 
(14.9%), anxiety (10.3%) and adjustment disorders (19.4%) were most prevalent.[2] In 
addition to the mental burden, psychiatric disorder may also negatively affect somatic 
outcomes. Depression in cancer patients is related to a higher mortality, possibly due to 
smoking or reduced anticancer treatment adherence.[3]
In addition to psychiatric disorder, cancer-related mental burden is commonly 
operationalised as degree of psychological distress, which is defined as a multi-
dimensional emotional experience that may interfere with the ability to cope with 
cancer and its consequences.[4] Although psychiatric disorder and psychological 
distress overlap conceptually, psychological distress is self-reported and extends along 
a continuum.[5] Psychological distress is also related to poorer treatment adherence [5] 
and mortality.[6]
There is emerging evidence that the mental burden of cancer patients might be 
associated with increased healthcare utilization. Faller et al. [7] studied mental 
healthcare utilization in a sample of 4020 German cancer patients. Psychiatric disorder 
appeared to be an correlate of mental healthcare utilization (OR=1.68) independently of 
symptoms of depression (OR=1.04) and anxiety (OR=1.08).[7] In addition, administrative 
data of 5055 heterogeneous-cancer patients indicated that depression was associated 
with non-mental healthcare visits (OR=1.76), emergency department visits (OR=2.45), 
overnight hospitalization (OR=1.81) and hospital readmission rates (OR=2.03).[8] No 
studies have been conducted on associations between anxiety or adjustment disorders 
and healthcare utilization in cancer patients.
Studies on psychological distress and healthcare utilization show similar patterns. 
Psychological distress was associated with mental healthcare utilization in a study on 
1602 Swiss childhood cancer survivors. Moreover, survivors not using mental healthcare 
more often used somatic healthcare.[9] In another large cross-sectional sample of 4326 
heterogeneous-cancer survivors and 57109 non-cancer patients, psychological distress 
was associated with increased use of outpatient and inpatient hospital healthcare, 
emergency healthcare, and prescription medication.[10]
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Moreover, use of complementary and alternative care in cancer patients has long 
been recognized.[11, 12] Previous studies have demonstrated associations between 
psychological distress symptoms and use of complementary healthcare services [13, 
14], although evidence for this association is mixed.[15] 
Thus, evidence suggests that both psychiatric disorder and psychological distress 
are associated with healthcare utilization in cancer patients. However, it is unclear 
how psychiatric disorder and psychological distress are associated with utilization of 
healthcare other than mental healthcare.
Therefore, the aim of this study was to provide a descriptive account of the associations 
between psychiatric disorder, psychological distress and mental, primary, somatic 
and complementary healthcare utilization. It was hypothesized that both psychiatric 
disorder and psychological distress would be associated with increased healthcare 
utilization and increased healthcare costs.
METHODS
Patients and procedure
This study was a secondary analysis of a multi-site randomized controlled trial (RCT) 
examining group- and Internet-based Mindfulness-Based Cognitive Therapy (MBCT) 
versus treatment as usual for distressed cancer patients.[16] The current study uses the 
baseline data prior to randomization. Eligibility criteria for the RCT were: a) (history of ) 
diagnosis of cancer, all types; b) a score of ≥11 on the Hospital Anxiety and Depression 
Scale (HADS); c) command of the Dutch language; d) computer literacy; e) stable on 
psychotropic medication for three months. Exclusion criteria were: a) severe psychiatric 
morbidity; b) (previous) participation in a mindfulness-based intervention. Patients 
were recruited between April 2014 and December 2015 (see Table 1 for recruitment 
details). After positive screening, exclusion criteria were assessed via telephone and 
patients were invited for a baseline interview. The study was approved by the local 
ethics committee (CMO Arnhem-Nijmegen 2013/542).
Assessments
Demographic and clinical information
Demographic and clinical information included: gender, date of birth, marital status, 
children and level of education, type of cancer diagnosis, anticancer treatment intent 
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(curative/palliative), current active anticancer treatment. When patients were unsure 
about their anticancer treatment intent the researchers sought advice from a consultant 
oncologist.
Psychiatric disorder
Presence of psychiatric disorder was assessed by the SCID-I [17] which is a semi-
structured psychiatric interview for DSM-IV-TR Axis I disorders. In this study, the 
sections on current and past depressive disorder, current anxiety disorder and current 
adjustment disorder were used. The SCID-I was administered by trained interviewers 
(FC and two research assistants). Two psychiatrists (EB and AS) and one psychologist 
(ML) supervised the administration of the SCID-I interviews and double-rated (n=97) of 
the audiotapes. Double-rated interviews were discussed together. The opinion of the 
supervisor was leading.
Psychological distress
Psychological distress was measured by the Hospital Anxiety and Depression Scale 
(HADS), a 14-item self-report scale that was originally developed to screen for anxiety 
and depression in medical outpatient clinics.[18] Internal consistency as measured by 
Cronbach’s α was .87 in the current sample. HADS-T has 7-item depression (HADS-D, 
α=.84) and anxiety (HADS-A, α=.80) subscales. The threshold of ≥11 corresponds 
to the threshold for screening for mental disorder in cancer patients.[19] Although 
the subscales of the HADS do not provide a good separation between anxiety and 
depression [20], we chose to explore the original subscales keeping aforementioned 
limitations in mind.
Healthcare utilization
The Trimbos/iMTA questionnaire for Costs associated with Psychiatric illnesses (TiC-P) 
[21] generates retrospective self-reported quantitative data about healthcare utilization 
(type of healthcare, its duration and medication use). The recommended retrospective 
time horizon of 3 months was used. Healthcare utilization was operationalised as counts 
of visits across four categories: 1. Mental healthcare including visits to social workers, 
psychologists and psychiatrists; 2. Primary healthcare including visits to general 
practitioners, occupational physicians and physical- and occupational therapists; 
3. Somatic healthcare including visits to medical outpatient clinics, emergency 
department, day healthcare units and overnight hospital stays. The costs analyses 
in the somatic healthcare category also included prescription medication costs; 4. 
Complementary healthcare utilization including visits to homeopaths, acupuncturists, 
traditional Chinese medicine and massage therapists. These categories were chosen on 
34
Chapter 2
basis of type of healthcare (mental vs. somatic), the distinction between primary and 
secondary healthcare, and insurance coverage (complementary healthcare is mostly 
out-of-pocket).
Healthcare costs
Cost estimates were derived from the Dutch reference manual for healthcare prices 
[22] and the Dutch website for national tariffs of prescription medications (https://
www.medicijnkosten.nl). Cost estimates for dieticians and complementary healthcare 
providers were provided by their professional associations.
Data-analysis
Statistical analyses were run in IBM SPSS Statistics version 24. Patients with and 
without psychiatric disorder were tested for differences on clinical and demographical 
variables using t-test and chi-square tests. The data structurally demonstrated variances 
surpassing means (overdispersion). Negative binomial regression was used to evaluate 
the association of psychiatric disorder (depressive, anxiety and adjustment vs. no 
disorder) and psychological distress with healthcare utilization in terms of incidence rate 
ratios (IRR) per category. Negative binomial regression provides regression coefficients 
which denote differences in logs of expected counts per unit change in the predictor 
variable. Exponentiation of these regression coefficients gives the IRR (e.g. incidence 
rate ratio of healthcare utilization in the past three months per unit increase in the 
predictor). The difference of two logs is equal to the log of their quotient and therefore, 
we can interpret the parameter estimate as the log of the ratio of expected counts. This 
explains the “ratio” in incidence rate ratios. In addition, what is referred to as a count is 
technically a rate.
It is known that mental burden and healthcare utilization are associated with gender 
[23, 24], age [25, 26] cancer severity [27, 28] and being under cancer treatment.[28] 
Therefore, these possible confounders were included as covariates. In addition, this 
model specification also provided the best goodness-of-fit statistics (lowest AIC/BIC):
g( ) = log( ) = + 
1
Ps.Distress / Ps.Disorder
1
 + 
2
Gender
2 
+ 
3
Age
3
 + 
4
AnticancerTreatmentIntent
4 
+ 
5
CurrentActiveCancerTreatment
5
 ⇒ = e + 1x1 + 2x2 + 3x3 + 4x4 + 5x5 = ex (x1 = [1 x
1
 x
2
 x
3
 x
4
 x
5
])
The healthcare utilization cost data were non-negative and displayed positive skew. 
Therefore, the healthcare utilization outcome data in costs in Euros were analyzed 
by means of a two-part modeling strategy [29] using a) logistic regression to assess 
whether psychiatric disorder/psychological distress were associated with whether or 
not patients had costs per category and b) if patients had costs, gamma regression 
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with a log link function to assess whether psychiatric disorder/psychological distress 
were associated with amount of costs. There were no missing data. We did not exclude 
outliers.
RESULTS
In total, 532 patients were screened after which 98 (18.4%) were excluded. After 
telephone assessment of 434 patients, another 141 (32.5%) were excluded or refused 
participation. Of the remaining 293 patients, 48 (16.4%) refused participation. In total, 
245 patients were randomized (see Table 1) and their baseline data were included in the 
current study.
There was considerable variability in tumour types, although the majority had breast 
cancer (n= 151, 61.6%). About one-third (36.3%) suffered from psychiatric disorder. Five 
(2.0%) patients suffered from a concurrent depressive and anxiety disorder. Of the five 
patients with concurrent anxiety disorders, only one patient had a main, cancer-related 
diagnosis. The other four anxiety disorders were social phobia (n=2) and specific phobia 
(n=2). These patients were therefore included in the depressive disorder-category only. 
Average HADS-T was 17.6 (SD=6.6). Patients with and without psychiatric disorder did 
not differ significantly on clinical and demographical variables (all p-values >.05). Table 
2 provides descriptive statistics on overall healthcare utilization per category.
Patients with psychiatric disorder were significantly more likely to use mental 
healthcare (see Table 3) and had more mental healthcare costs (see Table 4), even 
although almost half (n=38, 42.7%) did not use mental healthcare. Moreover, patients 
with psychiatric disorder demonstrated a nonsignificant trend towards enhanced use of 
somatic healthcare. No such trend was found for somatic healthcare costs. Patients with 
psychiatric disorder were not more likely to use primary and complementary healthcare. 
Considering specific disorders, we only found a significant associations between 
depression and adjustment disorder and mental healthcare use but no association with 
costs.
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TABLE 1: Baseline Sociodemographic and Clinical Characteristics (n=245)
Characteristic n %
Gender 
Female 210 85.7
Male 35 14.3
Age in years
Mean 51.7
SD 10.7
Married / in a relationship
Yes 202 82.4
No 43 17.6
Children
No 76 31.0
Yes 169 69.0
Education
High 166 67.8
Middle 77 31.4
Low 2 0.8
Diagnosis
Breast cancer 151 61.6
Gynecological cancer 18 7.3
Prostate cancer  16 6.5
Colon cancer 12 4.9
Non-hodgkin lymphoma 11 4.5
Skin cancer 5 2.0
Thyroid cancer 4 1.6
Bladder cancer 4 1.6
Neuroendocrine tumour 4 1.6
Other 20 8.2
Time since diagnosis in years
Mean 3.5 
SD 4.7
Anticancer treatment intent 
Curative 206 84.1
Palliative 39 15.9
Current anticancer  treatment
None 133 54.2
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TABLE 1: Continued
Characteristic n %
Hormone therapy 79 32.2
Combination of treatments 12 4.9
Immunotherapy 9 3.7
Radiotherapy 8 3.3
Chemotherapy 4 1.6
Psychiatric disorder
All 89 36.3
Depressive 42 17.1
Anxiety 27 11.0
Adjustment 20 8.2
Psychological distress (HADS)*
Total 17.7 6.6
Depression 8.2 3.8
Anxiety 9.4 3.7
Recruited via
Online media (social media, website) 66 26.9
Patient associations 43 17.6
Participating mental healthcare centers 41 16.7
Offline media (advertorials, leaflets) 27 11.0
Attended by next-of-kin 27 11.0
Healthcare providers 23 9.4
Unknown/ could not remember 18 7.3
* Hospital Anxiety and Depression Scale
Patients with higher psychological distress were more likely to report having utilized 
mental healthcare (see Table 3) and had higher mental healthcare costs (see Table 4). 
Moreover, higher psychological distress was associated with more complementary 
healthcare visits, but not with more costs. Higher psychological distress was not 
associated with more visits to primary or somatic healthcare, although patients with 
higher psychological distress did have higher primary healthcare related costs. In the 
analyses separating the depression and anxiety subscales, patients with more depressive 
symptoms were more likely to visit mental and primary healthcare. Patients with more 
anxiety symptoms were more likely to visit mental and complementary healthcare. 
Higher scores on either subscale were not associated with somatic or complementary 
healthcare costs.
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TABLE 2. Descriptives on healthcare utilization in the past 3 months: counts and costs (in Euros) 
per category (n=245)
Measure Mental Primary Somatic Complementary
Counts
1 > visits: n 106 216 214 71
1 > visits: % 43.3 88.2 87.3 29
Mean 2 7.22 6.51 1.07
SD 3.56 7.98 8.3 2.35
Range 0‐30 0‐48 0‐46 0‐20
Costs
Mean 121.27 280.51 1370.4 66.58
SD 221.01 403.27 2140.27 147.06
Range 0‐1466 0‐4604 0‐14016 0‐1250
TABLE 3. Incidence rate ratios (IRR) of healthcare utilization per independent variable and 
healthcare utilization category (n=245)
Mental 
Healthcare 
Utilization IRR 
(95% CI)
Primary 
Healthcare 
Utilization IRR 
(95% CI)
Somatic 
Healthcare 
Utilization IRR 
(95% CI)
Complementary 
Healthcare 
Utilization IRR 
(95% CI)
Psychiatric disorder (yes/no)
All 1.63
(1.18‐2.25)**
0.93
(0.70‐1.23)ns
1.30
(0.98‐1.72)ns
1.18
(0.81‐1.71)ns
Depressive 1.71
(1.11‐2.62)*
1.01
(0.70‐1.46)ns
1.34
(0.92‐1.95)ns
1.25
(0.78‐2.01)ns
Anxiety 1.43
(0.86‐2.37)ns
0.80
(0.51‐1.26)ns
1.35
(0.87‐2.11)ns
1.15
(0.63‐2.10)ns
Adjustment 1.77
(1.00‐3.10)*
0.97
(0.59‐1.61)ns
1.15
(0.70‐1.91)ns
1.48
(0.77‐2.83)ns
Psychological distress (per point increase)
Total 1.09
(1.06‐1.12)**
1.02
(1.00‐1.04)ns ns
1.00
(0.98‐1.03)ns
1.03
(1.00‐1.06)*
Depression 1.14
(1.09‐1.19)**
1.04
(1.00‐1.08)*
1.03
(0.99‐1.07)ns
1.04
(0.99‐1.10)ns
Anxiety 1.12
(1.07‐1.18)**
1.02
(0.98‐1.06)ns
0.98
(0.94‐1.02)ns
1.06
(1.01‐1.11)*
* p < .05, ** p < .01, ns p >.05
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DISCUSSION
This study explored how psychiatric disorder and psychological distress are associated 
with healthcare utilization and costs. Patients with psychiatric disorder, most notably 
depressive and adjustment disorder, were more likely to visit mental healthcare and have 
higher mental healthcare costs. Patients with psychiatric disorder also demonstrated 
a nonsignificant trend towards enhanced use of somatic healthcare. Furthermore, 
patients with higher psychological distress were more likely to report having utilized 
mental and complementary healthcare and were more likely to demonstrate mental 
healthcare-related costs.
Although the percentage of patients with psychiatric disorder having received mental 
healthcare was higher than reported previously (57.3 vs. 43.6 [8]), about half of patients 
with psychiatric disorder did not use mental healthcare. This is in line with research 
demonstrating that there is no one-on-one relationship between positive screen for 
psychological distress and subsequent wish for or use of mental healthcare.[30] For 
example, distressed patients could also choose to rely on family or prefer to not talk 
about it.[30] Moreover, lack of organizational and therapeutic integration of psycho-
oncological services in routine oncology care is a known barrier to using psychological 
services.[31] Ideally, mental healthcare professionals inform and support patients in 
making a conscious decision on their psychological needs and wishes.[32]
Patients with psychiatric disorder demonstrated a nonsignificant trend towards more 
use of somatic healthcare. A previous study found associations between depression and 
somatic healthcare utilization.[8] Patients with depression are perhaps more likely to 
somatize, amplify their symptoms and be more aware of bodily sensations, rendering 
them more likely to seek help in non-mental healthcare.[33] Psychiatric disorder was 
not associated with more costs. The present use of reference data on healthcare costs 
might have resulted in a too crude approximation of actual healthcare costs. Bottom-up 
micro-costing endeavours, aiming to determine every cost item involved of a specific 
healthcare procedure, could have translated into cost data more sensitive to presence 
of psychiatric disorder.
Both patients with depression and adjustment disorder showed increased mental 
healthcare utilization. Patients with anxiety disorder did not. Feelings of anxiety might 
be normalized in context of cancer, so anxiety disorder is often overlooked by healthcare 
providers.[34] Furthermore, although patients with adjustment disorder demonstrated 
more mental healthcare related visits, only anxiety disorder was associated with 
increased mental healthcare-related costs. Most likely, this inconsistent finding is caused 
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by analytical differences between the count and cost data. Furthermore, separate 
diagnoses of depression, anxiety and adjustment disorder were unrelated with visits or 
costs in primary, somatic or complementary healthcare. However, the separate analyses 
of specific disorders had a reduced sample size which may have led to underpowered 
analyses.[35]
Psychological distress appeared to be associated with visits to mental and 
complementary healthcare. The finding that complementary healthcare use was 
related to psychological distress, mainly anxiety symptoms, reflects earlier findings.
[13, 14] In our sample, 29% of the cancer patients appeared to use complementary 
healthcare even though this is often not fully reimbursed by healthcare insurance in 
The Netherlands. Although psychological distress was associated with complementary 
healthcare utilization, the majority (56%) using complementary healthcare did so 
without simultaneously consulting a mental healthcare professional. Patients resorting 
to complementary care might fear the stigma of mental healthcare, or they might prefer 
complementary approaches to improve their mental well-being. Some have argued 
that complementary healthcare use in distressed cancer patients is a sign of a lack of 
integration of psycho-oncological services.[36] This reiterates the point that mental 
healthcare professionals should be available to facilitate cancer patients to make a 
conscious choice whether, and how, they want to alleviate their mental burden.
The absence of an association between psychological distress and somatic healthcare 
utilization contradicts previous findings of Han et al. [10] that cancer survivors with severe 
psychological distress use more somatic healthcare services. A possible explanation 
for this difference might be that in The Netherlands, the general practitioner is the 
gatekeeper to somatic healthcare, and might prevent somatic healthcare by referring 
cancer patients to mental health services instead. Supporting this explanation, tentative 
results indicate an association between depressive symptoms and primary healthcare 
visits.
Future studies should substantiate the association between psychiatric disorders and 
somatic healthcare utilization to determine whether appropriate referral to mental 
healthcare in cancer patients possibly contributes to decreased utilization of somatic 
healthcare. Furthermore, more research is needed on the nature, outcomes and costs 
of complementary healthcare use. For some patients, referral to professionals offering 
evidence-based mental healthcare might be a better option than letting them seek 
their refuge with complementary healthcare providers offering less appropriate 
interventions.
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Study limitations
Our study sample was selective: self-referred, at least mildly distressed and interested 
in a Mindfulness-Based intervention. Moreover, the large majority of our patients were 
highly educated, female, Caucasian, had breast cancer and were treated with curative 
intent, so our sample was relatively homogenous. Although we cannot extrapolate 
our findings to all Dutch distressed cancer patients, these characteristics are in 
concordance with characteristics of cancer patients receiving psychosocial healthcare 
in The Netherlands.[37] Due to the cross-sectional nature of the data, we cannot rule 
out alternative explanations such as the possibility that increased healthcare utilization 
could increase mental burden.
Ideally, we would have used medical chart data of both primary healthcare and/or 
hospitals to check the reliability of the clinical and self-reported healthcare utilization 
data. We did not have access to data on cancer stages and co-morbid medical conditions. 
Moreover, self-reported healthcare utilization data are most likely less reliable. Therefore, 
all healthcare utilization data were gathered using an interview-based format and 
filled out together with a researcher to ensure reporting accuracy and completeness. 
Nevertheless, it remains possible that self-reported healthcare utilization was affected 
by psychiatric disorder, as it is known that depressive disorder affects memory functions.
[38]
Lastly, limitations inherent to the explorative nature and research questions of the 
current study should be mentioned: performing multiple testing without adjustment 
may have resulted in chance findings and psychiatric disorder and psychological 
distress were not compared head-to-head against each other.
Clinical implications
Notwithstanding the limitations, the results of our study suggest that there is room for 
improvement in terms of mental healthcare for cancer patients. A large proportion of 
cancer patients remains under the radar of mental healthcare. Patients scoring above 
the cut-off for psychiatric disorder should be offered further psychiatric diagnostics. 
Ideally, multiple methods are available to identify psychological needs of cancer 
patients [32], and mental healthcare professionals gauge patients’ needs and wishes. 
They can support patients in making a conscious choice to rely on family, refrain from 
seeking (regular) help, or to participate in evidence-based treatment such as cognitive 
behavioral therapy [39] or mindfulness-based interventions.[40]
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Conclusion
This study explored how psychiatric disorder and psychological distress are associated 
with healthcare utilization and costs. Patients with psychiatric disorder were more 
likely to visit mental healthcare and have more mental healthcare costs. Furthermore, 
patients with higher psychological distress were more likely to report having utilized 
mental and complementary healthcare and were more likely to demonstrate mental 
healthcare-related costs. Appropriate referral of cancer patients who are both in need of 
and receptive to psychological treatment could not only result in improved well-being 
of cancer patients, but also in a reduction of non-mental healthcare utilization.
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ABSTRACT
Background
Mindfulness-based interventions have shown to reduce psychological distress in cancer 
patients. The accessibility of mindfulness-based interventions for cancer patients could 
be further improved by providing mindfulness using an individual Internet-based 
format. The aim of this study is to test the effectiveness of a Mindfulness-Based Cognitive 
Therapy (MBCT) group intervention for cancer patients in comparison with individual 
Internet-based MBCT and treatment as usual (TAU).
Methods/Design
A three-armed multicenter randomized controlled trial comparing group-based 
MBCT to individual Internet-based MBCT and TAU in cancer patients who suffer 
from at least mild psychological distress (Hospital Anxiety and Depression Scale 
(HADS) ≥ 11). Measurements will be conducted prior to randomization (baseline), 
post-treatment and at 3 months and 9 months post-treatment. Participants initially 
allocated to TAU are subsequently randomized to either group- or individual Internet-
based MBCT and will receive a second baseline measurement after 3 months. Thus, 
the three-armed comparison will have a time span of approximately 3 months. The 
two-armed intervention comparison includes a 9-month follow-up and will also 
consist of participants randomized to the intervention after TAU. Primary outcome 
will be post-treatment psychological distress (HADS). Secondary outcomes are fear of 
cancer recurrence (Fear of Cancer Recurrence Inventory), rumination (Rumination and 
Reflection Questionnaire), positive mental health (Mental Health Continuum – Short 
Form), and cost-effectiveness (health-related quality of life (EuroQol –5D and Short 
Form-12) and healthcare usage (Trimbos and iMTA questionnaire on Costs associated 
with Psychiatric illness). Potential predictors: DSM-IV-TR mood/anxiety disorders (SCID-I) 
and neuroticism (NEO-Five Factor Inventory) will be measured. Mediators of treatment 
effect: mindfulness skills, (Five-Facets of Mindfulness Questionnaire- Short Form), 
working alliance (Working Alliance Inventory) and group cohesion (Group Cohesion 
Questionnaire) will also be measured.
Discussion
This trial will provide valuable information on the clinical and cost-effectiveness of 
group versus Internet-based MBCT versus TAU for distressed cancer patients.
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BACKGROUND
Cancer is a major healthcare challenge. Cancer causes more than a quarter of all deaths 
in OECD countries with more than 5 million new cases diagnosed every year, averageing 
about 261 cases per 100 000 people.[1] In The Netherlands it is expected that the 
incidence of cancer will increase with more than 40% between 2007 and 2020.[2] These 
numbers indicate that we are looking at a steadily increasing number of patients who 
will have to cope with cancer in the near future.
Living with cancer is a psychological burden. In a review of the prevalence of depression, 
anxiety and adjustment disorders in cancer patients in both palliative and non-palliative 
settings it was found that about one third of all patients suffer from a mood disorder in 
the first five years after diagnosis.[3] A recent epidemiological survey based on more 
than 2000 structured clinical interviews across major tumour entities found the most 
prevalent mental disorders to be anxiety (11.5%) adjustment (11.1%) and depressive 
disorders (6.5%).[4] Considering the rising prevalence of people living with cancer, the 
absolute number of cancer patients in need of psychological treatment is expected 
to increase. Addressing this increasing need calls for effective, widely available and 
accessible psychological treatment.
In recent years, many studies have assessed the effect of mindfulness-based interventions 
for cancer patients. Mindfulness is defined as intentionally paying attention to 
moment-by-moment experiences in a non-judgmental way.[5] Mindfulness-Based 
Stress Reduction (MBSR) [6] and Mindfulness-Based Cognitive Therapy (MBCT) [7], the 
latter developed specifically to prevent relapse in depression, are protocols designed 
to teach the cultivation of mindfulness. In a review of 22 studies, mindfulness-based 
interventions were found to be moderately effective in reduction of symptoms of 
anxiety and depression in cancer patients.[8] Recently, another randomized controlled 
trial (RCT) showed that mindfulness-based treatment was superior to both supportive-
expressive group therapy and a 1-day stress management condition in improving a 
range of psychological outcomes in a sample of 271 distressed breast cancer survivors.[9] 
Although any follow-up results should still be considered preliminary, the recent review 
indicates that effect sizes (ES) at follow-up were significant with small to moderate ESs 
for nonrandomized studies and small ESs for RCTs.
Psychological treatment for cancer patients implies treatment for people who have 
difficulty with travelling due to cancer -related impairments or fatigue. Also, treatment 
scheduling should be flexible, allowing for adaptation to individual circumstances, 
for example ongoing radio- or chemotherapy. Taking this into account, Internet-
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based treatment might hold promise to address these problems. A recent review 
concludes that guided Internet-based Cognitive Behavioural Therapy (CBT) “appears 
to be a promising and effective treatment for chronic somatic conditions to improve 
psychological and physical functioning and disease-related impact”.[10] In addition to 
its clinical effectiveness, research also suggests evidence for the cost-effectiveness of 
Internet-based CBT for somatic populations.[11, 12]
Literature on the effectiveness of Internet-based mindfulness treatment is still scarce. 
There are a few studies in non-clinical populations which show that Internet-based 
mindfulness treatment resulted in an improvement of mindfulness skills and reduction 
of perceived distress.[13-15] Recently, encourageing evidence was presented for 
the feasibility and efficacy of Internet-based mindfulness treatment in a study of 62 
underserved and distressed cancer patients.[16] Compared to treatment as usual (TAU) 
patients reported an increase of mindfulness and a reduction of depressive and stress 
symptoms. This provides preliminary evidence for the effectiveness of Internet-based 
mindfulness treatment compared to TAU.
Direct comparisons of Internet-based mindfulness treatment to existing group treatments 
for distressed cancer patients are absent, let alone follow-up comparisons. One of the 
biggest challenges in internet intervention research is low treatment adherence [17] 
which affects treatment effectiveness.[18] A recent study of Internet-based MBCT for 
treatment of chronic cancer-related fatigue using a treatment format similar to ours 
indicated a non-adherence rate of 38%, which is higher than in comparable face-to-face 
interventions.[19] The current trial will provide the first description of the relative long-
term effectiveness of group- compared to Internet-based MBCT by including a follow-
up measurement up to 9 months post-treatment and keeping close track of treatment 
adherence in both intervention arms.
Thus, it is unknown whether Internet-based MBCT has similar effectiveness as group-
based MBCT in alleviating distress in cancer. Therefore, we primarily compare post-
treatment psychological distress between group-based and Internet-based MBCT. Also, 
effectiveness in reducing psychological distress up to nine months post-treatment will 
be compared between group- and Internet-based MBCT. Moreover, we would like to 
determine whether the two interventions could reduce fear of cancer recurrence and 
rumination. Also, at the other end of the psychological spectrum, both group- and 
Internet-based MBCT might be able to improve positive mental health in cancer patients 
compared to TAU. Furthermore, alongside the clinical trial, cost-effectiveness of both 
MBCT interventions compared to TAU will be determined. We expect both interventions 
to be cost-effective compared to TAU.
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We do not expect all individuals to benefit similarly from the two interventions. 
Therefore, studying predictors of each intervention’s effect potentially enables us to 
determine who benefits most from what treatment – group-based or Internet-based 
MBCT. In this study we would like to explore two possible predictors: the presence/
absence of a DSM-IV-TR mood/anxiety disorder and the personality trait neuroticism.
Research on mindfulness-based interventions for cancer patients has focused on the 
prevalence and treatment of distress rather than psychiatric disorders. Not much is 
known on the effectiveness of MBCT in oncology patients suffering from a mood and/
or anxiety disorder as opposed to patients suffering from distress. We are interested to 
see if the presence of a psychiatric disorder is a better predictor of treatment outcome 
than psychological distress.
Moreover, previous research has shown that a high score on neuroticism has a negative 
effect on (group) psychotherapy outcome.[20] This study aims to explore the hypothesis 
that higher neuroticism at baseline has a negative predictive value for the primary 
outcome measure and to explore possible differences in treatment outcome between 
group- and Internet-based MBCT.
As it is known that mindfulness skills mediate the relationship between mindfulness 
practice and improvements in psychological symptoms (e.g. [21]), we hypothesize that 
the improvement on the Hospital Anxiety and Depression Scale (HADS) in the MBCT 
intervention arms is mediated by mindfulness skills. Moreover, weekly measurements 
(MAAS and I-PANAS-SF) will be used to test the hypothesis that an increase in mindfulness 
skills antedates changes in affect during the intervention.
One of the differences between face-to-face and online treatment is the relationship 
with the therapist. Working alliance, or therapeutic alliance, is a long-recognized 
concept in psychotherapy research. Although it is known that a working alliance is 
realizable in Internet-based therapy [22], little is known about the possible difference in 
working alliance between group- and Internet-based MBCT. We would be interested to 
see if working alliance mediates the relationship between intervention and outcome in 
both interventions.
The relationship with both the therapist and other group members in group-based 
treatment, or group cohesion, is often considered to be one of the most important 
contributors to positive treatment effect in group therapy. The current study aims to 
assess whether group cohesion mediates the relationship between the group-based 
MBCT intervention and outcome.   
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In conclusion, the primary aim of this study is to compare the effectiveness of group- 
and Internet-based MBCT to TAU to reduce distress in cancer patients after treatment. 
Secondary outcome measures will be fear of cancer recurrence, rumination, and positive 
mental health. In addition, possible effect predictors (DSM-IV-TR mood/anxiety disorder 
and neuroticism) and mediators (mindfulness skills, working alliance, group cohesion) 
of treatment outcome will be explored. In order to determine the long-term stability 
of intervention effects, assessments will take place 3 and 9 months post-treatment. 
Alongside the clinical trial, the cost-effectiveness of both MBCT interventions compared 
to TAU will be determined. As far as we know, this is the first direct comparison between 
group-based MBCT, Internet-based MBCT and TAU.
METHODS/DESIGN
Study design
This study is a multicenter, parallel group randomized controlled trial. Participants are 
randomized to group-based MBCT, Internet-based MBCT or TAU. Participants initially 
randomized to TAU are subsequently randomized to either group- or Internet-based 
MBCT which participants receive after a waiting-list period of three months. During the 
waiting-list period, participants know which treatment they will receive after the waiting 
list and participants are allowed to receive care as usual, except for any mindfulness-
based intervention. The study protocol has been approved by our ethical review board 
(CMO Arnhem-Nijmegen) and is registered under number 2013/542.
Setting
The group MBCT is provided at the Radboud University Medical Centre in Nijmegen, the 
Jeroen Bosch Hospital in ‘s Hertogenbosch and at four mental health institutes specialized 
in psycho-oncology (Helen Dowling Institute (Bilthoven), Ingeborg Douwes Centrum 
(Amsterdam), De Vruchtenburg (Leiden), Het Behouden Huys (Haren)). The Internet-
based MBCT has been developed with, protected and hosted by IPPZ, a commercial 
e-health company in The Netherlands. Patients receive an invitational e-mail with the 
conditions of use. The Internet-based MBCT is accessed using a personal double-step-
verification- protected webpage on the participants’ own personal computer, mobile 
phone or tablet device.
Study population
Inclusion criteria of the study are a) a cancer diagnosis, any tumour or stage b) a score of 
11 or higher on the Hospital Anxiety and Depression Scale (HADS), c) computer literacy 
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and internet access d) a good command of the Dutch language and e) willingness 
to participate in either MBCT intervention. Exclusion criteria are a) severe psychiatric 
morbidity such as suicidal ideation and/or psychosis b) change in psychotropic 
medication dosage within a period of three months prior to baseline c) current or 
previous participation in a mindfulness-based intervention (> 4 sessions of MBCT or 
MBSR).
Procedure
Participants are recruited in aforementioned participating centers and recruited via 
social media, patient associations and advertorials in local newspapers. Patients who are 
interested in participation can enroll themselves at our website (www.bemind.info) at 
which point they complete the HADS. Patients with a score of 11 or higher are contacted 
by telephone by one of the researchers. During this call more information about the study 
is provided and eligible patients are invited for a research interview. The subsequent 
research interview is conducted face-to-face or by telephone depending on participant 
preference. Written informed consent, demographic and clinical characteristics are 
obtained on paper via regular mail. Subsequently the Structured Clinical Interview for 
DSM-IV-TR Axis-I disorders (SCID-I) is administered to diagnose possible mood/anxiety 
disorders and the Trimbos and iMTA questionnaire on Costs associated with Psychiatric 
illness (TiC-P) to assess medical and productivity loss costs. The participant completes 
the remainder of the (self-report) questionnaires online.
Randomization
Randomization is stratified for setting and minimized for a) gender, b) stage of 
disease (curative versus palliative) and c) type of cancer (breast cancer versus other). 
Randomization is computerized using a randomization website specifically designed 
for the current study. Randomization is conducted by one of the researchers (EB) who is 
not involved in the follow-up assessments.
Follow-up assessments
Follow-up assessments take place directly post-treatment and at three and nine 
months follow-up. The follow-up assessments are similar to the baseline assessment: 
participants are contacted by telephone in order to re-administer the SCID-I and the 
TiC-P and participants receive an online survey with the self-report scales. In case of 
dropout, the researcher tries to contact the participant at least three times to complete 
the outcome measures and to identify the main reason for dropout.
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Intervention
The MBCT curriculum used in both group and Internet-based MBCT interventions 
is primarily based on the MBCT program by Segal, Williams and Teasdale.[23] The 
program was adapted to the oncology patient in terms of tailoring psycho-educative 
elements to themes relevant to the cancer patient (e.g. cancer-related fatigue) and 
adapted movement exercises (for patients suffering from edema). In both conditions, 
participants receive guided mindfulness meditation exercises for home practice and a 
reader with home practice instructions and background information.
The group-based MBCT curriculum consists of 8 weekly 2,5 hour group sessions, a silent 
day between session six and seven and home practice assignments of about 45 minutes, 
6 days per week (see table 2). During the weekly sessions the teacher guides different 
mindfulness exercises and introduces new exercises, and home practice assignments 
are discussed.
The Internet-based MBCT intervention is similar to group MBCT in curriculum content, 
but different in delivery. Participants in the Internet-based MBCT intervention log in 
on a secure personal webpage where all content relevant to that week’s session can 
be downloaded. Participants are asked to read the weekly information and do the 
mindfulness exercises and write down their experiences in their personal log. They are 
encouraged to correspond with their personal teacher about their practice experiences 
via a secure, integrated mailing system. The teacher replies to this log on a predetermined 
day of the week and guides the participant through the curriculum. Participants can 
continue with next weeks’ session only after registering their experiences in their log 
for the previous week. Participants are encouraged to follow the intervention within the 
nine-week structure. However, the teacher can decide to extend this period in case of 
illness or holidays.
All teachers fulfill the advanced criteria of the Association of Mindfulness-based Teachers 
in The Netherlands and Flanders) which are in concordance with the UK Mindfulness-
Based Teacher Trainer Network Good Practice Guidelines for teaching mindfulness-
based courses [24], including a minimum of 150 hours of education in MBSR/MBCT 
background and theory, training in teaching formal and informal meditation practices, 
psycho-education and inquiry, supervision and giving an MBSR or MBCT course 
including a reflection report, b) relevant professional training, c) minimum of three years 
of practicing meditation regularly and attending retreats, d) having attended MBSR/
MBCT as a participant, e) continued training and f ) giving a minimum of two courses per 
two year. Three full-day plenary supervision meetings are held during the intervention 
phase of the trial, consisting of mindfulness practices, workshops, small group teachings 
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and plenary discussions about difficulties or practical issues. All teachers are involved 
in both group and Internet-based MBCT. Teachers without prior Internet-based MBCT 
experience are provided with guidelines and supervised by more experienced Internet-
based MBCT teachers.
In the group-based MBCT condition, sessions are videotaped to evaluate teacher 
competence and protocol adherence using the Mindfulness-Based Interventions - 
Teachers Assessment Criteria (MBI-TAC).[25] The MBI-TAC was translated to Dutch 
using the guidelines of the International Test Commission.[26] Group-based MBCT 
participants are requested to complete the same form for their teachers’ competence. 
As the MBI-TAC is not applicable to Internet-based treatment and there are currently no 
other ways to evaluate teacher competence in Internet-based mindfulness treatment, 
teacher competence will not be assessed in the Internet-based condition using a 
standardized measurement.
Primary outcome measure
Psychological distress
For a measurement scheme we refer to Table 1. The primary outcome measure is the 
post-treatment total score on the HADS, a 14-item self-report screening scale that was 
originally developed to indicate the possible presence of anxiety and depressive states 
in the setting of a medical outpatient clinic.[27, 28] As earlier research in a palliative 
setting suggested the total HADS score should be used, this score will be used rather than 
individual depression and anxiety subscales.[29] The HADS shows good psychometric 
properties in the general medical population, including oncology patients in palliative 
phase.[30] Internal consistency as measured with Cronbach’s α varied from .84 to .90.
[28, 31] Test-retest reliability was good as Pearson’s r > .80 were obtained.[28, 32]
Secondary outcome measures
Fear of cancer recurrence
Fear of cancer recurrence is assessed with the Fear of Cancer Recurrence Inventory 
(FCRI; [33]). This 42-item 4-point Likert scale questionnaire has been found to have a 
robust factor structure with Cronbach’s α=0.75 to 0.91 across subscales and test-retest 
reliabilities over a two-week interval of 0.58 to 0.83 across subscales. The FCRI is positively 
associated with other measures of anxiety symptoms, intrusive thoughts and avoidance 
and negatively associated with quality of life in a large sample of cancer patients.[33]
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TABLE 1: Measurement scheme
Variable goal Measure Target Sc
re
en
in
g
T0 D
ur
in
g 
T0
b 
TA
U
 o
nl
y
T1 T2 T3
Primary outcome HADS Psychological distress x x x x x x
Secondary outcomes FCRI Fear of cancer recurrence x x x x x
RRQ Rumination Reflection 
Questionnaire
x x x x x
MHC-SF Mental Health 
Continuum – Short Form
x x x x x
Effect predictors SCID DSM-IV Axis I disorders x x x x x
NEO-FFI Personality dimensions x x
Process measures FFMQ-SF Mindfulness skills x x x x x
WAI Working alliance x
GCQ Group cohesion x
MAAS Mindfulness skills x
I-PANAS-SF Mood x
Calendar Mindfulness adherence x
Cost-effectiveness TiC-P Healthcare costs and 
productivity
x x x x x
EQ-5D Health-related quality 
of life x x x x x
SF-12 Health-related quality of 
life (general health)
x x x x x
Rumination
Rumination is measured by the rumination subscale of the Rumination and Reflection 
Questionnaire (RRQ; [34]). Subjects rate their level of agreement of disagreement on a 
five-point rating scale (e.g., “I always seem to be re-hashing in my mind recent things 
I’ve said or done”). The Dutch version has Cronbach’s alphas ranging between .88 and 
.93.[35]
Positive mental health
Positive mental health is measured by the Mental Health Continuum-Short Form (MHC-
SF; [36]) which comprises 14 items, representing various feelings of well-being in the 
past month rated on a 6-point Likert scale (never, once or twice a month, about once 
a week, two or three times a week, almost every day, every day). The MHC-SF contains 
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three subscales: emotional, psychological and social well being. The short form of the 
MHC has shown excellent internal consistency (> .80). The test-retest reliability of the 
MHC-SF over three successive 3 month periods was .68 and the 9 month test-retest in a 
Dutch sample was .65.[37]
Medical and societal costs
Data on medical and societal costs and data on health-related quality of life are 
collected to conduct the cost-effectiveness – analysis. Data on medical and societal 
costs are gathered using the TiC-P.[38] The TiC-P generates quantitative data about 
direct healthcare utilization (the type of care, its duration and medication) and indirect 
societal costs (cancer-related absence from work and cancer-related impairment in non-
paid work). Unit cost estimates are derived from the national manual for cost prices in 
the healthcare sector.[39] Unit cost estimates are combined with resource utilization 
data to obtain a net cost per patient over the entire follow-up period. Unit cost estimates 
are derived from the national manual for cost prices in the healthcare sector. Costs of 
reduced ability to work are estimated using the friction costs method. Treatment costs 
are calculated using activity-based-costing methods, thus measuring actual resources 
(time of therapist, time of patients, facilities) used. Unit cost estimates are combined 
with resource utilization data to obtain a net cost per patient over the entire follow-up 
period.
Quality of life
To measure the health-related quality of life of cancer patients, a validated health-
related quality of life instrument is used, the EuroQol-5D (EQ-5D; [40]). The EQ-5D is 
a generic instrument comprising five domains: mobility, self-care, usual activities, 
pain/discomfort and anxiety/depression. The EQ-5D index is obtained by applying 
predetermined weights to the five domains. This index gives a societal-based global 
quantification of the participant’s health status on a scale ranging from 0 (death) to 
1 (perfect health). Participants are also asked to rate their overall quality of life on a 
visual analogue scale (EQ- 5D VAS) consisting of a vertical line ranging from 0 (worst 
imaginable health status) to 100 (best imaginable). The EQ-5D is available in a validated 
Dutch translation.[41] Because there are indications that the Short Form-12 (SF-12; [42]), 
another questionnaire on health-related quality of life, is more sensitive to change in 
populations with less severe morbidity than the EQ-5D [43], the SF-12 is administered 
as well. The SF-12 consists of 12 items yielding two summary scores for physical and 
mental health. Scoring is norm based with a mean of 50 (SD = 10); higher scores indicate 
better health.
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TABLE 2: MBCT curriculum content
Theme of 
session Meditation exercise Didactic teaching Homework
1. The 
automatic pilot
• Body scan • Intention of 
participating
• Raisin exercise
• Bodyscan
• Mindful eating
• Mindful routine activity
2. Dealing with 
barriers
• Body scan • Observation exercise 
“walking through the 
streets”
• Mindfulness of the 
breath
• Bodyscan or mindfulness of 
the breath
• Positive experiences diary
• Mindful routine acitivity
3. Mindfulness 
of the breath
• Movement 
exercises lying 
down
• Mindfulness of the 
breath and body
• 3-minutes breathing 
space
• Body scan or movement 
exercises
• Negative experiences diary
• 3-minute breathing space 
three times a day
4. Staying 
present
• Sitting meditation
• Walking 
meditation
• Psycho-education 
“reacting/responding 
stress” 
• Sitting meditation or walking 
meditation or movement 
exercises
• Stress diary
• 3-minute breathing space
• Walking meditation
5. Allowing • Sitting meditation
• Walking 
meditation
• Psycho-education 
“anxiety, anger and 
depression, helping and 
non-helping thoughts”
• Sitting meditation
• Mindful communication 
exercise
• 3-minute breathing space
• Walking meditation
6. Mindful 
communication
• Movement 
exercises standing 
up
• 3-minute 
breathing space in 
stressful situations 
• Psycho-education 
“communication”
• Nonverbal (Aikido) and 
verbal (Deeply listening) 
communication 
exercises 
• Sitting meditation, movement 
exercises or body scan
• 3-minute breathing space
• Walking meditation
Silence day • Various exercises
• Silent lunch and 
tea breaks
7. Taking care of 
yourself
• Sitting meditation, 
open awareness
• 3-minute 
breathing space
• Energy balance and 
relapse prevention
• Mindful exercise at will
• Relapse prevention plan
• 3-minute breathing space
8. From stress to 
inner strength
• Body scan • Training evaluation and 
looking forward
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Effect predictors
Presence of DSM-IV Axis I mood/anxiety disorders is assessed by the SCID-I [44] 
which is a structured clinical interview. The interviewer rates answers on standardized 
questions during the interview on a scoring form. Subsequently, the presence or 
absence of symptoms is assessed. The SCID-I is administered by trained interviewers. An 
experienced psychiatrist (EBI) supervises the administration of the SCID-I. In the current 
study, neuroticism is assessed with the NEO Five Factor Inventory.[45] A shorter version 
of the Revised NEO Personality Inventory (NEO-PI-R), the NEO-FFI has 60 items (12 per 
domain) derived from the original 240 items. The five factor domains assessed by this 
measure are neuroticism, extraversion, openness to experience, agreeableness, and 
conscientiousness. The psychometric properties of the Dutch NEO-FFI are good.[46]
Process measures
Mindfulness skills
Mindfulness skills are assessed with the 24-item Five Facet Mindfulness Questionnaire 
Short Form (FFMQ-SF). The FFMQ consists of five subscales: observing, describing, acting 
with awareness, non-judging of inner experience and non-reactivity to inner experience. 
The FFMQ is sensitive to change in mindfulness-based interventions (e.g. [21]). A Dutch 
24-item short form of the FFMQ (FFMQ-SF) was developed and assessed in a sample 
of 376 adults with clinically relevant symptoms of depression and anxiety and cross-
validated in an independent sample of patients with fibromyalgia.[47] The FFMQ-SF was 
positively related to well-being and openness to experience and inversely related to 
measures of psychological symptoms, experiential avoidance, and neuroticism.
In addition, in both group and Internet-based MBCT the following process measures 
are administered at the start of each weekly session in order to determine processes of 
change during both interventions. In the group MBCT they are handed out in paper by 
the teacher, in the Internet-based MBCT intervention they are provided online at the 
beginning of a new training week. The Mindful Attention Awareness Scale (MAAS; [48]) 
is administered weekly to assess mindful attention in daily life. The MAAS has been shown 
to have an similar factor structure in cancer patients as in the general population.[49] 
Chronbach’s alpha for the Dutch version ranged between .82 and .87.[50] Positive and 
negative affect is assessed weekly using the International Positive and Negative Affect 
Scale - Short Form I-PANAS-SF). The crosscultural factorial invariance, internal reliability, 
temporal stability, and convergent and criterion-related validities of the I-PANAS-SF 
were found to be acceptable.[51]
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Working alliance
Working alliance is measured with a translated and shortened form of the Working 
Alliance Inventory (WAI; [52]), consisting of three subscales assessing: 1) how closely 
client and therapist agree on and are mutually engaged in the goals of treatment, 2) 
how closely client and therapist agree on how to reach the treatment goals, and 3) 
the degree of mutual trust, acceptance, and confidence between client and therapist. 
Patients score on a 5-point scale ranging from rarely to always.[53, 54] The 12-item 
inventory was validated in a Dutch-speaking sample and a recent study showed that 
internal consistency of the short form was >.80 for all separate subscales and .87 for the 
total.[55] The WAI is administered before session 2, 5 and 9.
Group cohesion
Self-reported group cohesion is assessed in the group MBCT condition with the Dutch 
Group Cohesion Questionnaire (GCQ) that has been used in cancer patients before.[56] 
The GCQ consists of four subscales: the bond with the group as whole, the bond with 
other members, cooperation within the group and the instrumental value of the group 
bond. Each item is rated from 1 (totally disagree) to 6 (totally agree). Internal consistency 
of all scales was reported to range from adequate to good (0.66–0.88).[57] The GCQ is 
administered before session 2, 5 and 9.
Adherence
Adherence is assessed during the entire treatment period with a calendar (both for 
group and Internet-based MBCT) on which participants fill out whether they adhere 
to both formal (e.g. the sitting meditation) and informal (e.g. 3-min breathing space) 
mindfulness exercises.
Semi-structured interviews
In order to more fully understand how interventions bring about change, it is important 
to complement quantitative research with qualitative research.[58] For this reason 
participants’ views on barriers and facilitators of the Internet-based MBCT are explored 
in more detail by conducting semi-structured interviews in a purposive sample of 
participants in the trial.
Statistics
Sample size
Based on post treatment HADS scores within the routine outcome data of cancer patients 
who received mindfulness at the Helen Dowling Institute, we expected post treatment 
HADS scores of 10.6 (SD=6.4) in the MBCT interventions and 14.8 (SD=8.1) in the TAU 
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condition. In the power calculation we ignored the dependency caused by the therapy 
groups, which has been found in previous research to be small.[59] As we compare both 
group and Internet-based MBCT to TAU, we corrected the corresponding alpha level to 
0.025. Assuming a power of 0.9, a sample size of 65 per condition is needed. Taking an 
estimated expected dropout rate of 15% in the group MBCT and TAU and 30% in the 
Internet-based MBCT into account, we aim to recruit 76 participants in the group MBCT 
and TAU conditions and 93 in the Internet-based MBCT, thus 245 patients in total.
Statistical analysis
All analyses are carried out using the intention to treat and per protocol samples. The 
primary analysis is aimed at showing superiority of group MBCT and Internet-based 
MBCT compared to TAU in terms of psychological distress directly post treatment in 
the intention to treat sample. Secondary analyses of the stability of the treatment effect 
are conducted using the data from the assessments at 3 and 9 months post-treatment, 
using linear mixed models to control for possible dependency caused by the repeated 
measurements.
We will use the bootstrapping procedure as it provides the most powerful and 
reasonable method of obtaining confidence limits for specific indirect effects under most 
conditions.[60] In all mediation analyses, post-treatment HADS scores are controlled for 
baseline HADS scores. Residual change scores for all potential mediators are calculated.
[61] To explore whether the mediators (partly) affect the relation of condition on post-
treatment symptom levels, the model including the potential mediators is compared 
with the model without mediators for both univariate and multivariate models. 
Subsequently, 95% bias corrected and accelerated confidence intervals (95% CI) [62] 
are calculated to explore the contribution of each individual mediator and the group of 
mediators in total.
Cost-effectiveness
The economic evaluation is based on the general principles of a cost-utility analysis and 
is performed alongside the clinical trial which compares three alternatives: 1) group 
MBCT; 2) Internet-based MBCT, and 3) TAU. Primary outcome measures for the economic 
evaluation are: costs (here we follow the Dutch guidelines for costing research [39]) 
and quality adjusted life years (QALY) measured by the EQ-5D. Secondary analyses 
will explore the possible differences in outcome with HrQoL measured by SF-12. The 
societal perspective is operationalised by including productivity losses/gains applying 
the friction cost method on a per patient basis by means of the TiC-P.[38]
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The incremental cost-effectiveness ratio (ICER) “cost per Quality-Adjusted Life Year (QALY) 
gained” based on EQ-5D utilities according to the Dutch algorithm [41] is computed and 
uncertainty surrounding these parameters is determined using the bootstrap method 
(dealing with potential skewness in the distributions). A cost-effectiveness acceptability 
curve will be derived that is able to evaluate efficiency by using a range of thresholds 
(Willingness To Pay for a QALY gained). The impact of uncertainty surrounding relevant 
deterministic parameters on the ICER is subsequently explored using one-way sensitivity 
analyses on the range of extremes.
The cost analysis exists of two main parts. First, on patient level, volumes of care is 
measured using patient questionnaires. Per arm (intervention and control groups) full 
cost-prices are determined using activity based costing. The second part of the cost 
analysis consists of determining the cost prices for each volume of consumption in 
order to use these for multiplying the volumes registered for each participating patient. 
The Dutch guidelines for cost analyses are used with regard to prices.[39] For units of 
care/resources where no guideline or standard prices are available real cost prices are 
determined.
DISCUSSION
A significant proportion of cancer patients suffers from psychological distress and is in 
need of appropriate psychological treatment.[4] An increase in the number of patients 
who will have to deal with the consequences of having cancer is to be expected [2, 
3], which calls for more widely accessible and effective psychosocial treatment. 
Mindfulness-based treatment has proven to be effective in reducing psychological 
distress in cancer patients.[8]  
Providing Internet-based mindfulness could hold promise in terms of increasing 
accessibility: patients do not have to travel and treatment planning is more flexible 
in the light of individual circumstances. Therefore, the current trial investigates the 
effectiveness in reducing psychological distress of both group- and Internet-based 
MBCT compared to TAU.
Furthermore, although the need of cost-effectiveness evaluations of psycho-oncological 
interventions has long been recognized [63], information on the cost-effectiveness of 
mindfulness interventions is largely absent. In addition to the clinical effectiveness, 
the current trial also investigates cost-effectiveness of both group- and Internet-based 
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MBCT interventions compared to TAU. We hope that our trial provides further insight 
into the accessibility, effectiveness and cost-effectiveness of group and Internet-based 
MBCT in the reduction of psychological distress in patients with cancer.
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LIST OF ABBREVIATIONS
TAU Treatment as Usual
CBT Cognitive Behavioral Therapy
ES Effect Size
MBCT Mindfulness-Based Cognitive Therapy
MBSR Mindfulness-Based Stress Reduction
HADS Hospital Anxiety and Depression Scale
MAAS Mindful Attention and Awareness Scale
I-PANAS-SF International Positive and Negative Affect Scale Short Form
SCID-I Structural Clinical Interview for DSM-IV Axis I Disorders
TiC-P and iMTA questionnaire for Costs associated with Psychiatric illnesses
MBI-TAC Mindfulness-Based Interventions – Teacher Assessment Criteria
FCRI Fear of Cancer Recurrence Inventory
MHC-SF Mental Health Continuum – Short Form
EQ-5D EuroQol-5 Dimensions
SF-12 Short-Form-12
NEO-FFI NEO-Five Factor Inventory
NEO-PI-R NEO-Personality Inventory-Revised
FFMQ-SF Five Factor Mindfulness Questionnaire – Short Form
WAI Working Alliance Inventory
GCQ Group Cohesion Questionnaire
ICER Incremental Cost Effectiveness Ratio
QALY Quality Adjusted Life Year
67
Comparing group- and Internet-based Mindfulness-Based Cognitive Therapy with Treatment as Usual: study protocol
REFERENCES
1. OECD Health Policy Studies - Cancer Care: Assuring quality to improve survival. [pdf ] Last 
updated November 2013, Accessed May 7th 2015]; Available from: http://www.oecd.org/
els/health-systems/Focus-on-Health_Cancer-Care-2013.pdf.
2. KWF Kankerbestrijding, Kanker in Nederland tot 2020: Trends en prognoses. 2011.
3. Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, Meader N, Prevalence of 
depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-
care settings: a meta-analysis of 94 interview-based studies. The Lancet Oncology, 2011. 12(2): 
p. 160-174.
4. Mehnert A, Brähler E, Faller H, Härter M, Keller M, Schulz H, Wegscheider K, Weis J, Boehncke 
A, Hund B, Reuter K, Richard M, Sehner S, Sommerfeldt S, Szalai C, Wittchen H-U, Koch U, 
Four-Week Prevalence of Mental Disorders in Patients With Cancer Across Major Tumour Entities. 
Journal of Clinical Oncology, 2014. 32(31): p. 3540-3546.
5. Segal ZV, Williams JMG, Teasdale JD, Mindfulness-based cognitive therapy for depression: A 
new approach to relapse prevention. 2002, New York: Guilford Press.
6. Teasdale JD, Segal ZV, Williams JMG, Ridgeway VA, Soulsby JM, Lau MA, Prevention of relapse/
recurrence in major depression by mindfulness-based cognitive therapy. Journal of Consulting 
and Clinical Psychology, 2000. 68(4): p. 615-623.
7. Kabat-Zinn J, An Outpatient Program in Behavioral Medicine for Chronic Pain Patients Based 
on the Practice of Mindfulness Meditation - Theoretical Considerations and Preliminary-Results. 
General Hospital Psychiatry, 1982. 4(1): p. 33-47.
8. Piet J, Wurtzen H, Zachariae R, The Effect of Mindfulness-Based Therapy on Symptoms of Anxiety 
and Depression in Adult Cancer Patients and Survivors: A Systematic Review and Meta-Analysis. 
Journal of Consulting and Clinical Psychology, 2012. 80(6): p. 1007-1020.
9. Carlson LE, Doll R, Stephen J, Faris P, Tamagawa R, Drysdale E, Speca M, Randomized controlled 
trial of Mindfulness-based cancer recovery versus supportive expressive group therapy for 
distressed survivors of breast cancer. Journal of Clinical Oncology, 2013. 31(25): p. 3119-3126.
10. Van Beugen S, Ferwerda M, Hoeve D, Rovers MM, Spillekom-van Koulil S, van Middendorp 
H, Evers AW, Internet-Based Cognitive Behavioral Therapy for Patients With Chronic Somatic 
Conditions: A Meta-Analytic Review. Journal of Medical Internet Research, 2014. 16(3): p. e88.
11. Andersson E, Ljótsson B, Smit F, Paxling B, Hedman E, Lindefors N, Andersson G, Rück C, Cost-
effectiveness of internet-based cognitive behavior therapy for irritable bowel syndrome: results 
from a randomized controlled trial. BMC Public Health, 2011. 11(1): p. 215.
12. Van Os-Medendorp H, Koffijberg H, Eland-de Kok PCM, van der Zalm A, de Bruin-Weller MS, 
Pasmans SGMA, Ros WJG, Thio HB, Knol MJ, Bruijnzeel-Koomen CAFM, E-health in caring for 
patients with atopic dermatitis: a randomized controlled cost-effectiveness study of internet-
guided monitoring and online self-management training. British Journal of Dermatology, 
2012. 166(5): p. 1060-1068.
68
Chapter 3
13. Cavanagh K, Strauss C, Cicconi F, Griffiths N, Wyper A, Jones F, A randomised controlled trial of 
a brief online mindfulness-based intervention. Behavioural Research and Therapy, 2013. 51(9): 
p. 573-578.
14. Morledge TJ, Allexandre D, Fox E, Fu AZ, Higashi MK, Kruzikas DT, Pham SV, Reese PR, Feasibility 
of an Online Mindfulness Program for Stress Management—A Randomized, Controlled Trial. 
Annals of Behavioral Medicine, 2013: 46(2): p. 137-148.
15. Krusche A, Cyhlarova E, King S, Williams JMG, Mindfulness online: a preliminary evaluation of 
the feasibility of a web-based mindfulness course and the impact on stress. BMJ Open, 2012. 
2(3).
16. Zernicke KA, Campbell TS, Speca M, McCabe-Ruff K, Flowers S, Carlson LE, A Randomized Wait-
List Controlled Trial of Feasibility and Efficacy of an Online Mindfulness–Based Cancer Recovery 
Program: The eTherapy for Cancer Applying Mindfulness Trial. Psychosomatic Medicine, 2014. 
76(4): p. 257-267.
17. Wangberg SC, Bergmo TS, Johnsen JA, Adherence in Internet-based interventions. Patient 
preference and adherence, 2008. 2: p. 57-65.
18. Eysenbach G, Issues in evaluating health websites in an Internet-based randomized controlled 
trial. Journal of Medical Internet Research, 2002. 4(3): p. E17.
19. Everts FZB, van der Lee ML, de Jager Meezenbroek E, Web-based individual Mindfulness-Based 
Cognitive Therapy for cancer-related fatigue—A pilot study. Internet Interventions, 2015. 2(2): 
p. 200-213.
20. Ogrodniczuk JS, Piper WE, Joyce AS, McCallum M, Rosie JS, NEO-five factor personality traits 
as predictors of response to two forms of group psychotherapy. International Journal of Group 
Psychotherapy, 2003. 53(4): p. 417-442.
21. Gu J, Strauss C, Bond R, Cavanagh K, How do mindfulness-based cognitive therapy and 
mindfulness-based stress reduction improve mental health and wellbeing? A systematic review 
and meta-analysis of mediation studies. Clinical Psychology Review, 2015. 37: p. 1-12.
22. Cook JE, Doyle C, Working alliance in online therapy as compared to face-to-face therapy: 
Preliminary results. CyberPsychology & Behavior, 2002. 5(2): p. 95-105.
23. Segal ZV, Williams JMG, Teasdale JD, Mindfulness-based cognitive therapy for depression. 2012: 
Guilford Press.
24. UK Network for Mindfulness-Based Teachers Good practice guidelines for teaching mindfulness-
based courses. 2011:[Available from: http://mindfulnessteachersuk.org.uk/pdf/teacher-
guidelines.pdf ].
25. Crane RS, Kuyken W, Williams JMG, Hastings RP, Cooper L, Fennell MJV, Competence in 
Teaching Mindfulness-Based Courses: Concepts, Development and Assessment. Mindfulness, 
2012. 3: p. 76-84.
26. Hambleton RK, Guidelines for Adapting Educational and Psychological Tests: A progress report. 
European Journal of Psychological Assessment, 1994. 10: p. 229-244.
27. Zigmond AS, Snaith RP, The hospital anxiety and depression scale. Acta Psychiatrica 
Scandinavica, 1983. 67(6): p. 361-370.
69
Comparing group- and Internet-based Mindfulness-Based Cognitive Therapy with Treatment as Usual: study protocol
28. Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM, A validation 
study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. 
Psychological Medicine, 1997. 27(2): p. 363-370.
29. Le Fevre P, Devereux J, Smith S, Lawrie SM, Cornbleet M, Screening for psychiatric illness in 
the palliative care inpatient setting: a comparison between the Hospital Anxiety and Depression 
Scale and the General Health Questionnaire-12. Palliative Medicine, 1999. 13(5): p. 399-407.
30. Akechi T, Okuyama T, Sugawara Y, Shima Y, Furukawa TA, Uchitomi Y, Screening for depression 
in terminally ill cancer patients in Japan. Journal of pain and symptom management, 2006. 
31(1): p. 5-12.
31. Bjelland I, Dahl AA, Haug TT, Neckelmann D, The validity of the Hospital Anxiety and Depression 
Scale: an updated literature review. Journal of Psychosomatic Research, 2002. 52(2): p. 69-77.
32. Herrmann C, International experiences with the Hospital Anxiety and Depression Scale-a review 
of validation data and clinical results. Journal of Psychosomatic Research, 1997. 42(1): p. 17-
41.
33. Simard S, Savard J, Fear of Cancer Recurrence Inventory: development and initial validation of a 
multidimensional measure of fear of cancer recurrence. Supportive Care in Cancer, 2009. 17(3): 
p. 241-251.
34. Trapnell PD, Campbell JD, Private self-consciousness and the five-factor model of personality: 
distinguishing rumination from reflection. Journal of Personality and Social Psychology, 1999. 
76(2): p. 284-304.
35. Luyckx K, Schwartz SJ, Berzonsky MD, Soenens B, Vansteenkiste M, Smits I, Goossens L, 
Capturing ruminative exploration: Extending the four-dimensional model of identity formation 
in late adolescence. Journal of Research in Personality, 2008. 42(1): p. 58-82.
36. Keyes CL, Mental illness and/or mental health? Investigating axioms of the complete state 
model of health. Journal of Consulting and Clinical Psychology, 2005. 73(3): p. 539-548.
37. Lamers S, Westerhof GJ, Bohlmeijer ET, ten Klooster PM, Keyes CL, Evaluating the psychometric 
properties of the mental health Continuum-Short Form (MHC-SF). Journal of Clinical Psychology, 
2011. 67(1): p. 99-110.
38. Hakkaart-van Roijen L, Straten Av, Tiemens B, Donker M, Handleiding Trimbos/iMTA 
questionnaire for Costs associated with Psychiatric illness (TiC-P). 2002, Institute of Medical 
Technology Assessment (iMTA).
39. Hakkaart-van Roijen L, Tan S, Bouwmans C, Handleiding voor kostenonderzoek: Methoden en 
standaard kostprijzen voor economische evaluaties in de gezondheidszorg. 2010: College voor 
zorgverzekeringen.
40. The EuroQol Group, EuroQol--a new facility for the measurement of health-related quality of 
life. The EuroQol Group. Health Policy, 1990. 16(3): p. 199-208.
41. Lamers L, Stalmeier P, McDonnell J, Krabbe P, Van Busschbach J, Kwaliteit van leven 
meten in economische evaluaties: het Nederlands EQ-5D-tarief. Nederlands tijdschrift voor 
geneeskunde, 2005. 149(28): p. 1574-1578.
42. Ware Jr JE, Kosinski M, Keller SD, A 12-Item Short-Form Health Survey: construction of scales 
and preliminary tests of reliability and validity. Medical care, 1996. 34(3): p. 220-233.
70
Chapter 3
43. Johnson JA, Coons SJ, Comparison of the EQ-5D and SF-12 in an adult US sample. Quality of 
Life Research, 1998. 7(2): p. 155-166.
44. First MB, Spitzer RL, Gibbon M, Williams JB, Structured Clinical Interview for DSM-IV® Axis I 
Disorders (SCID-I), Clinician Version, Administration Booklet. 2012: American Psychiatric Pub.
45. Costa PT, McCrae RR, Normal personality assessment in clinical practice: the NEO Personality 
Inventory. Psychological assessment, 1992. 4(1): p. 5-13.
46. Hoekstra HA, Ormel J, de Fruyt F, Handleiding NEO Persoonlijkheids-vragenlijsten NEO-PI-R en 
NEO-FFI. 1996, Lisse, The Netherlands: Swets Test Services.
47. Bohlmeijer E, Peter M, Fledderus M, Veehof M, Baer R, Psychometric properties of the Five Facet 
Mindfulness Questionnaire in depressed adults and development of a short form. Assessment, 
2011. 18(3): p. 308-320.
48. Brown KW, Ryan RM, The benefits of being present: Mindfulness and its role in psychological 
well-being. Journal of Personality and Social Psychology, 2003. 84: p. 822-848.
49. Carlson LE, Brown KW, Validation of the Mindful Attention Awareness Scale in a cancer 
population. Journal of Psychosomatic Research, 2005. 58(1): p. 29-33.
50. Schroevers M, Nykliček I, Topman R, Validatie van de nederlandstalige versie van de Mindful 
Attention Awareness Scale (MAAS). Gedragstherapie, 2008. 1(3): p. 225-240.
51. Thompson ER, Development and validation of an internationally reliable short-form of the 
positive and negative affect schedule (PANAS). Journal of Cross-Cultural Psychology, 2007. 
38(2): p. 227-242.
52. Horvath AO, Greenberg LS, Development and validation of the Working Alliance Inventory. 
Journal of Counseling Psychology, 1989. 36(2): p. 223-233.
53. Stinckens N, Ulburghs A, Claes L, De werkalliantie als sleutelelement in het therapiegebeuren: 
Meting met behulp van de WAV-12, de Nederlandstalige verkorte versie van de Working Alliance 
Inventory. Tijdschrift voor klinische psychologie, 2009. 39: p. 44-60.
54. Hatcher RL, Gillaspy JA, Development and validation of a revised short version of the Working 
Alliance Inventory. Psychotherapy Research, 2006. 16(1): p. 12-25.
55. Janse P, Boezen-Hilberdink L, van Dijk MK, Verbraak MJPM, Hutschemaekers GJM, Measuring 
feedback from clients: The psychometric properties of the Dutch Outcome Rating Scale and 
Session Rating Scale. European journal of psychological assessment, 2014. 30(2): p. 86-92.
56. May AM, Duivenvoorden HJ, Korstjens I, van Weert E, Hoekstra‐Weebers JE, van den Borne B, 
Mesters I, van der Schans CP, Ros WJ, The effect of group cohesion on rehabilitation outcome in 
cancer survivors. Psycho‐Oncology, 2008. 17(9): p. 917-925.
57. Trijsburg R, Bogaerds H, Letiche M, Bidzjel L, Duivenvoorden H, De ontwikkeling van de Group 
Cohesion Questionnaire (GCQ). 2004: Universiteit van Amsterdam/ Erasmus Universiteit 
Rotterdam: Amsterdam/ Rotterdam.
58. Shennan C, Payne S, Fenlon D, What is the evidence for the use of mindfulness-based 
interventions in cancer care? A review. Psycho-Oncology, 2011. 20(7): p. 681-697.
71
Comparing group- and Internet-based Mindfulness-Based Cognitive Therapy with Treatment as Usual: study protocol
59. Van Aalderen J, Donders A, Giommi F, Spinhoven P, Barendregt H, Speckens A, The efficacy of 
mindfulness-based cognitive therapy in recurrent depressed patients with and without a current 
depressive episode: a randomized controlled trial. Psychological Medicine, 2012. 42(5): p. 989-
1001.
60. Preacher KJ, Hayes AF, Asymptotic and resampling strategies for assessing and comparing 
indirect effects in multiple mediator models. Behavioural Research Methods, 2008. 40(3): p. 
879-891.
61. MacKinnon DP, Introduction to Statistical Mediation Analysis. 2008: Erlbaum Psych Press: 
London.
62. Efron B, Better bootstrap confidence intervals. Journal of the American statistical Association, 
1987. 82(397): p. 171-185.
63. Carlson LE, Bultz BD, Efficacy and medical cost offset of psychosocial interventions in cancer 
care: making the case for economic analyses. Psycho-Oncology, 2004. 13(12): p. 837-49.

Chapter 4
Face-to-Face and Internet-Based Mindfulness-
Based Cognitive Therapy Compared With 
Treatment as Usual in Reducing Psychological 
Distress in Patients With Cancer:  
A Multicenter Randomized Controlled Trial
Journal of Clinical Oncology 2018; 36(23): 2413-2421
74
Chapter 4
ABSTRACT
Purpose
Mindfulness-based cognitive therapy (MBCT) has been shown to alleviate psychological 
distress in patients with cancer. However, patients experience barriers to participating 
in face-to-face MBCT. Individual Internet-based MBCT (eMBCT) could be an alternative. 
The study aim was to compare MBCT and eMBCT with treatment as usual (TAU) for 
psychological distress in patients with cancer.
Patients and Methods
We obtained ethical and safety approval to include 245 patients with cancer with 
psychological distress (≥11 on the Hospital Anxiety and Depression Scale) in the study. 
They were randomly allocated to MBCT (n=77), eMBCT (n=90), or TAU (n=78). Patients 
completed baseline (T0) and postintervention (T1) assessments. The primary outcome 
was psychological distress on the Hospital Anxiety and Depression Scale. Secondary 
outcomes were psychiatric diagnosis, fear of cancer recurrence, rumination, health-
related quality of life, mindfulness skills, and positive mental health. Continuous 
outcomes were analyzed using linear mixed modeling on the intention-to-treat sample. 
Because both interventions were compared with TAU, the type I error rate was set at p< 
.025.
Results
Compared with TAU, patients reported signiﬁcantly less psychological distress after 
both MBCT (Cohen’s d, .45; p<.001) and eMBCT (Cohen’s d, .71; p< .001) . In addition, 
post-treatment prevalence of psychiatric diagnosis was lower with both MBCT (33% 
improvement; p=.030) and eMBCT (29% improvement; p=.076) in comparison with TAU 
(16%), but these changes were not statistically signiﬁcant. Both interventions reduced 
fear of cancer recurrence and rumination, and increased mental health–related quality 
of life, mindfulness skills, and positive mental health compared with TAU (all ps , .025). 
Physical health–related quality of life did not improve (p=.343).
Conclusion
Compared with TAU, MBCT and eMBCT were similarly effective in reducing psychological 
distress in a sample of distressed heterogeneous patients with cancer.
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INTRODUCTION
From 2025 onward, 20 million people worldwide will be diagnosed with cancer each year.
[1] Approximately one third of patients with cancer suffer from signiﬁcant psychological 
distress[2], resulting in reduced quality of life, decreased compliance with medical care, 
and prolonged duration of hospital stay.[3,4] The prevalence of psychiatric disorders in 
oncologic settings is 30% to 40%.[3] Effective and accessible interventions are needed 
to reduce psychological distress and psychiatric disorders in patients with cancer.
Mindfulness-based interventions (MBIs)[5,6] such as mindfulness-based cognitive 
therapy (MBCT) teach participants to be more mindful in daily life through meditation 
exercises, yoga, group discussions, and didactic teaching.[5] A 2012 meta-analysis of 
randomized controlled trials (RCTs) of MBIs in 955 patients with cancer found signiﬁcant 
improvements in depressive and anxiety symptoms.[7] Since then, a number of RCTs 
have conﬁrmed this.[8-13]
However, because MBIs typically require in-person attendance at classes over several 
weeks, many patients with cancer experience barriers to participation. These may 
include impairments due to illness and anticancer treatments, adverse effects that result 
in advice to avoid groups of people, or limited transportation options.[14] Consequently, 
uptake of face-to-face interventions for patients with cancer has been lower than, for 
instance, telephone- based interventions.[15]
In contrast, Internet-based interventions are easily accessible and save travelling time.
[16] Therapist-guided Internet interventions have been shown to be effective for 
psychiatric and somatic conditions.[17] Although evidence for Internet-based MBIs 
(eMBIs) in cancer is scarce, one controlled study of 62 patients found that synchronous 
videoconferencing sessions led to signiﬁcant improvements in mood, stress symptoms, 
and mindfulness skills.[18] In addition, an uncontrolled cohort of 257 fatigued patients 
showed signiﬁcant improvements in fatigue and psychological distress after individual 
eMBCT.[19]
To date, no study has simultaneously compared the effectiveness of both MBCT and 
Internet-based MBCT (eMBCT) with treatment as usual (TAU). The primary aim of this 
RCT was to investigate whether MBCT and eMBCT were each superior to TAU in reducing 
psychological distress in a sample of distressed patients with cancer. Moreover, we 
hypothesized that there would be a reduction of psychiatric diagnoses, fear of cancer 
recurrence, and rumination, and an improvement in health-related quality of life, 
mindfulness skills, and positive mental health in both interventions compared with TAU. 
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We explored moderators of intervention dropout and outcome in the interventions: sex, 
age, cancer diagnosis, anticancer treatment intent, psychiatric diagnosis, neuroticism, 
and therapist.
PATIENTS AND METHODS
Trial Design
A three-armed multicenter, parallel group RCT was conducted to compare the 
effectiveness of MBCT and eMBCT with TAU in reducing psychological distress in 
patients with cancer. Anticipated dropout rates were 15% in MBCT and TAU, and 30% in 
eMBCT.[19] Given the anticipated dropout rates, the allocation ratio was 1:1.2:1. Patients 
randomly assigned to receive TAU were secondarily randomly assigned to MBCT or 
eMBCT, to be given after the TAU period of 3 months. The study was approved by the 
ethical review board of the Radboud University Medical Center (CMO Arnhem-Nijmegen 
2013/542). All centers provided local ethics approval. The study was registered on 
Clinicaltrials.gov (NCT02138513) shortly afterthe start of recruitment and was reported 
following CONSORT guidelines.[20] A protocol article was published in advance of trial 
completion.[21]
Participants
Inclusion criteria were (1) a cancer diagnosis, any tumour type or stage, at any time, 
receiving or not receiving treatment; (2) a score of 11on the Hospital Anxiety and 
Depression Scale (HADS); (3) computer literacy and Internet access; (4) ability to 
participate in both MBCT and eMBCT; and (5) good command of the Dutch language. 
Exclusion criteria were (1) severe psychiatric morbidity, such as suicidal ideation and/or 
current psychosis; (2) change in psychotropic medication within a period of 3 months 
before baseline; and (3) previous participation in four or more sessions of an MBI.
Procedure
Patients were recruited from April 2014 to December 2015 via healthcare professionals 
in six centers (n=64; 26%) via online media (n=49; 20%), ofﬂine media (n=44; 18%), 
patient associations (n=43; 18%), and peers (n=27; 11%). Eighteen patients (7%) could 
not remember how they heard about the study. Interested patients ﬁlled out the HADS 
on the research Web site. Patients with HADS ≥11 received a phone call from one of the 
researchers, during which the remaining inclusion and exclusion criteria were assessed. 
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Once patients provided oral and written consent and had completed the baseline 
assessment, they were randomly assigned to MBCT, eMBCT, or TAU and informed about 
their allocation by E.B.
Intervention
Face-to-face MBCT
The MBCT protocol [6] was tailored to patients with cancer by including cancer-
related psycho-education and adapted movement exercises. The MBCT consisted 
of eight weekly 2.5-hour group sessions, a 6-hour silent day, and daily home practice 
assignments guided by audio ﬁles. Each participant in both interventions received a 
folder with information on each session.
Internet-based Mindfulness-based cognitive therapy
The eMBCT was delivered individually and included weekly asynchronous written in- 
teraction with a therapist over e-mail. Patients were granted access to a secure Web site 
containing material for 8 weeks plus a silent day and an inbox. Each session included an 
introduction and daily meditation exercises with meditation audio ﬁles. Patients were 
asked to practice and ﬁll out practice diaries on a daily basis. They were provided with 
(ﬁctional) patients’ descriptions to emphasize common experiences and clarify the use 
of the diaries. Patients were given written instructions after week 5 to prepare for their 
silent day at home. In the week of the silent day, patients were provided with a program 
similar to the MBCT silent day. At the end of the silent day, eMBCT patients wrote about 
their experiences in an essay. The therapist provided written feedback on the completed 
forms and the essay via the secured inbox on a prearranged day of the week. Having 
completed four or more sessions of MBCT was deﬁned as a minimum adequate dose in 
both interventions.[22]
Treatment as usual
TAU consisted of all healthcare that patients usually received. Except for not participating 
in MBIs during the study period, there were no restrictions on healthcare utilization. 
Data on healthcare utilization were gathered using the Trimbos/iMTA questionnaire for 
Costs associated with Psychiatric illnesses.[23]
Therapists
Fourteen therapists participated: seven provided both interventions, two only provided 
MBCT, and ﬁve only provided eMBCT. All therapists fulﬁlled the criteria of the UK 
Mindfulness-Based Teacher Therapist Network Good Practice Guidelines for Teaching 
MBIs. [24] supervision meetings were held during the intervention phase of the trial. 
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All face-to-face MBCT sessions were videotaped to evaluate therapist competency 
using the Mindfulness-Based Interventions-Teachers Assessment Criteria.[25] Therapist 
competency levels were determined by two independent therapists who evaluated two 
random sessions from each of the nine therapists providing face-to-face MBCT (who 
treated 80.8% of all patients receiving either intervention). Interrater reliability was 
.72. Of the nine therapists rated, four were considered proﬁcient (n=64 patients), three 
were considered competent (n=64 patients), and two were considered beginner (n=7 
patients).
Measures
Primary outcome
Psychological distress was measured with the HADS, a 14-item self-report scale 
designed to assess anxiety and depression in medical outpatients.[26,27] It has good 
psychometric properties in the general medical population, including patients with 
cancer in palliative care.[28] The internal consistency in this sample was high (α = .87).
Secondary Outcomes
Psychiatric diagnosis was assessed by the SCID-I.[29] The SCID-I was administered by 
trained interviewers following or having completed a Master in Behavioral Science (FC), 
supervised by either an experienced psychiatrist (EB and AS) or psychologist (ML). All 
interviews were audio taped. Fear of cancer recurrence was assessed with the severity 
subscale of the Fear of Cancer Recurrence Inventory (FCRI).[30, 31] Rumination was 
measured by the rumination subscale of the Rumination and Reflection Questionnaire 
(RRQ)[32], health-related quality of life by the mental and physical scales of the Short-
Form 12 (SF-12)[33] using Dutch norm scores from a clinical sample[34], mindfulness 
skills by the Five Facet Mindfulness Questionnaire Short Form (FFMQ-SF)[35] and positive 
mental health by the Mental Health Continuum-Short Form (MHC-SF).[36] As a potential 
moderator, neuroticism was measured by the Neuroticism Extraversion Openness-Five 
Factor Inventory (NEO-FFI).[37] Further details of the measures used are included in the 
study protocol.[21]
Sample size 
The sample size calculation was based on previous post-intervention HADS scores of 
cancer patients who received MBCT at the Helen Dowling Institute (M=10.6, SD=6.4) 
compared to those who had not (M=14.8, SD=8.1). With 90% power, n=65 patients 
per condition were needed. Due to anticipated differential dropout rates between 
treatment arms, the recruitment target was n=245: n=76 in each of MBCT and TAU, and 
n=93 in eMBCT.
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Randomization and blinding
Once patients provided oral and written consent and completed the baseline 
assessment, they were randomized to MBCT, eMBCT or TAU by a computer-generated 
allocation sequence designed by an independent biostatistician. This custom software 
was accessed by researcher EB via a study-specific website. Randomization was carried 
out with a fixed block size of sixteen stratified for region and minimized for sex, cancer 
diagnosis (breast vs. other) and anticancer treatment intent (curative vs. palliative). 
After randomization, EB informed patients of their allocation by email. EB planned 
and invited participants for the follow-up assessments, the standardised psychiatric 
interviews were conducted by FC and research assistants who were blind to treatment 
allocation. Both EB and FC instructed patients not to mention their treatment condition 
at the beginning of each psychiatric interview.
Statistical analysis
Statistical analyses were carried out using SPSS22 (IBM). Differences between conditions 
in demographic and clinical variables were tested by chi-square analysis and t-tests. 
Continuous outcomes were analyzed with linear mixed modeling in a model with 
uncorrelated residual errors and random intercepts, including group allocation and its 
interaction with time and stratification (region) and minimization (sex, cancer diagnosis, 
anticancer treatment intent) variables as fixed factors. Since both MBCT and eMBCT 
were compared to TAU, the two-sided type I error rate was corrected to .025 for the two 
direct (e)MBCT comparisons with TAU. All reported analyses used the Intent-To-Treat 
(ITT) sample. Missing continuous outcomes were imputed with Automatic Multiple 
Imputation (MI) on basis of linear regression (20 iterations). The multiple imputation-
dataset was considered the primary dataset. Cohen’s d effect size (ES) were calculated 
using post-intervention means and baseline pooled SD’s. These statistics are commonly 
used in psychological contexts to compare effect sizes across studies[38] and in 
accordance with Cohens’ guidelines, Cohens’s d effect sizes were interpreted as small 
(0.2 to 0.5), medium (0.5 to 0.8) or large (>0.8).[39]
In addition, the Reliable Change Index (RCI) was calculated by dividing the observed 
difference score by the standard error of measurement. Each participant was categorized 
as improved (RCI <-1.96), no change (-1.96 to 1.96) or deteriorated (RCI >1.96).[40] 
Improvements in terms of psychiatric diagnosis and RCI were assessed using chi-square 
analyses.
Exploratory moderation analyses of dropout were done using logistic regression 
including an interaction term between completer (yes/no) and possible moderators: 
80
Chapter 4
sex, age, cancer diagnosis, anticancer treatment intent, psychiatric diagnosis, 
neuroticism, and therapist. Exploratory moderation analyses of the primary outcome 
were done by including a three-way interaction term between condition, time and 
possible moderators: sex, age, cancer diagnosis, anticancer treatment intent, psychiatric 
diagnosis, neuroticism, and therapist. First, moderators were assessed in two separate 
analyses of either intervention compared to TAU. Second, moderators were assessed in 
analyses of the two intervention conditions only.
RESULTS
Study sample
In total, 532 patients were screened with the HADS (see Figure 1), of which 98 (18.4%) 
were excluded for scoring below 11. Of 434 patients who were contacted by telephone, 
24 (5.5%) were excluded because of previous experience with mindfulness, 22 (5.1%) 
could not be contacted and 95 (21.9%) declined participation due to possible travelling 
distance (55, 12.7%), strong randomization preference (12 (2.8%), of which 4 had a 
preference for eMBCT and 8 for in-person group MBCT, and scheduling difficulties (11, 
2.5%). Of the remaining 293 patients, another 10 (3.4%) could not be contacted and 38 
(13.0%) declined participation after the baseline assessment. There were no significant 
differences in mean HADS scores between the 133 decliners (M=20.4, SD=5.6) and those 
who were randomized (M=20.6, SD=6.2). In total, 245 cancer patients were randomly 
assigned to MBCT (n=77), eMBCT (n=90) or TAU (n=78). The three conditions did not 
differ in terms of baseline demographic or clinical characteristics (see Table 1). The 
number of months between baseline and post-intervention assessments did not differ 
between MBCT (M=5.4, SD=2.3) and eMBCT (M=5.9, SD=1.8) (p =.13), but was higher in 
both intervention conditions than in TAU (M=3.5, SD=0.9) (p <.001).
Seventy out of 77 (90.9%) patients started MBCT and 71 (%) completed four or more 
sessions (M=7.9, SD=1.3) (see Figure 1). Eighty-two out of 90 (91.1%) patients started 
eMBCT and 71 completed four or more session (M=8.6, SD=12). The amount of 
estimated daily minutes of mindfulness practice did not differ significantly between 
MBCT (n=56, M=30.6, SD=26.0) and eMBCT (n=70, M=28.7, SD=29.3) (p = .69). Dropouts 
from the interventions were significantly higher in the eMBCT than in the MBCT group: 
(χ2(1, n=167) = 3.92, p = .047). Non-response on the post-treatment assessment was 
substantial (16.9% in MBCT, 16.7% in eMBCT and 10.3% in TAU) but did not differ 
significantly between conditions (p = .41). Non-responders were more often female 
(p=.033) and had less education (p=.037) than responders.
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TABLE 1: Baseline Sociodemographic and Clinical Characteristics (n=245).
Characteristic
All
n=245 n (%)
MBCT
n=77 n (%)
eMBCT
n=90 n (%)
TAU
n=78 n (%) p
Sex .912
Female 210 (85.7) 67 (87.0) 77 (85.6) 66 (84.6)
Male 35 (14.3) 10 (13.0) 13 (14.4) 12 (15.4)
Age, years .464
Mean 51.7 52.1 52.4 50.4
SD 10.7 11.4 10.7 9.9
Married / in a relationship .491
Yes 202 (82.4) 65 (84.4) 76 (84.4) 61 (78.2)
No 43 (17.6) 12 (15.6) 14 (15.6) 17 (21.8)
Children .314
Yes 169 (69.0) 48 (62.3) 65 (72.2) 56 (71.8)
No 76 (31.0) 29 (37.7) 25 (27.8) 22 (28.2)
Education  .451
High 166 (67.8) 54 (70.1) 56 (62.2) 56 (71.8)
Middle 77 (31.4) 22 (28.6) 34 (37.8) 21(26.9)
Low 2 (0.8) 1 (1.3) 0 1(1.3)
Diagnosis  .724
Breast cancer 151 (61.6) 53 (68.8) 53(58.9) 45 (57.7)
Gynecological cancer 18 (7.3) 2 (2.6) 9 (10.0) 7 (9.0)
Prostate cancer  16 (6.5) 6 (7.8) 7 (7.8) 3 (3.8)
Colon cancer 12 (4.9) 4 (5.2) 4 (4.4) 4 (5.1)
Non-hodgkin’s lymphoma 11 (4.5) 1 (1.3) 3 (3.3) 7 (9.0)
Skin cancer 5 (2.0) 1 (1.3) 3 (3.3) 1 (1.3)
Thyroid cancer 4 (1.6) 1 (1.3) 1 (1.1) 2 (2.6)
Bladder cancer 4 (1.6) 1 (1.3) 2 (2.2) 1(1.3)
Neuroendocrine tumour 4 (1.6) 1 (1.3) 2 (2.2) 1 (1.3)
Other 20 (8.2) 7 (9.1) 6 (6.7) 7 (9.0)
Years since diagnosis .616
Mean 3.5 3.9 3.3 3.2
SD 4.7 5.7 4.0 4.3
Anticancer treatment intent .472
Curative 206 (84.1) 68 (88.3) 74 (82.2) 64 (82.1)
Palliative 39 (15.9) 9 (11.7) 16 (17.8) 14 (17.9)
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TABLE 1: Continued.
Characteristic
All
n=245 n (%)
MBCT
n=77 n (%)
eMBCT
n=90 n (%)
TAU
n=78 n (%) p
Current treatment .694
None 133 (53.1) 43 (55.8) 49 (54.4) 41 (52.6)
Hormone therapy 79 (32.2) 22 (28.6) 28 (31.1) 29 (37.2)
Combination of treatments 12 (4.9) 4 (5.2) 4 (4.4) 4 (5.1)
Immunotherapy 9 (3.7) 1 (1.3) 5 (5.6) 3 (3.8)
Radiotherapy 8 (3.3) 5 (6.5) 3 (3.3) 0 
Chemotherapy 4 (1.6) 2 (2.6) 1 (1.1) 1 (1.3)
Healthcare Utilization
There were no significant differences in healthcare utilization between the intervention 
conditions and TAU (see Table 2) except for the proportion of patients receiving day-
ward treatment (e.g. chemotherapy), which was higher in TAU.
Safety
A total of (n=21) (S)AEs unrelated to the intervention were reported in MBCT (n=6), 
in eMBCT (n=9) and TAU (n=6). One SAE occurred during the study period: a patient 
passed away after randomization due to illness.
Intervention outcomes
In between-group comparisons of both interventions compared with TAU, patients 
in the MBCT and eMBCT conditions reported signiﬁcantly less psychological distress 
postintervention than did those receiving TAU, with small to medium effect sizes (Cohen’s 
d, .45 and .71, respectively; Table 3; Figure 2). The proportion of patients demonstrating 
reliable improvement was signiﬁcantly greater in MBCT than TAU (36% v 14%; χ2 [1, 
n=134] = 8.44; p=.004) and in eMBCT than TAU (37% v 14%; χ2 [1, n = 145] = 9.95; p=.002) 
(see Table 4). Improvement in rates of psychiatric diagnosis favored both interventions 
compared with TAU but were not statistically signiﬁcant (MBCT: 32% v 16%; χ2 [1, n=126] 
= 4.73; p=.030; and eMBCT: 29% v 16%; χ2 [1, n=138] = 3.15; p=.076). Compared with 
TAU, both MBCT and eMBCT signiﬁcantly reduced fear of cancer recurrence (Cohen’s 
d, .27 and .53, respectively), rumination (Cohen’s d, .42 and .51, respectively), and 
improved mental health–related quality of life (Cohen’s d, .59 and .67, respectively), but 
not physical health–related quality of life (Cohen’s d, .35 and .24, respectively). They also 
resulted in better mindfulness skills (Cohen’s d, .47 and .82, respectively) and increased 
positive mental health compared with TAU (Cohen’s d, .12 and .44, respectively).
83
Comparing group- and Internet-based Mindfulness-Based Cognitive Therapy with Treatment as Usual: study results
Screened (n=532)
Randomized
(n=245)
Treatment as
usual
(n=78, 31.8%)
Completed T1
assessment
(n=70, 89.7%)
Eligible (n=434)
Ineligible (n=98)
HADS too low (n=98)
Declined after screening (n=95)
Travel distance (n=55)
Unknown/no reason provided (n=18)
Other services needed (n=12)
Physical limitations (n=10)
Excluded (n=24)
Experience with mindfulness (n=21)
Severe psychiatric morbidity (n=3)
Declined after baseline (n=38)
Strong randomization preference (n=12)
Scheduling difficulties (n=11)
Not interested after baseline (n=15)
Not started
(n=0)
Discontinued
(n=1, 1.3%)
MBCT during TAU (n=1)
Lost to follow up
(n=8, 10.3%)
No reason provided (n=4)
Medical reason (n=3)
Withdrawal (n=1)
Completed
Treatment as
usual
(n=77, 98.7%)
Group-based
MBCT
(n=77, 31.4%)
Completed T1
assessment
(n=64, 83.1%)
Not started
(n=7, 9.1%)
Scheduling (n=2)
Group unavailable (n=2)
Medical reason (n=1)
Other intervention (n=1)
Deceased (n=1)
Discontinued
(<4 sessions)
(n=6, 7.8%)
No motivation (n=2)
Medical reason (n=2)
Too burdensome (n=1)
MBCT experience (n=1)
Lost to follow up
(n=13, 16.9%)
No reason provided (n=5)
Withdrawal (n=4)
Medical reason (n=2)
Authors’ mistake (n=1)
Deceased (n=1)
Completed
Group-based
MBCT
(n=64, 83.1%)
Internet-based
MBCT
(n=90, 36.7%)
Completed T1
assessment
(n=75, 83.3%)
Not started
(n=8, 8.9%)
Other intervention (n=4)
No reason provided (n=2)
Medical reason (n=1)
Computer difficulties (n=1)
Discontinued
(<4 sessions)
(n=19, 21.1%)
No motivation (n=6)
Scheduling (n=3)
Too burdensome (n=3)
Computer difficulties (n=3)
No reason provided (n=2)
Medical reason (n=2)
Lost to follow-up
(n=15, 16.7%)
)
No reason provided (n=8)
Withdrawal (n=6)
Medical reason (n=1)
Completed
Internet-based
MBCT
(n=63, 70.0%)
Unreachable (n=22)
Unreachable (n=10)
Baseline
assessment
(n=293)
FIGURE 1. CONSORT diagram (n=245). HADS, Hospital Anxiety and Depression Scale; MBCT, 
mindfulness-based cognitive therapy; TAU, treatment as usual.
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Moderation
Exploratory analyses yielded no significant moderation of intervention dropout or 
primary outcome in the analyses comparing both interventions to TAU separately 
(all p-values >.05), except for neuroticism. In the analyses comparing either MBCT 
interventions to TAU, there was a significant interaction between neuroticism and 
intervention condition (MBCT vs. TAU p = .014, eMBCT vs. TAU p = .004). Patient scoring 
higher on neuroticism on baseline improved more on psychological distress in both 
intervention conditions than in TAU.
types of cancer. Because one inclusion criterion was the ability and
willingness to attend both MBCT and eMBCT, the sampling frame
for the current study was probably not representative of patients who
would prefer eMBCT in clinical practice. Because treatment pref-
erence is often positively correlated with treatment outcome,45 we
would expect that this RCT underestimated rather than over-
estimated the effects of eMBCT.
In terms of research implications, long-term results should be
gathered to examine the stability of effects. In addition, data on
cost-utility of MBIs in patients with cancer should be collected.46
Internet interventions do not involve the costs of transportation,
traveling time, space, equipment, cleaning, and other overhead
expenses and thus could be more cost effective. Possible mediators of
the effect, such as mindfulness skills or rumination, should be further
investigated.47,48 Moreover, mediation analyses could also examine
possible differences in adherence in both MBCT and eMBCT.
In terms of clinical implications, implementation of eMBCT
could make MBIs more accessible for patients with cancer without
having to compromise intervention efﬁcacy. However, intervention
dropout could possibly be improved by the delivery mode of
eMBIs.49 Qualitative work demonstrates that aspects such as the
individual nature and the asynchronous interaction of the eMBCT
used in this study are helpful for some patients.50 Future studies
should assess how different eMBCT designs (eg, blended designs
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Fig 2. Change in Hospital Anxiety and
Depression Scale (HADS) scores be-
tween baseline and postintervention for
(A) mindfulness-based cognitive therapy
(MBCT), (B) Internet-based mindful-based
cognitive therapy (eMBCT), and (C) treat-
ment as usual (TAU) groups. The blue di-
agonal line represents no change in HADS
between baseline and postintervention,
and the gray upper and lower lines repre-
sent the upper (above indicates de-
teriorated) and lower (below indicates
improved) bounds of the 95% CI of the
Jacobson-Truax reliable change index (RCI).
Table 4. Clinically Signiﬁcant Improvement Measured by Jacobson-Truax Reliable Change Index on HADS and Psychiatric Diagnosis Between Baseline and Post-
intervention for MBCT, eMBCT, and TAU Groups
Improvement
Reliable Change Index (n = 209) Psychiatric Diagnosis (n = 202)
MBCT
(n = 64)
P*
eMBCT
(n = 75)
P*
TAU
(n = 70)
MBCT
(n = 64)
P*
eMBCT
(n = 76)
P*
TAU
(n = 62)
No. % No. % No. % No. % No. % No. %
Improved 23 36 .004 28 37 .002 10 14 21 33 .030 22 29 .076 10 16
No change 39 61 47 63 54 77 34 67 50 66 49 79
Deteriorated 2 3 .184 0 0 .010 6 9 0 0 .075 4 5 .910 3 5
Abbreviations: eMBCT, Internet-based MBCT; HADS, Hospital Anxiety and Depression Scale; MBCT, mindfulness-based cognitive therapy; TAU, treatment as usual.
*Between group x2 tests for the respective condition compared with TAU.
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FIGURE 2. Change in Hospital Anxiety and Depression Scale (HADS) scores between baseline and 
postintervention for(A) mindulness-based cognitive therapy (MBCT), (B) Internet-based mindful-
based cognitive therapy (eMBCT), and (C) treatment as usual (TAU) groups. The blue diagonal 
line represents no change in HADS between baseline and postintervention, and the gray upper 
and lower lines represent the upper (above indicates deteriorated) and lower (below indicates 
improved) bounds of the 95% CI of the Jacobson-Truax reliable change index (RCI).
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DISCUSSION
To our knowledge, this is the first study to simultaneously compare MBCT and eMBCT 
with TAU in a large sample of distressed heterogeneous patients with cancer. Both 
MBCT and eMBCT resulted in a statistically significant and clinically reliable reduction 
of psychological distress compared with TAU. Both interventions demonstrated similar 
reductions of fear of cancer recurrence, rumination, and improvements in mental (but 
not physical) health–related quality of life, mindfulness skills, and positive mental health 
compared with TAU.
Our study confirms previous findings regarding the effectiveness of eMBIs for cancer 
patients.[14,19] Although the group-based setting is considered important for MBIs,[41] 
the current study suggests that individual guided eMBCT with limited teacher feedback 
is also effective, thus improving the accessibility of this intervention for cancer patients. 
However, eMBCT did result in higher dropout rates than MBCT. Exploratory analyses 
did not yield any moderators of intervention dropout. Further, possibly qualitative, 
research examining reasons for dropout is critical to improve efficacy of web-based 
interventions.[42]
A strength of the current study is the patient-centred nature of the recruitment across 
multiple regions as in previous research we encountered difficulties with consecutive 
sampling of patients in hospital outpatient settings.[43] Other strengths are that the 
interventions followed strict protocols, was delivered by qualified therapists, and 
therapist competency was rated by two independent, experienced therapists. We 
systematically collected data on healthcare utilization during the study. The study used 
a broad array of outcome measures, including both observer-rated interviews and self-
report questionnaires.
In addition to these strengths, the study has some limitations. The study was not 
powered to directly compare or determine non-inferiority of eMBCT to MBCT, as this 
would have required a larger sample size. As with other psycho-oncology research, 
the majority of the patients were middle-aged breast cancer patients. Although this 
is in line with the characteristics of cancer patients seeking psychosocial support,[44] 
this might limit generalizability to patients with other types of cancer. As one inclusion 
criterion was the ability and willingness to attend both MBCT and eMBCT, the sampling 
frame for the current study was probably not representative of patients who would 
prefer eMBCT in clinical practice. As treatment preference is often positively correlated 
with treatment outcome,[45] we would expect that this RCT under- rather than over-
estimated the effects of eMBCT.
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In terms of research implications, long-term results should be gathered to examine the 
stability of effects. In addition, data on cost-utility of MBIs in cancer patients should be 
collected.[46] Internet interventions do not involve costs of transportation, travelling 
time, space, equipment, cleaning, and other overhead costs and thus could be more 
cost effective. Possible mediators of the effect, such as mindfulness skills or rumination, 
should be further investigated.[47,48] Moreover, mediation analyses could also examine 
possible differences in adherence in both MBCT and eMBCT.
In terms of clinical implications, implementation of eMBCT could make MBIs more 
accessible for cancer patients without having to compromise intervention efficacy. 
However, intervention dropout could possibly be improved by the delivery mode of 
eMBIs.[49] Qualitative work demonstrates that aspects such as the individual nature 
and the asynchronous interaction of the current eMBCT is helpful for some patients.[50]
Future studies should assess how different eMBCT designs (e.g. blended designs 
combining the advantages of face-to-face and Internet-based elements)[51] could 
further improve intervention accessibility, adherence and effectiveness.[50]
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LIST OF ABBREVIATIONS
RCT Randomized Controlled Trial
MBI Mindfulness-based intervention
MBCT Mindfulness-Based Cognitive Therapy
eMBI Internet-Based Mindfulness-Based Intervention
TAU Treatment As Usual
HADS Hospital Anxiety and Depression Scale
eMBCT Internet-based Mindfulness-based Cognitive Therapy
MBI:TAC Mindfulness-Based Interventions: Teachers Assessment Criteria
FCRI Fear of Cancer Recurrence Inventory
RRQ Rumination Reflection Questionnaire
SF-12 Short Form-12
FFMQ-SF Five Facet Mindfulness Questionnaire - Short Form
MHC-SF Mental health Continuum - Short Form
NEO-FFI Neuroticism-Extraversion-Openness Five-Factor Inventory
SCID-I Structured Clinical Interview for DSM-IV-TR Axis I disorders
ITT Intention to treat
MI Multiple Imputation
RCI Reliable Change Index
ES Effect Size
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ABSTRACT
Background
The number of patients living with cancer is growing, and a substantial number of 
patients suffer from psychological distress. Mindfulness-based interventions (MBIs) seem 
effective in alleviating psychological distress. Unfortunately, several cancer patients 
find it difficult, if not impossible, to attend a group-based course. Internet-based MBIs 
(eMBIs) such as Internet-based mindfulness-based cognitive therapy (eMBCT) may offer 
solutions. However, it is yet to be studied what facilitators and barriers cancer patients 
experience during eMBCT.
Objective
This study aimed to explore facilitators and barriers of individual asynchronous 
therapist-assisted eMBCT as experienced by both patients and therapists.
Methods
Patients with heterogeneous cancer diagnoses suffering from psychological distress 
were offered eMBCT. This 9-week intervention mirrored the group-based MBCT protocol 
and included weekly asynchronous written therapist feedback. Patients were granted 
access to a website that contained the eMBCT protocol and a secured inbox, and they 
were asked to practice and fill out diaries on which the therapist provided feedback. In 
total, 31 patients participated in an individual posttreatment interview on experienced 
facilitators and barriers during eMBCT. Moreover, eight therapists were interviewed. The 
data were analyzed with qualitative content analysis to identify barriers and facilitators 
in eMBCT.
Results
Both patients and therapists mentioned four overarching themes as facilitators and 
barriers: treatment setting (the individual and Internet-based nature of the treatment), 
treatment format (how the treatment and its guidance were organized and delivered), 
role of the therapist, and individual patient characteristics.
Conclusions
The eMBCT provided flexibility in when, where, and how patients and therapists engage 
in MBCT. Future studies should assess how different eMBCT designs could further 
improve barriers that were found.
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INTRODUCTION
Cancer poses a major psychological challenge for individuals. A meta-analysis of 
psychiatric disorder in oncological and hematological settings yielded a prevalence of 
psychiatric disorder of 30% to 40%.[1] In the coming decades, a great increase is expected 
in the number of people living with cancer.[2] This means that a growing number of 
cancer patients are in need of effective and accessible psychological treatment.
Mindfulness-based interventions (MBIs) such as mindfulness-based stress reduction 
(MBSR) [3] and mindfulness-based cognitive therapy (MBCT) [4], the latter more 
oriented toward those in need of clinical psychological treatment, could be viable 
intervention options for cancer patients. Mindfulness is defined as follows: “paying 
attention, on purpose, in the present moment and nonjudgmentally”.[5] Its practice 
enables participants to recognize habitual, conditioned modes of reacting, and to make 
a radical shift in how they relate to their thoughts, feelings, and body sensations, as well 
as to outer circumstances [6], such as when coping with cancer.
Evidence for the effectiveness of MBIs for cancer patients has rapidly expanded. In 
2015, an overview including six systematic reviews in heterogeneous cancer patients 
demonstrated significant small to moderate effects on various psychosocial outcomes 
in cancer patients.[7] In addition, studies confirmed these effects at longer-term 
follow-up.[8,9] Moreover, studies demonstrated that the effect of MBIs in breast cancer 
patients might be mediated by nonreactivity, reduced catastrophizing, and increased 
self-kindness.[10,11]
 Notwithstanding the potential of MBIs, several cancer patients encounter practical and 
psychosocial barriers that hamper access and participation in psychological treatments 
such as MBIs. These barriers include cancer-related illness, fatigue, limited mobility 
or disability, limited transportation options, and time constraints.[12,13] Internet-
based interventions, such as Internet-based MBIs (eMBIs), may offer solutions to these 
problems. Mobile MBI apps have already demonstrated their potential.[14] Internet-
based interventions are easily accessible, available 24×7, save travelling time, and could 
be less costly.[15] Evidence of over 100 well-controlled trials suggests that Internet-
based treatments can be as effective as group-based psychological treatments for a 
wide range of psychiatric and somatic conditions.[16]
Moreover, a previous review suggests that eMBIs may be helpful in alleviating symptom 
burden of patients with physical health conditions, particularly when the eMBI is 
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tailored to specific symptoms.[17] A total of 16 studies examining eMBIs for people with 
chronic physical health conditions were reviewed, of which two specifically targeted 
cancer patients.
A randomized controlled trial (RCT; n=62) investigated the quantitative feasibility of 
Internet-based MBSR for cancer patients (mindfulness-based cancer recovery [MBCR]).
[13] The Internet-based MBCR (eMBCR) consisted of synchronous videoconferencing 
sessions. Feasibility targets for recruitment and adherence (5% response rate, 30% 
eligible, and 85% consented) were achieved, and patients considerably improved on 
mood disturbance, stress symptoms, spirituality, and acting with awareness in the Web-
based group relative to waitlist controls. Results suggested that eMBCR led to improved 
energy while also inducing relaxation.[18] In addition, an uncontrolled cohort study 
(n=257) of severely fatigued cancer patients evaluated an Internet-based mindfulness-
based cognitive therapy (eMBCT).[12] In total, 34.6% (89/257) of the patients showed 
clinically relevant improvement in fatigue severity and 61.8% (159/257) of the patients 
adhered to treatment. In sum, evidence for eMBIs in cancer is scarce, but the first results 
seem promising.
However, how to optimally deliver eMBIs remains unknown.[17] It is unclear whether 
either synchronous (real time, e.g., instant messageing or videoconferencing) or 
asynchronous (delayed, e.g., email or message boards) is to be preferred. Patients are 
supposed to engage in an experiential inquiry-based learning process together with 
the therapist in eMBIs [6], but it is unknown whether such an experiential inquiry-
based learning process is at all possible in an asynchronous format. In addition, it is 
unclear whether either facilitated (guided) or self-directed eMBIs are to be preferred. It 
is argued that the therapists’ capacity to embody qualities and attitudes of mindfulness 
in the process of teaching is vital for effective delivery of MBIs.[6] Guidance seems to 
be a beneficial feature of Internet-based interventions in general [19], and exploratory 
subgroup analyses of a systematic review indicated higher effect sizes of stress and 
mindfulness skills for guided than unguided eMBIs.[15] However, a previous review also 
provided some initial support for unguided eMBIs.[20]
In short, the question of which eMBI delivery format is preferable in terms of program 
adherence, mindfulness skills, and outcome improvement needs further investigation.
[17]
Previously, a qualitative study has provided important perspectives for examining the 
user experience in an MBI. In a qualitative study of an eMBI for recurrent depression, 
patients identified aspects such as flexibility and reduced cost, as well as the need for 
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support in time management.[21] Qualitative information on how patients and their 
therapists experience eMBCT could identify barriers and facilitators, and inform us 
whether it is possible to design useful, user-friendly, and effective eMBIs for cancer 
patients and where to improve delivery mode and design if necessary and possible. 
Therefore, the aim of this study was to gain understanding of the experienced facilitators 
and barriers of asynchronically delivered eMBCT in a sample of heterogeneous cancer 
patients and their therapists.
METHODS
Study Population and Procedure
The patients of this study took part in a 3-armed trial on the (cost-) effectiveness of 
MBCT for distressed cancer patients (Clinicaltrials.gov no. NCT02138513).[22] Patients 
were randomized to either eMBCT, group-based MBCT, or treatment as usual. The RCT 
is described in more detail in a protocol paper.[22] Patients for this trial were mainly 
recruited via online media (26.9%, 66/245), patient associations (17.6%, 43/245), and 
participating mental healthcare centers (16.7%, 41/245). In total, 245 cancer patients 
with any tumour type and any stage of disease scoring 11 or higher on the Hospital 
Anxiety and Depression Scale were randomized. The local ethics committee approved 
this study (CMO Arnhem Nijmegen 2013/542).
Qualitative Assessments: Semistructured Interviews (Patients) and Focus Group 
(Therapists). Both patients randomized to eMBCT and their therapists were invited by 
the researcher to talk about the following questions:
• How did you experience the eMBCT?
• What facilitated and what impeded your participation in eMBCT?
• How did you experience the relationship with the therapist or patient?
• How would you improve the eMBCT?
The abovementioned questions were followed by specific probes. Questions were 
asked in an open nondirective manner, allowing participants to speak freely about their 
experiences. Patients were interviewed via telephone or in groups within 3 months 
after eMBCT treatment completion or dropout. Patients were purposefully sampled 
to gather an even distribution of completers versus noncompleters and breast cancer 
versus other tumour types. Patient interviews were conducted by FC and EJ. FC is a 
PhD student with an MSc degree in behavioral science with no prior experience in 
qualitative research. He was the trial coordinator for the larger RCT [22], and had 
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conducted baseline and posttreatment research interviews before inviting patients for 
the posttreatment interview. EJ is a psychologist and mindfulness teacher with an MSc 
degree in psychology with prior experience with qualitative research.
Therapists were invited for a focus group interview during the last plenary therapist 
supervision session approximately 3 months after completing the last MBCT. Both the 
patient interviews and therapist focus group started by explaining confidentiality and 
the explorative nature of the interview. AS and ML conducted the focus group interviews. 
AS is a professor of psychiatry in the role of principle investigator of the larger RCT [22], 
with experience in several qualitative research projects in MBIs. ML is a senior researcher 
and clinical psychologist in the role of principle investigator of the larger RCT [22], with 
experience in several qualitative research projects on MBIs.
Data Analysis
We used conventional qualitative content analysis to analyze the data in which coding 
categories are derived directly from the text data.[23] We used ATLAS.ti version 7.1 
software (Scientific Software Development GmbH, Berlin, Germany). Analysis started 
as soon as the first interview was conducted and continued with each additional 
interview. Interviews were transcribed verbatim, and each transcript was coded by 2 
independent researchers (FC and EJ) to identify facilitators and barriers. Coding was 
performed as closely related to the patient’s words as possible to minimize subjectivity. 
After 5 interviews, FC and EJ compared codes with each other, and a common coding 
scheme was developed. Remaining transcripts were coded using this common coding 
scheme and earlier transcripts were recoded. New codes were added when data were 
encountered that did not fit in the existing coding scheme. After 12 interviews, a larger 
group of researchers (FC, EJ, MS, ML, and AS) discussed all data within the coding 
scheme. Some codes were combined during this process, whereas others were split 
in subcategories. After 31 interviews, no new codes were added and it was concluded 
that saturation had been reached. All codes referring to the same phenomenon were 
grouped in a hierarchical structure in subcategories, and subcategories in themes by FC 
and EJ. The group of researchers (FC, EJ, MS, ML, and AS) subsequently discussed this 
classification until reaching consensus.
Intervention and Therapists
The eMBCT was based on the MBCT protocol for recurrent depression published by 
Segal et al.[4] The content was adapted to cancer patients by particularly tailoring the 
psychoeducation (eg, manageing cancer-related fatigue, pain, fear of cancer recurrence, 
and effects of cancer on partner communication) and movement exercises to their 
needs.[24]
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The eMBCT was mainly text-based and included asynchronous interaction with a 
therapist similar to the study of Bruggeman Everts et al.[12] Patients were granted 
access to a website divided into a workspace containing 9 sessions (8 weeks + 1 full-
day silent retreat) and a secured inbox. The therapist initiated the eMBCT by sending a 
welcome message to the patient. When patients logged-in, they were presented with the 
overview of all information and assignments due for that week. Each session contained 
an introductory text, and daily formal (eg, sitting meditation) and informal exercises 
(eg, awareness of everyday activities) with guided audiotaped files and accompanying 
diaries. Sessions also contained other home practice such as the pleasant or unpleasant 
events’ diary.
The eMBCT was performed individually. To demonstrate the rationale and possible 
obstacles of each exercise, patients were provided with experiences of other (fictional) 
patients. Patients were asked to practice and complete the diaries on a daily basis. 
The therapist provided written feedback on their progress via the secured inbox 
on a prearranged day of the week. Next week’s session only became available after 
completing the previous session. Patients always had access to their therapist via the 
inbox. Patients and therapists were notified via their regular email when they received a 
message via the secured inbox.
We defined adherence as having attended ≥4 sessions. Therapists without prior eMBCT 
experience were provided with guidelines and were supervised by more experienced 
eMBCT therapists. See Table 1 for therapists’ characteristics. All therapists fulfilled the 
advanced criteria of the Association of Mindfulness-based Teachers in The Netherlands 
and Flanders, which are in concordance with the UK Mindfulness-Based Teacher Trainer 
Network Good Practice Guidelines for teaching mindfulness-based courses.[25]
TABLE 1. Demographical characteristics of Internet-based Mindfulness-based Cognitive Therapy 
therapists.
Variable (n=8) Mean (SD) n (%)
Age, years 55.50 (7.2)
Gender, female 6 (75)
Years of experience in teaching MBCTa 8.75 (2.7)
Prior experience with eMBCTb 4 (50)
aMBCT: mindfulness-based cognitive therapy.
ceMBCT: Internet-based mindfulness-based cognitive therapy.
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RESULTS
Sample
Out of the 125 patients randomized to eMBCT, 45 were invited for a posttreatment 
interview. In total, 12 patients declined and 2 recordings failed. As a result, 31 interviews 
were used in the qualitative analysis. Interviews lasted from 5 to 25 min. Out of the 
patients interviewed, 14 had participated in 4 or more sessions of eMBCT, 10 had 
attended less than 4 sessions of eMBCT, and 7 had not started at all. See Table 2 for 
patient characteristics.
A total of 11 out of 12 eMBCT therapists were invited for a focus group interview after 
completion of all eMBCTs. Out of these 12 therapists, 7 therapists agreed to participate 
and 1 therapist agreed to provide an individual interview with FC for scheduling 
reasons. Therapists declined either because of having provided too few individual 
online treatments to share experiences (n=1) or because of scheduling reasons (n=2). 
The focus group interview lasted for 90 min. The single individual therapist interview 
lasted for 25 min. The final sample of therapists included both therapists who had 
experience with online mindfulness before this project (n=4) and therapists who had 
no prior experience with online mindfulness before this project (n=4). See Table 2 for 
therapist characteristics.
All patient facilitators (Textbox 1), patient barriers (Textbox 2), therapist facilitators 
(Textbox 3), and therapist barriers (Textbox 4) could be divided into the following 
four themes: treatment setting, treatment format, role of the therapist, and patient 
characteristics. First, patients’ facilitators and barriers are presented per each theme. 
Then, therapists’ facilitators and barriers are presented per each theme.
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TABLE 2. Demographic and clinical characteristics of Internet-based Mindfulness-based Cognitive 
Therapy patients.
Variable (n=31) Mean (SD) n (%)
Age, years 53.0 (12.3)
Gender, male 6 (19)
Education level
Secondary 14 (45)
Vocational or university 17 (55)
Time since diagnosis 3.2 (2.7)
Cancer diagnosis
Breast 16 (52)
Other 15 (48)
Cancer treatment intent
Curative 24 (77)
Active cancer treatment
Yes 11 (35)
Psychological distress, HADSa 16.2 (7.1)
MBCTb adherence
Completer 14 (45)
Dropouts 10 (32)
Other priorities 4 (40)
Too difficult 3 (30)
Too intensive 1 (10)
Illness 1 (10)
Missed peers 1 (10)
No start 7 (23)
Wanted MBCT 3 (43)
Illness 1 (14)
Other priorities 1 (14)
Could not log in 1 (14)
Needed mental health services 1 (14)
aHADS: Hospital Anxiety and Depression Scale. bMBCT: mindfulness-based cognitive therapy.
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PATIENTS
Facilitators and barriers experienced by patients are depicted in Textboxes 1 and 2.
TEXTBOX 1. Patient facilitators across four themes and subthemes.
Patient facilitators 
 ⚫ Theme 1: treatment setting
 ⚪ Time management
 – Program at own time improves receptivity
 ⚪ Individual setting
 – Sense of autonomy
 – Not having to cope with other patients’ stories
 ⚪ Home setting
 – Not having to travel
 ⚫ Theme 2: treatment format
 ⚪ Website
 – Clear and easy to navigate
 – Privacy precautions
 ⚪ Diaries
 – Rereading own notes
 – Stimulated reflection
 ⚫ Theme 3: role of the therapist
 ⚪ Practical guidance
 – Clarifying practical matters
 ⚪ Mindfulness
 – Deepened understanding
 – Embodiment stimulated practice
 ⚫ Theme 4: patient characteristics
 ⚪ Writing fluency
 – Written expression in describing experiences
 ⚪ Curiosity
 – Curiosity stimulated perseverance
Patient Theme 1: Treatment Setting—Facilitators
Treatment setting concerned subthemes on the external conditions of the eMBCT: 
flexibility of timing, the individual nature, and the home practice environment of the 
training.
Time Management
It was considered convenient to be able to manage your own time schedule, which 
increased treatment receptivity. One patient stated the following:
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Because you can start when you are ready and have the peace of mind for it, you can 
absorb it much better, because you actually want to at that moment. [Female breast 
cancer patient (curative), 65 years, completer]
TEXTBOX 2. Patient barriers across four themes and subthemes.
Patient barriers 
 ⚫ Theme 1: treatment setting
 ⚪ Time management
 – Responsibility for time management
 ⚪ Individual setting
 – No learning from peer group
 ⚪ Home setting
 – Lack of privacy in own home
 ⚪ Illness barriers
 – Cancer-related reading impairments
 ⚪ Lack of information
 – Lack of information before start
 ⚫ Theme 2: treatment format
 ⚪ Website
 – Complicated
 ⚪ Diaries
 – Complicated to fill out
 – Obligatory nature was burdensome
 – Describing experiences was confrontational
 ⚫ Theme 3: role of the therapist
 ⚪ Asynchronicity
 – No dialogue emerging
 ⚪ Frequency
 – Wished more frequent feedback
 ⚫ Theme 4: patient characteristics
 ⚪ Writing fluency
 – Lack of verbal fluency made diaries difficult
Individual Setting
A patient indicated that the individual setting facilitated a sense of autonomy that 
helped in taking care of himself:
I didn’t feel like doing the movement exercises. In a group setting I would have had to 
explain myself, so you are more inclined to go along with the group. But now, being 
on my own, I carried full responsibility for my own actions. Getting this space felt 
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comfortable, because there were moments at which the therapy really asked a lot of 
me. At those times I could allow myself to take a time out and decide when I wanted to 
continue again. [Male prostate cancer patient (palliative), 65 years, completer]
Furthermore, it was considered to be facilitating not to be confronted with other 
patients’ cancer stories. One patient stated the following:
This only was about me and I didn’t have to spend energy on someone else’s story. 
[Female breast cancer patient (curative), 27 years, completer]
Home Setting
Being able to complete the sessions and exercises in your own home environment and 
not having to travel was appreciated. One patient stated:
For me, it was ideal because I knew that the group-based MBCT would take place at [the 
mental health institute] and it was impossible to reach by public transport. [Female 
breast cancer patient (curative), 27 years, completer]
Patient Theme 1: Treatment Setting—Barriers
Time Management
Responsibility for your own time management was mentioned as a barrier because it 
required a lot of self-discipline. One patient stated:
What I like about it is that I can manage my own time which went very well the first 
couple of weeks. After a while some chores interrupted me and then at the end of the 
day I realized: I still have to practice. Sometimes I did not do it anymore and sometimes 
I did. So you have to be very disciplined to stick to the schedule. [Female cervical cancer 
patient (curative), 46 years, completer]
Individual Setting
Patients described the lack of a group setting as a drawback of the intervention. They 
missed the peer support and the ability to learn together in the eMBCT. One patient 
stated:
I am a rational being. In a group there are always others who help me to unravel my 
emotions. This helps me. And I know, when I sit behind my computer my autopilot 
turns on and the treatment becomes a rational, experimental exercise. [Female breast 
cancer patient (curative), 54 years, no start]
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Home Setting
Other patients mentioned that they felt less comfortable having to do exercises at 
home, not having the privacy they needed. One patient stated:
I practiced in my home office, but that room is connected to my living room. I found it 
uncomfortable to practice with my husband around, and even though he would never 
be eavesdropping, I felt restricted in doing certain exercises. [Female colon cancer 
patient (curative), 60 years, completer]
Illness Barriers
One patient indicated that her cancer type caused her to have trouble reading. As the 
eMBCT was mainly text-based, this was a problem to her. She stated the following:
It was mainly physical, I didn’t have the energy and my vision is in such a bad state. 
Even with medication, my vision is bad. And my eyes itch and burn and hurt. [Female 
bone marrow cancer patient (palliative), 55 years, no start]
Lack of Information
Moreover, patients indicated that they would have wished more information on the way 
the platform and course were organized before the start of the training. One patient 
stated:
Expectation management would have helped a lot, I had a very brief instruction. And 
I have to choose where to put my energy into. What is expected of me, can I handle it, 
does it fit in my planning? [Female breast cancer patient (curative), 54 years, no start]
Patient Theme 2: Treatment Format—Facilitators
The treatment format theme included codes on the facilitators and barriers of the means 
by which the eMBCT was internally organized and delivered.
Website
The website was accessible and navigating throughout the website was easy. One 
patient stated:
Opening the exercises and the way [the website] guided you through the structure was 
easy. [Male skin cancer patient (curative), 61 years, completer]
Moreover, patients valued the privacy precautions and indicated that the website felt 
safe. One patient stated:
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I thought it was neat that I could see who visited my profile. In my case it was only my 
therapist according to the system, so I presume that the system is right, but it felt well 
taken care of. [Female melanoma patient (curative), 33 years, completer]
Diaries
The diaries proved to be of value for patients because it enabled them to read back and 
learn from their own experiences. One patient stated:
 In my own [diaries] I looked back to see what my experiences were yesterday, or how 
did I handle this last time? [Female melanoma patient (curative), 33 years, completer]
Patients also indicated that having to write stimulated reflection upon experiences. One 
patient stated:
Writing about my feelings was different from when I would have talked about it. It 
was more reflective, less spontaneous. I noticed that when I mailed I checked it again 
and again and added a few things. This really was an advantage. It really made me 
think about what I felt and experienced. Because of the writing itself this really hit me. 
[Female breast cancer patient (curative), 61 years, dropout]
Patient Theme 2: Treatment Format—Barriers
Website
The website was complicated to some patients. One patient stated:
The website and its explanation was not really user friendly. There were many steps you 
had to take before you could do what you actually had to do. [Female breast cancer 
patient (palliative), 49 years, dropout]
Diaries
A patient mentioned that the diaries were complicated to fill out:
I got the message that some fields still needed to be filled out. In general, I couldn’t find 
where to fill out what in the diaries and it made me quit. [Male prostate cancer patient 
(palliative), 78 years, dropout]
Patients thought it was burdensome that the diaries were obligatory. One patient stated:
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It was so much. Filling out the diaries every day […]. I subscribed for a mindfulness 
course because I didn’t feel well and all of a sudden, you have this huge obligation. 
[Male palate cancer patient (curative), 30 years, dropout]
The diaries were also considered quite confronting at times. One patient stated:
When you had a negative experience, filling out the diary made me revive the negative 
moment. [Female cervical cancer patient (curative), 50 years, dropout]
Patient Theme 3: Role of the Therapist—Facilitators
This theme included codes on the role of the therapist and the way the therapist 
facilitated or hindered participating in eMBCT.
Practical Guidance
Patients indicated that the therapist was often able to clarify practical aspects that were 
unclear. One patient stated:
I always want to do things right, and I wasn’t sure about how I did the meditation 
exercises in the beginning. Is this the way I am supposed to do this? So after a while I 
just mailed my therapist asking questions about the how and what of exercises, and I 
got a prompt reply most of the times.
[Female melanoma patient (curative), 33 years, completer]
Mindfulness
The ways in which therapists provided feedback enriched patients’ understanding of 
underlying mindfulness values, such as the mild and nonjudgmental attitude. One 
patient stated:
(My therapist) was very patient and gave me all the space I needed […]. She was like 
this all the time, in everything she did, not forcing, but stimulating me. “Do it for yourself 
when you do the exercises. If you do them, you could benefit a lot.” This made me feel 
more connected. [Female breast cancer patient (curative), 52 years, completer]
The embodiment of mindfulness values, such as the nonjudgmental attitude, supported 
and motivated patients to practice with the right intentions. One patient stated:
My therapist struck me as very mild. “Don’t force yourself, be gentle,” that certainly 
stood out. I don’t know how she would have been if I hadn’t practiced as much, but she 
was gentle with me. [Female melanoma patient (curative), 33 years, completer]
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Patient Theme 3: Role of the Therapist—Barriers
Asynchronicity
The asynchronous nature of the feedback proved to be a barrier. According to the 
patient, the written feedback of therapist did not seem to encourage a dialogue but 
rather seemed limited to giving responses to questions. One patient stated:
Suppose I tell you I found the exercise uncomfortable. I then send you a message 
saying “I found it uncomfortable.” Only after 3 days I then get a reply “What was 
uncomfortable? Can you specify what you mean?” I then specify what I mean in another 
message. You keep sending messages back and forth over a period of time. If you have 
a conversation with someone, you have direct interaction. It is a totally different mode 
of communication. In a business context I think messageing is fine. In this context it 
was unhelpful. [Female breast cancer patient (curative), 56 years, dropout]
Frequency
As the therapist provided feedback on past weeks’ diaries, sometimes questions were 
left unanswered for a whole week. Some patients would have liked to have more 
frequent feedback. One patient stated:
Just two three times a week a brief moment of contact saying “how are you”? [Female 
cervical cancer patient (curative), 50 years, dropout]
Patient Theme 4: Patient Characteristics—Facilitators
Individual characteristics seemed to influence the fit between patient and eMBCT.
Writing Fluency
The ability to express themselves in writing was very helpful for some to give words 
to their subjective experiences and to ask for clarification to the therapist if it was 
necessary. One patient stated:
I am an easy writer, which perhaps set my experience apart from others. I can imagine 
that if you have a hard time expressing what you do and feel it would be different. 
[Female breast cancer patient (curative), 61 years, dropout]
Curiosity
Curiosity sparked some to look beyond initial difficulties and to persevere in times of 
lack of motivation. One patient stated:
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I think I was curious about the coming exercises. Maybe those will be more pleasant 
to do. This made me continue for a few more weeks. [Female colon cancer patient 
(curative), 60 years, completer]
Patient Theme 4: Patient Characteristics—Barriers
Writing Fluency
The heavy reliance on writing skills was a barrier to some patients. One patient stated:
I liked doing the exercises, but having to write down my experiences on a daily basis 
[…], to sit down and write it all down, it put me off. For whom am I doing this? [Female 
breast cancer patient (curative), 51 years, completer]
THERAPISTS
Facilitators and barriers experienced by therapists are depicted in Textboxes 3 and 4.
TEXTBOX 3. Therapist facilitators across four themes and their subthemes.
Therapist facilitators 
 ⚫ Theme 1: treatment setting
 ⚪ Timing
 – Flexibility
 ⚪ Individual setting
 – Tailoring to patient
 – Better suited to some patients
 ⚫ Theme 2: treatment format
 ⚪ Asynchronicity
 – More time for reflection
 ⚪ Schedule
 – Maintaining a schedule prevents dropout
 ⚪ Writing
 – Stimulated reflection
 – Becomes more goal oriented
 ⚪ Anonymity
 – Stimulates openness
 ⚫ Theme 3: role of the therapist
 ⚪ Feedback
 – Providing group context
 – Provides reassurance
 – Personalizing training
 ⚫ Theme 4: patient characteristics
 ⚪ Self-discipline
 – Supporting self-sufficiency
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TEXTBOX 4. Therapist barriers across four themes and their subthemes.
Therapist barriers 
 ⚫ Theme 1: treatment setting
 ⚪ Timing
 – Larger time investment
 – More flexibility warranted
 ⚪ Individual setting
 – No modeling by peers
 – Elaboration on personal themes
 ⚫ Theme 2: treatment format
 ⚪ Asynchronicity
 – No present moment experiences
 – Difficulty to maintain continuity
 ⚪ Technical issues
 – Technical issues cause delay
 ⚪ Writing
 – No nonverbal communication
 – Limited in therapeutical repertoire
 – Lack of understanding not readily apparent
 ⚫ Theme 3: role of the therapist
 ⚪ Feedback
 – Empty diaries impair feedback
 – More explicit checking and self-disclosure necessary
 ⚪ Mindfulness
 – Embodying behind computer
 ⚫ Theme 4: patient characteristics
 ⚪ Self-efficacy
 – Lack of self-efficacy
 ⚪ Writing fluency
 – Lack of ability in written expression
Therapist Theme 1: Treatment Setting—Facilitators
Timing
Therapists welcomed the fact in that they were able to choose at what time to provide 
feedback, which made them adaptive to circumstances. One therapist stated:
You can provide feedback in between other chores. Sometimes you plan to give 
feedback from 9 to 10 and then someone enters your office. There goes your planning. 
I then tell myself […] “I’ll have time at another moment.” This is an advantage, you can 
do it in your own time. [Female MBCT therapist, 60 years, 6 years of experience, prior 
eMBCT experience]
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Individual Setting
The individual nature of eMBCT allowed for tailoring to the patients’ specific 
circumstances and giving feedback on individual real-life examples, which increases the 
relevance of the feedback. One therapist stated:
In the group you only have limited amount of time during which you must touch 
upon the most important themes. Online I have much more choice where to provide 
feedback on, what it means for a specific patient to react on autopilot, and which 
personal themes emerge. [Male MBCT therapist, 40 years, 10 years of experience, prior 
eMBCT experience]
Another important advantage of the individual nature of eMBCT is that it can be 
provided to patients who may otherwise be unsuitable for the group. Another therapist 
stated:
Some patients can be so disruptive in a group. They don’t get the point and only tell 
their own story. Sometimes you actually wished to provide someone in a group with 
an individual online training so you can address the individual themes. [Female MBCT 
therapist, 60 years, 6 years of experience, prior eMBCT experience]
Therapist Theme 1: Treatment Setting—Barriers
Timing
Therapists indicated that providing feedback costs a considerable amount of time, 
which made it difficult for them to stick to a fixed time window. One therapist stated:
Especially in the beginning, it took me much longer. Because of asking questions, or 
clarifying issues. Or referring back to earlier diary entries. [Female MBCT therapist, 54 
years, 12 years of experience, no prior eMBCT experience]
Furthermore, therapists indicated that working online required much more flexibility 
and resulted in fragmentation of the times spent on eMBCT. One therapist stated:
When a patient indicates that the programme does not work, I start looking for help 
immediately. Even though I receive this mail outside of the time window for feedback. 
[Female MBCT therapist, 60 years, 6 years of experience, prior eMBCT experience]
Individual Setting
Learning from fellow peer experiences in a group setting can be very helpful, and 
therapists felt limited in bringing in peer experiences themselves. One therapist stated:
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In one-on-one contact, you can bring in experiences from other patients but to really 
experience them first hand provides another perspective. [Female MBCT therapist, 58 
years, 11 years of experience, prior eMBCT experience]
Moreover, it was often difficult to find the balance between elaboration on personal 
themes and the eMBCT theme. One therapist stated:
A tension emerged between someone’s personal themes and combining those with 
this week’s mindfulness theme. Sometimes I thought, “this patient is occupied by 
something entirely different.” [Female MBCT therapist, 54 years, 5 years of experience, 
no prior eMBCT experience]
Therapist Theme 2: Treatment Format—Facilitators
Asynchronicity
Therapists and patients interacted asynchronically. This meant that according to the 
therapists, patients had time for reflection. One therapist stated:
Because there is some time between practice and feedback some experiences get 
the time to settle in. Patients can think about it, read it again, check with themselves 
what they experienced and how they reacted to it. This time in between could perhaps 
engage patients. [Female MBCT therapist, 60 years, 6 years of experience, prior eMBCT 
experience] 
Moreover, the asynchronous contact was beneficial to therapists. One therapist stated:
Sometimes my irritation causes me to cut patients off. Behind the computer I can tell 
myself “let’s put this to a rest for now.” [Female MBCT therapist, 54 years, 5 years of 
experience, no prior eMBCT experience]
Schedule
Maintaining a fixed interaction schedule between therapist and patient was very helpful 
in preventing treatment dropout. One therapist stated:
When patients are able to put in work on a weekly basis and we stick to this rhythm, a 
kind of synchronicity emerges and assignments and my feedback to these assignments 
flow naturally. [Female MBCT therapist, 62 years, 10 years of experience, no prior 
eMBCT experience]
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Writing
Writing feedback stimulated contemplation in therapists themselves. One therapist 
stated:
By taking a step back I recognized, hey, it annoys me what patients write down. Or I 
thought by myself, “come on, start practicing.” Then I thought, “stop.” You can read 
back your own feedback and then think by yourself “I should not do this.” [Female 
MBCT therapist, 54 years, 5 years of experience, no prior eMBCT experience]
Due to increasing experience, they got more efficient in their feedback over time. One 
therapist stated:
I became a lot more economical in my feedback over time. I tend to scan more for 
abnormalities or diary entries which I don’t recognize, or diary entries of which I think 
“this could influence dropout.” I tend to reply less, but what I say is then more relevant. 
[Male MBCT therapist, 40 years, 10 years of experience, prior eMBCT experience]
Anonymity
The fact that patients were able to write about their experiences rather anonymously 
was helpful in opening up to experiences, which meant that in general, they shared 
their experiences in rather great detail. Moreover, it rendered the therapist to use 
patients’ own quotes. One therapist stated:
Patients think I don’t see them and they don’t see me. They tend to confide more to a 
diary. Sometimes they told me “I don’t know whether I should write everything down 
in such an uncensored manner.” And I encouraged them to do so. I sometimes used 
quotes from their own diaries and they asked me “Wow, did I write this down?” They 
sometimes used impressive words.
[Female MBCT therapist, 54 years, 5 years of experience, no prior eMBCT experience]
Therapist Theme 2: Treatment Format—Barriers
Asynchronicity
Therapists were unable to comment on present moment experiences. This made it 
difficult to communicate what mindfulness is about. One therapist stated:
The experience-driven nature, the contact when a patient says something or shows 
emotion with which you can work instantly, which everyone immediately feels, that is 
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direct. And it has a lot of impact. This is why things are so slowed down in the online. 
You have no direct experience to work with. [Female MBCT therapist, 54 years, 11 years 
of experience, no prior eMBCT experience]
The asynchronicity made it more difficult to maintain continuity and to prevent dropout 
from the eMBCT. One therapist stated:
Whenever a life event took place or I fell ill myself […] the schedule started to get awry 
fairly quickly. Patients hand in their diaries too late […] and you start hopping from 
miscommunication to miscommunication. In the worst case, the training gets bogged 
down and the output is zero. [Female MBCT therapist, 62 years, 10 years of experience, 
no prior eMBCT experience]
Technical Issues
Therapists indicated that technical issues also proved to be a barrier to treatment 
continuity. One therapist stated:
The technical background might have been a possible reason for dropout. I thought it 
was difficult myself. The whole logistics of where to find what, how the site was built up, 
where I had to click. I didn’t think it was intuitive. It took me some time. [Female MBCT 
therapist, 54 years, 11 years of experience, no prior eMBCT experience]
Writing
Therapists indicated that a major drawback of the communication in writing is the 
complete lack of nonverbal communication. One therapist stated:
I prefer to see someone’s nonverbal emotions. And to show that I open up. I had to think 
about this, how do I do this in writing? Is that even possible? [Female MBCT therapist, 
58 years, 11 years of experience, prior eMBCT experience]
Moreover, they sometimes felt as if their therapeutical repertoire was limited by writing. 
One therapist stated:
I noticed that my feedback sometimes, as it was in writing only, did not contain 
everything I wanted to say. My repertoire is bigger and I was not always able to use 
all my skills. [Female MBCT therapist, 62 years, 10 years of experience, no prior eMBCT 
experience]
Sometimes, because of emphasis on reading and writing, it only became clear at a later 
stage that the patient did not fully understand everything. One therapist stated:
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Sometimes patients come up with issues that have been taken care of already. Maybe 
because the training relies so heavily on reading and writing, patients absorb the 
training differently. [Female MBCT therapist, 49 years, 6 years of experience, no prior 
eMBCT experience]
Therapist Theme 3: Role of the Therapist—Facilitators
Feedback
Therapists indicated that it was facilitating for patients that they were able to provide a 
group context. One therapist stated:
You can provide examples from other patients or a funny example from a group 
situation. [Female MBCT therapist, 60 years, 6 years of experience, prior eMBCT 
experience]
In their feedback, they considered it motivating to provide reassurance very explicitly. 
One therapist stated:
In the online training I am much more complimentary for doing the exercises despite 
being so tired, and in the group I am much less inclined to do so. [Female MBCT 
therapist, 60 years, 6 years of experience, prior eMBCT experience]
Therapists were also involved in making the training more personal. One therapist 
stated:
I make it very clear from the start that “I write this feedback to you. This is not standardized 
feedback,” so the patient knows he or she is dealing with an actual person. Someone 
actually replied “Good to know that there is a person at the other side.” [Female MBCT 
therapist, 54 years, 5 years of experience, no prior eMBCT experience]
Therapist Theme 3: Role of the Therapist—Barriers
Feedback
A lack of diary entries was a turnoff for therapists in providing stimulating feedback. 
One therapist stated:
I noticed that it was not very stimulating when patients filled out very little. I think my 
own feedback will have been much shorter as well, and I much easier reverted to saying 
“good luck next week.” [Male MBCT therapist, 40 years, 10 years of experience, prior 
eMBCT experience]
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Therapists indicated that they experienced it as a barrier that more explicit disclosure 
and checking with the patient is necessary. One therapist stated:
I tell more about myself, “I recognize this when doing the body scan myself,” far more 
often than I used to do in a group setting, and you have to be very explicit, check and 
check again how things come across. [Female MBCT therapist, 58 years, 11 years of 
experience, prior eMBCT experience]
Mindfulness
Therapists also stated that it was hard for them to embody mindfulness values behind 
the computer. One therapist stated:
When patients start to get doubtful, or skeptical about the training, the power of your 
presence can be really important. Not in the sense of being able to convince people but 
with a visible nonverbal way of saying, “everything is OK,” and showing this by being 
embodied. You can’t do this via the PC. [Female MBCT therapist, 62 years, 10 years of 
experience, no prior eMBCT experience]
Therapist Theme 4: Patient Characteristics—Facilitators
Self-Discipline
Therapists indicated that for some patients, the eMBCT was partly a training in self-
discipline, which supported patients’ self-sufficiency after the training. One therapist 
stated:
Some patients train in self-discipline. They have to, which maybe renders them more 
likely to continue practicing. Yes, dropout is higher, but those who do finish the training 
are very disciplined in doing so and did it more on their own, without the group context. 
More self-reliant, which is in line with mindfulness. [Female MBCT therapist, 54 years, 5 
years of experience, no prior eMBCT experience]
Therapist Theme 4: Patient Characteristics—Barriers
Self-Efficacy
In the eMBCT, patients need to be resolute and determined. This was mentioned as a 
barrier to complete eMBCT. One therapist stated:
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When a patient was not able to login, the webmaster provided a link. The patient then 
neglected this link. If someone helps you, as a patient you must go for it and say “OK 
thank you, I will try again, and if it doesn’t work, I will mail you again.” [Female MBCT 
therapist, 62 years, 10 years of experience, no prior eMBCT experience]
Writing Fluency
Therapists indicated that a lack of writing skills made it difficult to understand patients’ 
messages. One therapist stated:
Sometimes it was difficult to read past the spelling mistakes and to actually see what 
someone meant, and not to write down constantly “what do you mean?” [Female 
MBCT therapist, 58 years, 11 years of experience, prior eMBCT experience]
DISCUSSION
Principal Findings
The aim of this study was to gain qualitative understanding of the facilitators and barriers 
of eMBCT in a sample of heterogeneous cancer patients. Both eMBCT completers 
and dropouts participated in posttreatment interviews. Moreover, we conducted 
a focus group interview with eMBCT therapists. In all, this study adds to the existing 
quantitative evidence for eMBIs in cancer [7,8] by providing a qualitative perspective. 
Four overarching themes emerged, which were largely convergent between patients 
and therapists: treatment setting, treatment format, role of the therapist, and patient 
characteristics. Patients and therapists are much more flexible in when, where, and how 
they engage in eMBCT compared with group-based MBCT.
However, most eMBCT advantages seemed to come at a price. When patients and 
therapists mentioned a certain aspect as facilitating (eg, the individual setting: not 
having to cope with other patients’ stories), they also mentioned it as barrier (no peer 
support).
Patients and therapists reported similar advantages and disadvantages of the timing, 
the individual nature, the asynchronous nature (for patients, this was detrimental to 
the relevance of therapist feedback, and for therapists, this was a threat to treatment 
continuity), the diaries, and the importance of self-discipline. The fact that so many 
aspects of the eMBCT were mentioned both as facilitator and barrier emphasizes the 
importance of offering flexibility in eMBIs.[21]
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There were also differences between patients and therapists. As known from a previous 
qualitative study on eMBCT [21], bearing the responsibility for time management was a 
barrier for patients. For therapists, the eMBCT seemed to require a larger time investment 
compared with group-based MBCT. Moreover, therapists were more concerned with the 
(vulnerability of ) continuity of the training. They also mentioned that missing out on 
nonverbal information rendered them unable to spot patient withdrawal at an early 
stage, and to determine the reason for empty diaries. Furthermore, therapists seemed 
more bothered by communicating mindfulness values in eMBCT than patients. Patients 
specifically mentioned asynchronicity as barrier to the role of the therapist because the 
asynchronous communication hindered emergence of a dialogue.
Clinical Implications
Although studies to date do not suggest that differences between how therapists 
handle the contact with their clients explain much variance in treatment outcome 
[16], the necessity of training and support for Internet-based therapists should be 
acknowledged. New eMBCT therapists should understand the importance of flexible 
availability and the dynamics of asynchronous interaction to pick up early signs of 
patient withdrawal.
The current eMBCT was individual, asynchronous, and therapist-assisted. One important 
adaptation may be to offer a peer support group.[26] The group context in MBIs supports 
perspective taking and the transition from personal story into investigation of common 
patterns of distress [6], and may foster skills relevant to valuing self and feeling close to 
others, which may help participants feel less isolated.[21] As a stand-alone intervention, 
formal online peer support group interventions for cancer patients have demonstrated 
preliminary feasibility and effectiveness.[27]
Another consideration may be to employ a synchronous videoconferencing format.
[13] This takes away the barriers associated with asynchronous delivery and may 
facilitate dialogue with the therapist and peer support. A possible caveat may be that 
videoconferencing does not alleviate the scheduling issues inherent in group eMBIs 
[13] and that synchronous videoconferencing solutions are technically much more 
demanding. An alternative to videoconferencing may be to include synchronous written 
conversations (or “chats”) with therapists or trained volunteers. Chats are becoming 
increasingly popular as Web-based mental health interventions by themselves and 
show inconclusive but promising evidence .[28]
Eventually, one could employ a blended format, combining the advantages of Web and 
group-based therapy.[29] Blended eMBIs could have group-based group meetings at 
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the start, midst, and end of the programme. The meeting at the start of the intervention 
could be used to address practical and technical matters, a midtreatment meeting 
to address common barriers experienced by patients during practice, and meeting 
at the end to say goodbye to each other and support patients to take responsibility 
for the continuation of their mindfulness practice in the future. In between group-
based sessions, patients could be offered online sessions. In our view, these practical 
arrangements could greatly improve the acceptability and effectiveness of eMBCT.
Research Implications
Previous studies have provided encourageing quantitative evidence, for example, 
eMBIs in cancer patients.[13] Together with this study, these results provide support 
for a larger, quantitative trial directly comparing eMBCT with group-based MBCT for 
cancer patients. Moreover, it would be interesting to directly compare individual eMBCT 
with individual group-based MBCT. Future trials should test for differences in treatment 
accessibility, program adherence, and treatment outcome between eMBCT with and 
without peer support, with and without synchronous communication modalities, and 
with and without therapist assistance.[17] This would allow us to further elucidate the 
predictors and mediators of treatment effect in Internet-based interventions [30] to 
help us determine which patient to offer group-based versus Internet-based treatment. 
Moreover, all of the abovementioned design alterations likely impact cost-effectiveness 
of the interventions, which should be considered.[31] Thus, future studies should 
preferably assess how different eMBCT delivery formats influence program adherence, 
mindfulness skills, and treatment outcome, and how different versions of eMBCT 
delivery formats compare both qualitatively and quantitatively with group-based MBCT.
Strengths and Limitations
This is the first study to qualitatively explore facilitators and barriers of eMBCT for cancer 
patients. The relatively large sample size enabled us to reach data saturation and report 
a broad view of experiences. Moreover, we interviewed both completers and dropouts. 
Furthermore, we had the opportunity to gather data in the therapists. Nevertheless, our 
results should be interpreted within the limitations of our findings. We did not perform 
member checks to ensure validity of the verbatim transcripts. Moreover, the sample 
of the larger RCT consisted of cancer patients who self-selected themselves for a trial 
on an MBI. This implies that our findings cannot be extrapolated to cancer patients in 
general. In addition, some patients or therapists who participated in the training and 
were invited for focus groups or individual interviews declined participation, which may 
further limit the generalizability of our findings to all participating patients.
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Conclusions
We aimed to gain understanding of the facilitators and barriers of individual, 
asynchronous, and therapist-assisted eMBCT for cancer patients. Patients and therapists 
reported similar advantages and disadvantages of the timing, the individual nature, the 
asynchronous nature, the diaries, and the importance of self-discipline. Future studies 
should assess how different eMBCT delivery formats could further improve treatment 
accessibility, program adherence, and treatment outcome.
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ABSTRACT
Objective
It was previously determined that group-based face-to-face MBCT (MBCT) and individual 
internet-based MBCT (eMBCT) are equally efficacious compared to treatment as usual 
(TAU) in reducing psychological distress. In this study the incremental cost-effectiveness 
of both interventions compared to TAU was assessed.
Methods
This cost-effectiveness study included 245 self-referred heterogeneous cancer patients 
with psychological distress who were randomized to MBCT, eMBCT or TAU. Healthcare 
costs and (informal) work-related productivity losses were assessed by interview. 
Outcomes were expressed in EuroQol-5D-3L utility scores and Quality Adjusted Life 
Years (QALY). An economical evaluation with a time-horizon of 3 months was conducted 
from the societal perspective in the intention-to-treat sample. In addition, secondary 
explorative analyses of costs and quality of life during the 9 month-follow-up were 
conducted based on linear extrapolation of TAU.
Results
Paid work-related productivity losses and societal costs were lower in both intervention 
conditions compared to TAU during the 3-month intervention period. Moreover, quality 
of life (utility scores) improved in eMBCT versus TAU (Cohen’s d: .54) and MBCT versus TAU 
(.53). At a willingness to pay of €20000 per QALY, the mean incremental net monetary 
benefit was €1916 (SD=€783) in eMBCT and €2365 (SD=€796) in MBCT versus TAU. 
Exploration of costs demonstrated an equal pattern of eMBCT and MBCT being superior 
to TAU. Quality of life at 9 months follow-up remained improved in both interventions.
Conclusions
Results indicate that eMBCT and MBCT are cost-saving treatments whilst simultaneously 
improving quality of life for distressed cancer patients.
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BACKGROUND
Psychological distress is a negative emotional experience which impedes coping 
with cancer and its treatment.[1] Psychological distress is highly prevalent in cancer 
patients[2] and results in serious consequences such as reduced quality of life, 
decreased compliance with medical care, prolonged duration of hospital stay[3, 4] and 
increased (inadequate) healthcare use.[5] Although not all distressed cancer patients 
subsequently wish for psychological treatment[6], the availability of effective treatment 
for psychological distress in cancer patients is required.
Psychological treatment in cancer patients yield small to medium effects in reducing 
psychological distress.[7] In addition to cognitive behavioural therapy, Mindfulness-
based interventions (MBIs)[8, 9] are offered in oncological settings. Several randomized 
controlled trials (RCTs) indicate that MBIs result in significant improvements of 
depressive and anxiety symptoms in cancer patients.[10-16]
MBIs are usually offered as an eight-week, face-to-face group training. However, 
attending group-based MBI is not always possible for cancer patients due to illness, 
anticancer treatments, fatigue and/or limited transportation options.[17] Internet-based 
interventions, on the other hand, are easily accessible, available 24/7 when delivered 
asynchronously and save travelling time.[18, 19] A recent multicentre RCT in 245 self-
referred heterogeneous cancer patients with (mild) psychological distress showed 
that both group-based Mindfulness-based Cognitive Therapy (MBCT) and individual 
internet-based MBCT (eMBCT) had a significant and moderate effect in reducing 
psychological distress in comparison to Treatment as Usual (TAU).[15] The uncontrolled 
follow-up period of 9 months demonstrated consolidation of treatment effects in both 
interventions, with a slightly better effect in the eMBCT than MBCT condition.[20]
However, it remains unknown whether (e)MBCT provides value for money.[21] A study in 
129 breast cancer patients suffering from persistent pain explored cost-effectiveness of 
MBCT compared to wait-list control with a time horizon of 6 months. When willingness-
to-pay (WTP) was €0, the MBCT intervention was cost-effective with a probability of 
85% and remained cost-effective with a probability of 70% to 82% when smaller effect 
and higher MBCT costs were assumed.[22] Another study in 104 breast cancer patients 
compared the cost-effectiveness of Mindfulness-Based Stress Reduction (MBSR) to wait-
list controls with a time horizon of 12 weeks. MBSR was more costly ($+666) with an 
incremental QALY gain of +0.03 compared to wait-list controls, resulting in an ICER of 
$22,200/QALY.[23] Another study in 191 breast cancer patients investigated the cost-
effectiveness of Mindfulness-Based Art Therapy (MBAT) compared to an active support 
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group with a time horizon of 9 weeks. MBAT demonstrated the potential to achieve 
parity with the support group intervention if some intervention-related costs were 
reduced.[24]
In short, the first studies demonstrate a tentatively positive view of the economic 
potential of MBIs. However, these studies included homogeneous samples of breast 
cancer patients and did not include an economic evaluation of an electronically delivered 
format of MBCT. Therefore, the primary aim of the current study was to evaluate the cost-
effectiveness of both eMBCT and MBCT compared to TAU in a heterogeneous sample of 
distressed cancer patients from the societal perspective in the period from baseline (T0) 
to post-treatment (T1). The secondary aim was to explore costs and quality of life during 
the 9 month-follow-up (12-month time horizon) based on a linear extrapolation of TAU.
METHODS
Trial design, participants, procedure
Study methods have been described in detail elsewhere.[15] The present study is an 
economic evaluation from a societal perspective based on the results of a three-armed 
multicentre, parallel group randomized controlled trial comparing the effectiveness 
of eMBCT and MBCT to TAU in reducing psychological distress in cancer patients. 
Randomization was stratified for treatment centre and minimized for anticancer 
treatment intent (curative/palliative) and cancer type (breast/other). As patients 
randomized to TAU received either eMBCT or MBCT after the control period, the time 
horizon of the economic evaluation was restricted to 3 months.
Inclusion criteria were: a) any cancer diagnosis, any tumour type or stage, at any 
time in the past, on or off treatment; b) a score of ≥ 11 on the Hospital Anxiety and 
Depression Scale (HADS);c) ability to attend MBCT both face-to-face and online; and 
d) good command of the Dutch language. Exclusion criteria were: a) severe psychiatric 
morbidity such as suicidal ideation and/or current psychosis; b) change in psychotropic 
medication dosage within a period of three months prior to baseline; c) current or 
previous participation in ≥ 4 sessions of an MBI. Patients were recruited from April 2014 
to December 2015 via self-referral. The study was approved by the ethical review board 
of the Radboud University Medical Center (CMO Arnhem-Nijmegen 2013/542) and all 
centers provided local ethics approval. The study was registered on Clinicaltrials.gov 
(NCT02138513), reported following CONSORT guidelines.[25] A protocol paper was 
published in advance.[26] All participants provided written informed consent prior to 
enrolment.
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Interventions
Face-to-face MBCT
The MBCT protocol[9] was followed except for slight tailoring to the cancer patient. 
MBCT consisted of eight weekly 2.5h group sessions guided by a therapist, a six-hour 
one-day silent retreat and daily home practice assignments of about 45  minutes. All 
therapists in this study were accredited in concordance with the UK Mindfulness-Based 
Teacher Trainer Network Good Practice Guidelines.
eMBCT
The eMBCT was identical to MBCT in terms of content but was delivered individually 
and included weekly asynchronous written interaction with a therapist over email. For 
more information on this intervention we refer to our other work.[15, 19]
Treatment as usual
Treatment as usual (TAU) consisted of all healthcare patients wished to receive. There 
were no restrictions on healthcare utilization during the study period, except they were 
asked not to participate in MBIs.
Measures
Healthcare costs
The Trimbos/iMTA questionnaire for Costs associated with Psychiatric illness (TiC-P)
[27] was used to collect information on direct healthcare use (e.g. general practitioner, 
mental healthcare and hospital day care visits) and paid and informal work-related 
productivity losses. The TiC-P is a self-report instrument, but in the current study the 
TiC-P was administered by the researchers in an interview format. The recommended 
time-horizon for determining healthcare costs by TiC-P of three months was used.[27]
Direct healthcare costs were calculated by multiplying volumes of care by standardized 
unit prices indexed using Dutch national price indices to the 2016 price level[28] (see 
Supplementary Table 1 (online only)). Prescription medication costs were retrieved from 
the Dutch national tariff list in 2017 (https://www.medicijnkosten.nl). Total, or societal, 
costs were calculated as the sum of medical and formal and informal productivity loss 
costs for T1, T1+T2, and T1+T2+(T3*2), reaching a time horizon of 12 months (9 months 
post-treatment).
Indirect costs – paid and informal work-related productivity losses
Indirect costs due to paid work-related productivity losses included absenteeism and 
presenteeism costs. Absenteeism costs - paid-work productivity losses due to absence 
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- were calculated by multiplying the number of hours patients were absent from their 
job by the gross wage per hour according to the Dutch guideline for health economic 
evaluations.[29]
Presenteeism costs – paid-work productivity losses due to being sick while at work - 
were calculated by multiplying estimated number of work hours lost by gross wage 
per hour. Indirect costs related to paid work-related productivity losses were calculated 
according to the Friction Cost (FC) method.[30] The friction period is the period needed 
to replace the ill worker and to restore the initial production level. A friction period of 
85 days was used. When patients were ill for a period longer than 4 weeks and shorter 
than the friction period, a maximum of 21.7 sick days were counted in accordance with 
guidelines.[29] Once patients met the friction period criterium of >85 sick days at a 
specific time point (starting count at baseline) no additional indirect costs due to work 
were included during the rest of the study period.
Indirect costs related to productivity loss in informal work was measured by multiplying 
the estimated amount of hours others took over informal work the patient due to illness 
by the gross estimated costs per hour.[29] The recall period for paid and informal work-
related productivity losses was 4 weeks (as per default). When applicable, both paid 
and informal work-related costs were proportionately extrapolated from 4 weeks to 3 
months to match the recall period of the healthcare use questionnaire. Dutch national 
price indices were used to index healthcare and productivity costs to the 2016 price 
level[28] and costs were presented in Euros.
Intervention costs
Additionally, intervention costs were €299.00 per person for patients participating in the 
MBCT and €331.16 per person for patients participating in eMBCT (see Supplementary 
Table 2 (online only)). In MBCT, travel and parking related costs were calculated on 
an individual basis.[29] Intervention development costs were regarded as sunk costs 
and were therefore disregarded because they would not need to be repeated if the 
intervention were adopted on a broader scale.[31]
Quality of life
To measure the health-related quality of life (QoL) of cancer patients, a validated health-
related QoL instrument was used: the EuroQol-5D-3L (EQ-5D).[32, 33] The EQ-5D index 
is obtained by applying predetermined weights to the five domains. This index gives 
a societal-based global utility score of the participant’s health status on a scale with 0 
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(death) and 1 (perfect health). From the utility scores at T0 and T1 QALYs were calculated 
for each patient using the Area Under the Curve (AUC) method: ((EQ5D T0 + EQ5D T1) 
/ 2) * (3/12).
Linear extrapolation
One way to deal with extrapolation of a cost pattern is to assume a linear relationship 
between costs and volume within some relevant range. Within that relevant range, the 
total cost varies linearly with volume, at least approximately. Outside of the relevant 
range, we presume the assumptions about linear cost behavior may be invalid. In terms 
of somatic care, patients followed clinical routine with which we did not intervene and 
which would remain similar after TAU. With regard to psychological care it is known that 
psychological distress levels are associated with healthcare consumption[5] and these 
did not change in patients receiving TAU only.[15] Therefore, the T1 measurement in 
TAU was linearly extrapolated up to 12 months.
Analyses
Descriptive analyses of mean differences between conditions were tested by one-
way ANOVAs including treatment (eMBCT, MBCT or TAU) as independent variable and 
healthcare costs/ paid work costs / informal work costs / societal costs / EQ-5D utility 
scores / QALYs as dependent variable on the complete-case intention-to-treat (ITT) 
sample. Analyses of follow-up costs per category included costs at baseline as a covariate. 
Post-hoc tests were conducted by simple contrasts using TAU as reference group with 
Bonferroni-corrected (due to two comparisons to TAU) one-sided p-values (considering 
the positive clinical RCT) rendering p≤.05 as significant. Cohen’s d effect sizes (ES) were 
calculated by dividing the difference in means by baseline pooled SDs of the respective 
conditions[34] and in accordance with Cohen’s guidelines, were interpreted as small (0.2 
to 0.5), medium (0.5 to 0.8), or large (.8).[34] Cost-effectiveness analyses were conducted 
from the societal perspective on the complete-case ITT sample including all patients 
who filled-out the TiC-P and EQ-5D at T1, T2 and T3. The mean healthcare costs per 
person were compared across groups. The bootstrapped replications were graphed on 
two cost-effectiveness planes (eMBCT vs. TAU and MBCT vs. TAU). The horizontal axis 
of these planes represents the incremental effects and the vertical axis represents the 
incremental costs. The QALY model assumes WTP= willingness to accept compensation.
In addition, the net monetary benefit (NMB) was determined: NMB = (effect E of 
intervention expressed in QALY * WTP) – costs C for intervention. If the incremental NMB 
(∆E * WTP - ∆C) is > 0, the intervention is considered to be cost-effective compared to 
an alternative. For the exact WTP is unknown, results of regression analyses with the 
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NMB as dependent variable were subsequently used to obtain a cost-effectiveness 
acceptability curve (CEAC) by plotting 1-p/2 against different levels of WTP (0, 20000, 
40000, 60000, 80000) for a QALY where p is the p-value from the coefficient on the 
treatment dummy variable in the regression analyses.[35]
RESULTS
Sample characteristics
In total, 245 self-referred heterogeneous cancer patients with psychological distress were 
randomly assigned to eMBCT (n=90), MBCT (n=77) or TAU (n=78) (See Figure 1). The three 
conditions did not differ in terms of baseline demographic or clinical characteristics (see 
Table 1). Intervention dropout was significantly higher in the eMBCT than in the MBCT 
group: (χ2(1, n=167) = 3.92, p = .047). Study dropout (number of missing measurements 
at end of treatment) did not differ between conditions. However, patients who dropped 
out from the study demonstrated significantly higher psychological distress scores 
compared to those who completed measurements (F(1,244)=5.82, p=.017). There 
were no significant differences between conditions in direct healthcare utilization. 
The three conditions did not differ in employment status at baseline. Of the patients 
who had a job at baseline, relatively more patients met the friction period criterium in 
both interventions compared to TAU, although this difference was not significant (χ2(2, 
n=245) = 5.25, p = .072).
Cost-effectiveness: 3 month time-horizon
Costs
Direct healthcare costs did not significantly differ between the two intervention 
conditions and TAU (see Table 2). Costs associated with paid work-related productivity 
losses were lower in both eMBCT and MBCT compared to TAU (p=.014 and p=.002, 
respectively). Costs associated with informal work did not differ significantly between 
conditions. Societal costs were significantly lower in both eMBCT and MBCT compared 
to TAU (p=.025 and p=.014).
Quality of life
When QoL was expressed in EuroQol-5D-3L utility scores, patients in the eMBCT 
and MBCT conditions reported significantly higher QoL at T1 than patients in TAU 
(F(2,198)=8.02, p < .001, see Table 2) with moderate effect sizes (eMBCT vs. TAU = .54 
and MBCT vs. TAU = .53) . When QoL was expressed in QALYs, there was a nonsignificant 
difference in favour of both interventions compared to TAU (F(2,198)=2.80, p = .063) 
with small to moderate effect sizes (eMBCT vs. TAU = .36 and MBCT vs. TAU = .34).
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TABLE 1: Baseline Sociodemographic and Clinical Characteristics (n=245).
Characteristic
All
n=245 n (%)
eMBCT
n=90 n (%)
MBCT
n=77 n (%)
TAU
n=78 n (%)  
Sex 0.912
Female 210 (85.7) 77 (85.6) 67 (87.0) 66 (84.6)
Male 35 (14.3) 13 (14.4) 10 (13.0) 12 (15.4)
Age, years 0.464
Mean 51.7 52.4 52.1 50.4
SD 10.7 10.7 11.4 9.9
Married / in a relationship 0.491
Yes 202 (82.4) 76 (84.4) 65 (84.4) 61 (78.2)
No 43 (17.6) 14 (15.6) 12 (15.6) 17 (21.8)
Children 0.314
Yes 169 (69.0) 65 (72.2) 48 (62.3) 56 (71.8)
No 76 (31.0) 25 (27.8) 29 (37.7) 22 (28.2)
Education  0.451
High 166 (67.8) 56 (62.2) 54 (70.1) 56 (71.8)
Middle 77 (31.4) 34 (37.8) 22 (28.6) 21(26.9)
Low 2 (0.8) 0 1 (1.3) 1(1.3)
Diagnosis  0.724
Breast cancer 151 (61.6) 53(58.9) 53 (68.8) 45 (57.7)
Gynecological cancer 18 (7.3) 9 (10.0) 2 (2.6) 7 (9.0)
Prostate cancer  16 (6.5) 7 (7.8) 6 (7.8) 3 (3.8)
Colon cancer 12 (4.9) 4 (4.4) 4 (5.2) 4 (5.1)
Non-hodgkin’s lymphoma 11 (4.5) 3 (3.3) 1 (1.3) 7 (9.0)
Skin cancer 5 (2.0) 3 (3.3) 1 (1.3) 1 (1.3)
Thyroid cancer 4 (1.6) 1 (1.1) 1 (1.3) 2 (2.6)
Bladder cancer 4 (1.6) 2 (2.2) 1 (1.3) 1(1.3)
Neuroendocrine tumour 4 (1.6) 2 (2.2) 1 (1.3) 1 (1.3)
Other 20 (8.2) 6 (6.7) 7 (9.1) 7 (9.0)
Years since diagnosis 0.616
Mean 3.5 3.3 3.9 3.2
SD 4.7 4 5.7 4.3
Anticancer treatment intent 0.472
Curative 206 (84.1) 74 (82.2) 68 (88.3) 64 (82.1)
Palliative 39 (15.9) 16 (17.8) 9 (11.7) 14 (17.9)
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TABLE 1: Continued.
Characteristic
All
n=245 n (%)
eMBCT
n=90 n (%)
MBCT
n=77 n (%)
TAU
n=78 n (%)  
Current treatment 0.694
None 133 (53.1) 49 (54.4) 43 (55.8) 41 (52.6)
Hormone therapy 79 (32.2) 28 (31.1) 22 (28.6) 29 (37.2)
Combination of treatments 12 (4.9) 4 (4.4) 4 (5.2) 4 (5.1)
Immunotherapy 9 (3.7) 5 (5.6) 1 (1.3) 3 (3.8)
Radiotherapy 8 (3.3) 3 (3.3) 5 (6.5) 0
Chemotherapy 4 (1.6) 1 (1.1) 2 (2.6) 1 (1.3)
Cost-effectiveness
The cost-effectiveness planes (Figure 2) revealed that the vast majority cost-effective 
pairs are located in the south-east quadrant where both interventions are more effective 
and less costly than TAU, i.e., dominate TAU. At a WTP of €20000 the mean incremental 
net monetary benefit was €1916 (SD=€783) in eMBCT versus TAU and €2365 (SD=€796) 
in MBCT versus TAU. The Cost-effectiveness Acceptibility Curve (CEAC) indicated that 
the probability of both interventions being cost-effective hovers around 99% regardless 
of the level of WTP per QALY gained (see Figure S1 (online only)).
Exploration of costs and quality of life during the 9 month-follow-up
Costs
Healthcare costs were significantly lower in eMBCT and MBCT compared to TAU in (p 
= .035 and p = .048, respectively). Paid work-related costs were significantly lower in 
both interventions compared to TAU (both p = <.001). Informal work-related costs were 
significantly lower in both interventions compared to TAU (p = .022 and p =.009). Societal 
costs were significantly lower in both interventions compared to TAU (both p = <.001).
Quality of life
Patients in both interventions maintained the increased QoL over the follow-up period 
with no significant differences between eMBCT and MBCT.
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Randomized
(n=245)
Treatment as
usual
(n=78, 31.8%)
Completed T1
assessment
(n=63, 80.7%)
Not started
(n=0)
Discontinued
(n=1, 1.3%)
MBCT during TAU (n=1)
Lost to follow up
(n=15, 19.2%)
No reason provided (n=8)
Withdrawal (n=3)
Illness progression (n=3)
Too burdensome (n=1)
Completed
Treatment as
usual
(n=77, 98.7%)
Group-based
MBCT
(n=77, 31.4%)
Completed T1
assessment
(n=64, 83.1%)
Not started
(n=7, 9.1%)
Scheduling (n=2)
Group unavailable (n=2)
Medical reason (n=1)
Other intervention (n=1)
Deceased (n=1)
Discontinued
(<4 sessions)
(n=6, 7.8%)
No motivation (n=2)
Medical reason (n=2)
Too burdensome (n=1)
MBCT experience (n=1)
Lost to follow up
(n=13, 16.9%)
Scheduling problem (n=4)
Withdrawal (n=3)
No reason provided (n=3)
Illness progression (n=2)
Deceased (n=1)
Completed
Group-based
MBCT
(n=64, 83.1%)
Internet-based
MBCT
(n=90, 36.7%)
Completed T1
assessment
(n=72, 80.0%)
Not started
(n=8, 8.9%)
Other intervention (n=4)
No reason provided (n=2)
Medical reason (n=1)
Computer difficulties (n=1)
Discontinued
(<4 sessions)
(n=19, 21.1%)
No motivation (n=6)
No reason provided (n=2)
Scheduling (n=3)
Medical reason (n=2)
Too burdensome (n=3)
Computer difficulties (n=3)
Lost to follow-up
(n=18, 20%)
No reason provided (n=5)
Withdrawal (n=5)
Scheduling problem (n=3)
Illness progression (n=2)
Too burdensome (n=2)
Unavailable due to mental
health problem (n=1)
Completed
Internet-based
MBCT
(n=63, 70.0%)
Lost to follow up
(n=13, 16.9%)
No reason provided (n=5)
Withdrawal (n=4)
Too burdensome (n=2)
Scheduling problem (n=1)
Deceased (n=1)
Lost to follow-up
(n=21, 23.3%)
No reason provided (n=9)
Withdrawal (n=8)
Illness (n=2)
Too burdensome (n=1)
Scheduling problem (n=1)
Completed T2
assessment
(n=64, 83.1%)
Completed T2
assessment
(n=69, 76.7%)
Lost to follow-up
(n=18, 23.4%)
)
No reason provided (n=7)
Withdrawal (n=6)
Too burdensome (n=2)
Deceased (n=2)
Illness (n=1)
Lost to follow-up
(n=20, 22.2%)
)
Withdrawal (n=12)
Illness (n=4)
No reason provided (n=3)
Too burdensome (n=2)
Deceased (n=1)
Completed T3
assessment
(n=59, 76.6%)
Completed T3
assessment
(n=70, 77.8%)
FIGURE 1: CONSORT flowchart of the cost-utility trial ran alongside clinical trial
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Figure 2: Incremental cost-effectiveness ratios (societal perspective) for both intervention 
conditions versus TAU during intervention period (T0-T1)  
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FIGURE 2: Incremental cost-effectiveness ratios (societal perspective) for both intervention 
conditions versus TAU during intervention period (T0-T1)
CONCLUSIONS
The aim of the current study was to evaluate the cost-effectiveness of both eMBCT and 
MBCT compared to TAU from the societal perspective in the period from baseline (T0) 
to post-treatment (T1) and to explore development of costs and quality of life during 
the 9 month-follow-up results in the period from baseline to 9 month-follow-up (T3) in 
a sample of self-referred (mildly) distressed cancer patients. Because the TAU condition 
did not have a follow-up beyond T1, possible long-term effects of both interventions 
compared to TAU were explored by linearly extrapolating the T1 measurement of TAU 
to T2 and T3.
Healthcare costs and informal work-related productivity losses did not significantly differ 
between conditions, costs associated with paid work were lower in the interventions 
compared to TAU. Importantly, the aggregated societal costs were significantly lower 
in both interventions compared to TAU at all post-treatment measurements – despite 
the added intervention costs. Patients in the eMBCT and MBCT conditions reported 
significantly higher QoL at T1 than patients in TAU with moderate effect sizes, although 
there were no significant differences between conditions in terms of QALYs. This latter 
might be explained as a power issue, as the difference demonstrated a nonsignificant 
trend in favour of both interventions compared to TAU.
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Several psychosocial interventions have previously been demonstrated to represent 
good value for money in cancer care.[36] A review of 11 cost-effectiveness studies of 
psychosocial interventions in cancer care indicate cost-effectiveness at different WTP 
thresholds, but that more research is necessary and that more research should be 
performed encompassing potential important cost drivers from a societal perspective, 
such as productivity losses or informal care costs.[37]
The current results are partly in line with previous findings on cost-effectiveness of 
MBIs for cancer patients [22-24] although it must be noted that there are considerable 
differences between the studies in terms of population, format of the MBI, from which 
perspective the cost-effectiveness analysis was conducted and whether authors used 
a disease specific or generic QoL measure. Moreover, the current results indicate cost-
savings. Most likely, this discrepancy with the most comparable study to date[23] is the 
result of the self-referred nature of the current sample as previous research indicates 
that higher levels of mental comorbidity results in higher healthcare costs in cancer 
patients.[5]
Study limitations
The most important limitation is lack of follow-up for the TAU group, which rendered it 
impossible to empirically determine long-term cost-effectiveness of both interventions 
compared to TAU. However, extrapolated follow-up results demonstrated comparable 
favourable effects of both interventions compared to TAU. Moreover, number of 
dropouts were significantly higher in the eMBCT than in the MBCT group. Lower usage 
than intended is a known problem in e-health intervention research[38] although 
it should be mentioned that not using the technology as defined or implied by its 
creators is not equal to non-adherence or to the participant is not using the technology 
at all. Patients could also drop-out because they experience sufficient improvement in 
psychological distress.[39]
Clinical implications
These results imply that offering Internet-based MBCT in clinical practice improves 
accessibility of psycho-oncological care whilst saving societal costs, without 
compromising intervention efficacy.
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SUMMARY
The present thesis focused on examining the effectiveness and cost-effectiveness of 
group-based Mindfulness-based Cognitive Therapy (MBCT) and Internet-based MBCT 
(eMBCT) compared to Treatment as Usual (TAU) in a sample of 245 distressed cancer 
patients.
The introductory chapter highlighted the background and relevance of this thesis. It 
described how many patients suffer from psychological distress, what the consequences 
of psychological distress in cancer patients are, what evidence-based psychological 
treatments for distressed cancer patients entail and what problems exist in the context 
of accessibility of evidence-based psychological treatments of cancer patients.
Chapter 2 explored the hypothesis that presence of psychiatric disorder and 
psychological distress is associated with increased healthcare utilization and costs. 
The study population consisted of the 245 mixed-cancer patients with at least mild 
symptoms of psychological distress (Hospital Anxiety and Depression Scale–T ≥ 11) who 
participated in the larger Randomized Controlled Trial (RCT). Patients were assessed 
with Structured Clinical Interview for DSM-IV-TR Axis I Disorders (SCID-I) for depressive, 
anxiety, and/or adjustment disorder. Psychological distress was measured by the HADS. 
Retrospective self-reported healthcare utilization in the past 3 months was collected 
by means of the TiC-P, a self-report questionnaire which was assessed in an interview-
format together with one of the researchers. Associations between psychiatric disorder, 
psychological distress and healthcare utilization were assessed in terms of incidence 
rate ratios and costs per category (mental, primary, somatic, and complementary) were 
assessed by negative binomial, logistic, and gamma regression. In total, 36% of patients 
suffered from psychiatric disorder, which was associated with mental healthcare 
utilization and costs. We observed a trend of higher somatic healthcare utilization in 
patients with psychiatric disorder. Psychological distress appeared to be associated with 
higher mental healthcare utilization and costs. Furthermore, psychological distress was 
also associated with complementary healthcare utilization.
The BeMind study, as described in Chapter 3 and 4, concerned a three-armed 
multicenter RCT in 245 mixed-cancer patients who were randomly allocated to MBCT 
(n=77), eMBCT (n=90) or TAU (n=78) and who suffered from at least mild psychological 
distress (Hospital Anxiety and Depression Scale (HADS) ≥ 11). Primary outcome was 
post-treatment psychological distress (HADS). Linear mixed-modelling was conducted 
in the intention-to-treat sample on the continuous outcomes. Dropout from the 
interventions was significantly higher in the eMBCT than in the MBCT group. Patients 
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reported significantly less psychological distress in both MBCT interventions compared 
to TAU. In addition, post-treatment prevalence of psychiatric diagnosis was lower in both 
MBCT (33% improvement) and eMBCT (29%) in comparison with TAU (16%), but these 
changes were not significant. Both interventions reduced fear of cancer recurrence, 
rumination and increased mental health-related quality of life, mindfulness skills and 
positive mental health compared to TAU. Physical health-related quality of life did not 
improve.
Chapter 5 aimed to explore facilitators and barriers of individual asynchronous 
therapist-assisted eMBCT as experienced by both patients and therapists. In total, 31 
patients participated in an individual post-treatment interview and eight therapists 
were interviewed in a focus group interview. Four overarching themes emerged which 
were largely convergent between patients and therapists: treatment setting, treatment 
format, role of the therapist, and patient characteristics. With regard to treatment 
setting, both patients and therapists mentioned that they are much more flexible in 
when, where, and how they engage in eMBCT compared with group-based MBCT. Both 
patients and therapists reported that they were facilitated by this sense of autonomy in 
the eMBCT. Patients indicated that they did not have to cope with other patients’ stories. 
Therapists indicated that they were better able to tailor the intervention to individual 
themes.
There were also differences between patients and therapists. For therapists, the eMBCT 
seemed to require a larger time investment compared with group-based MBCT. With 
regard to treatment format, patients specifically mentioned asynchronicity as barrier to 
the role of the therapist because the asynchronous communication hindered emergence 
of a dialogue. Therapists were more concerned with the (vulnerability of ) continuity of 
the training. They mentioned that missing out on nonverbal information rendered them 
unable to spot patient withdrawal at an early stage, and to determine the reason for 
empty diaries. Furthermore, with regard to role of the therapist, therapists sometimes 
experienced barriers in communicating mindfulness values in eMBCT, whereas patients 
felt they received the information on mindfulness values they needed.
Chapter 6 focused on the cost-effectiveness of both MBCT interventions compared to 
TAU. This cost-effectiveness study was conducted alongside the previously described 
RCT. Healthcare costs and (informal) work-related productivity losses were assessed 
by interview. Outcomes were expressed in EuroQol-5D-3L utility scores and Quality 
Adjusted Life Years (QALY). An economic evaluation with a time-horizon of 3 months 
was conducted from a societal perspective in the intention-to-treat sample. In addition, 
secondary explorative analyses of costs and quality of life during the nine month-
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follow-up were conducted based on a linear extrapolation of TAU. Paid work-related 
productivity losses and societal costs were lower in both experimental conditions 
compared to the control condition TAU during the 3-month intervention period. 
Moreover, quality of life (utility scores) improved in eMBCT and MBCT versus TAU with 
moderate effect sizes. Results indicate that both eMBCT and MBCT are cost-saving 
treatments whilst simultaneously improving quality of life for distressed cancer patients. 
Exploration of costs demonstrated an equal pattern of eMBCT and MBCT being superior 
to TAU. Quality of life improvements at 9 months follow-up remained steady in both 
experimental interventions compared to the outcome at three months.
GENERAL DISCUSSION
The research in this thesis robustly illustrates that MBCT and eMBCT are effective 
alternatives to usual care, leading to less psychological distress, less fear of cancer 
recurrence, less rumination and more positive mental health and well-being and 
quality of life. Moreover, our cost-effectiveness study demonstrated dominance of both 
interventions compared to TAU, indicating lower societal costs and higher quality of life.
Our results in Chapter 2 explored the probability of the cost-offset effect, or the 
hypothesis that cancer patients use less of other (perhaps inadequate) healthcare 
services when psychological distress is reduced.[1] Psychiatric disorder was not related 
to healthcare other than mental healthcare. This contradicts previous findings indicating 
an association between psychiatric disorders and somatic healthcare use [2], although 
we did find a nonsignificant trend in this direction. In The Netherlands, the general 
practitioner might serve as gatekeeper referring distressed patients to mental rather 
than somatic healthcare. In line, tentative results indicated an association between 
depressive symptoms and primary healthcare visits. In contrast to psychiatric disorder, 
psychological distress of cancer patients was found to be significantly associated 
with healthcare use other than mental healthcare – complementary healthcare. In 
part, this discrepancy between psychological distress and psychiatric disorder might 
be caused by the fact that psychological distress as a continuous outcome measure 
carries more information compared to the dichotomous nature of psychiatric disorder 
as outcome measure. With regard to the association between psychological distress and 
complementary healthcare use, it is known that mainly anxiety symptoms are associated 
with use of complementary healthcare in cancer care [3, 4] and some have argued that 
this demarcates a lack of integration of psycho-oncological services.[5] Although a 
recent critical appraisal indicates that MBIs in cancer care recently reflect decreases in 
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sub-clinical symptomatology rather than relief of psychiatric disorders[6], results in this 
chapter indicate that even a decrease in sub-clinical symptomatology could perhaps 
prevent unnecessary and possibly inadequate healthcare utilization.
The results of the RCT (Chapter 3 and Chapter 4) are in line with meta-analyses of 
previous RCTs on MBIs for reducing psychological distress in cancer patients.[7, 8] These 
effects of most of these interventions were found to be sustained in the medium term 
and even long term.[9] In line with this, the follow-up study of the BeMind project (not 
included in the current thesis) also demonstrated consolidation of treatment outcome 
during the nine-month follow-up period. Interestingly, results even demonstrate further 
improvements in cancer patients’ over time especially in eMBCT.[10]
Moreover, these results convincingly demonstrate that Internet-based MBCT renders 
MBCT much more accessible for cancer patients without extra costs and without 
compromising intervention efficacy. As many cancer patients experience barriers to 
participation in face-to-face psychological interventions.[11, 12], Internet-based delivery 
of psychological interventions might be especially powerful in the oncological context, 
where some many patients are hampered either by physical (e.g. travel distance) or 
mental barriers (e.g. not wanting to visit the hospital again).[13] Unfortunately, solid 
evidence for Internet-based MBIs in cancer care is virtually absent and the field is in 
dire need of well-conducted RCTs. One single controlled study (n=62) demonstrated 
feasibility of adapted internet-based MBSR for cancer patients.[14] Another pilot study 
confirmed that MBSR delivered via an iPad may be feasible and acceptable for breast 
cancer patients.[15] A recent RCT compared the effectiveness of a physiotherapy-led 
ambulant physical activity feedback (AAF) intervention to an individual internet-based 
MBCT intervention and psycho-education in n=167 cancer survivors. It was concluded 
that both interventions are effective for manageing fatigue severity compared to 
receiving psycho-educational emails.[16] The current study greatly contributes to the 
scarcely available evidence for Internet-based MBIs in cancer care.
Nevertheless, our qualitative research in Chapter 5 did indicate that there is much to 
be improved in the design and delivery of the Internet-based format. First, patients 
mentioned lack of peer support and the asynchronous communication with their 
therapist as disadvantages of Internet-based MBCT. Second, our RCT also demonstrated 
that the proportion of patients receiving a lower dosage of MBCT than intended was 
higher in Internet-based MBCT than in group-based MBCT. Patients dropped out due 
to lack of motivation, engaging in another intervention of preference and technical 
difficulties. However, the proportion of patients receiving a lower dosage of MBCT 
than intended was higher in internet-based MBCT, which although cost-effective 
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still was pretty resource intensive. Lower usage than intended is a known problem in 
e-health intervention research[17], although it should be mentioned that not using the 
technology as defined or implied by its creators is not equal to non-adherence or to the 
participant is not using the technology at all. Patients could also drop-out because they 
experience sufficient improvement in psychological distress.[18, 19]
Patients mentioned lack of peer support and the asynchronous communication with 
their therapist as disadvantages of internet-based MBCT. So, internet-based MBCT 
could and should be further improved to ensure adherence and scalability. Previous 
research indicated that increased interaction with a counsellor, more frequent intended 
usage, more frequent updates and more extensive employment of dialogue support 
significantly predicted better adherence.[17] This implies that technical improvement is 
necessary and possibly alternative modes of treatment delivery should be explored in 
future research.
The results of our cost-effectiveness analysis in Chapter 6 indicate that both MBCT 
and eMBCT have the potential to reduce societal costs already during the intervention 
period. This is a great achievement, as cost-effectiveness evaluations of psychological 
treatments are much needed in the field of psychosocial oncology [20] and in MBIs 
in general [21] to determine whether providing MBCT to cancer patients indeed is 
economically attractive. The current healthcare system increasingly asks for these 
studies as choices have to be made regarding optimal resource allocation. In this cost-
effectiveness study, we not only included healthcare costs, but also gathered data on 
productivity losses, informal healthcare costs and used QALYs as an outcome measure.
[20] The current results are partly in line with previous findings on cost-effectiveness of 
MBIs for cancer patients[22-24] although there is considerable heterogeneity in what 
circumstances previous cost-effectiveness analyses were conducted. For example, 
previous research on cost-effectiveness of MBIs is restricted to breast cancer patients. 
Moreover, we found MBCT to be cost-saving. This discrepancy with the most comparable 
study to date (Lengacher et al.[22]) is most probably the result of the self-referred nature 
of the current sample.
In short, our study on MBCT in cancer patients is the first to indicate that MBCT, both 
group- and Internet-based, yields lower psychological distress and higher quality of life 
whilst simultaneously saving societal costs.
Strengths
This thesis included the first large-scale RCT of eMBCT and MBCT in cancer patients in 
The Netherlands using a large, clinically representative heterogeneous sample of mixed-
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cancer patients in different stages of disease. This is a strength, as breast cancer patients 
are overrepresented in studies on MBIs in cancer patients so far [6] and expansion of the 
evidence-base of psycho-oncological interventions in e.g. advanced, non-breast cancer 
in psycho-oncological research is necessary.[25]
Moreover, we employed a patient-centred self-selected recruitment method. In the 
BeMind study, we managed to accrue over 500 and to include 245 patients in a period 
of about 20 months. In previous psycho-oncological research, consecutive sampling of 
patients in hospital outpatient settings lead to recruitment difficulties.[26] Since psycho-
oncology interventions differ from many other cancer treatments in that not all cancer 
patients would like treatment despite having psychological symptoms, self-referral 
recruitment can be less resource intensive than clinic-based consecutive recruitment 
and may facilitate more rapid attainment of recruitment targets.[27]
Furthermore, this study was conducted in a variety of clinical settings, again of benefit 
to the clinical representativeness.
With regard to choice of outcome measures, it may be of specific interest to the 
individual patient that MBCT does not only impact regulation and normalization of 
negative emotional experiences, but also at rediscovering aspects positive emotional 
well-being [28] which may, albeit overshadowed, still be present in the face of cancer. 
Becoming aware again of aspects of positive well-being may perhaps foster an upward 
spiral that might be promoted by MBCT.[29]
Concerning intervention fidelity, another strength is the use of protocolised MBCT. 
A recent systematic review indicated that MBIs in psycho-oncology are often poorly 
defined. [6] The MBCT curriculum used in both group and Internet-based MBCT 
interventions is primarily based on the MBCT program by Segal, Williams and Teasdale.
[30] The program was slightly adapted to the oncology patient in terms of psycho-
education and movement exercises. In both conditions, participants received guided 
mindfulness meditation exercises for home practice and a reader with home practice 
instructions and background information. The Internet-based MBCT intervention was 
similar to group MBCT in terms of protocollized curriculum content.
We took care of the quality of the MBCT intervention. Our mindfulness therapists, or 
teachers, fulfilled the advanced criteria of the Association of Mindfulness-based Teachers 
in The Netherlands and Flanders) which are in concordance with the UK Mindfulness-
Based Teacher Trainer Network Good Practice Guidelines for teaching mindfulness-based 
courses.[31] In addition, all involved teachers had previous experience with providing 
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psychological care to cancer patients. Three full-day plenary supervision meetings were 
held during the intervention phase of the trial. All teachers are involved in both group 
and Internet-based MBCT. Teachers without prior Internet-based MBCT experience 
were provided with guidelines and supervised by more experienced Internet-based 
MBCT teachers. Group sessions were videotaped to evaluate teacher competence and 
protocol adherence using the Mindfulness-Based Interventions - Teachers Assessment 
Criteria (MBI-TAC)[32] by two independent therapists who evaluated two random 
sessions from each of the nine therapists providing face-to-face MBCT (who treated 
80.8% of all patients receiving either intervention). Of the nine therapists rated, four 
were considered proficient, three competent and two beginner.
Limitations
In addition to the strengths of the current thesis, some limitations should be mentioned 
as well. Next to our primary research questions concerned at determining the efficacy 
of both MBCT interventions compared to TAU in reducing psychological distress at end 
of treatment, secondary research questions were also concerned with determining the 
consolidation of treatment effects over the course of the 9-month follow-up period. 
Due to ethical constraints, we chose to offer patients randomized to the TAU condition 
participation in one of the two interventions after three months. This did not allow us to 
determine whether consolidation of treatment effects is due to the MBCT interventions 
or simply due to natural recovery or regression to the mean, although it must be noted 
that we did not observe this tendency in the TAU group during the three month waiting-
list period. Moreover, a dedicated power analysis for determining long-term effects, was 
omitted.
In addition to determining the long-term effects in the three-armed comparison, the 
RCT was not powered to directly compare or determine non-inferiority of eMBCT to 
MBCT, or in other terms to determine whether the new intervention (eMBCT) is not 
unacceptably worse than an intervention already in use (MBCT).
MBCT and eMBCT differed not only in intervention delivery (online versus face-to-
face), but also in whether patient participated in a group setting together with peers 
or individually. Although a systematic review examining 43 studies on peer support 
programs for cancer patients demonstrated mixed results regarding its effectiveness 
on psychological well-being[33], participants often experience the peer group setting 
in MBIs as facilitating.[34] Qualitative research showed that the peer group setting in a 
MBSR setting for breast cancer patients provided an atmosphere which was experienced 
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as safe and supportive, which in turn stimulated mutual connections with and trust 
between fellow breast cancer patients.[35] This implies that the effects of intervention 
delivery and peer group support cannot be disentangled in the current study.
Our RCT did not include an active but a TAU control condition. The majority of mindfulness 
trials conducted with cancer populations have used wait-list control groups rather 
than active control or competing interventions.[36] Although this research design is 
reasonable during early intervention development and preliminary evaluation of 
efficacy, future studies on Internet-based MBCT need more rigorous designs, involving 
active control conditions.[21, 36] As a consequence, this study does not allow us to 
conclude whether MBCT and eMBCT are more effective than other evidence-based 
approaches for psychological and behavioural symptoms in patients with cancer, 
such as CBT. Nevertheless, TAU was clearly measured in the current study, which is an 
important improvement.[21] In The Netherlands, TAU can be considered to be of a high 
quality. In line, 31% of the included participants in the RCT received some sort of mental 
healthcare in addition to (e)MBCT as usual treatment during the intervention.
Future developments in treatment and research
MBIs have been investigated in an increasing number of studies and clinical 
applications in the past two decades. Dimidjian and Segal [21] painted a broader 
picture of the status quo on the evidence base for MBIs within a framework of clinical 
psychological science using the National Institutes of Health (NIH) stage model.[37] 
This stage model describes different phases of intervention research, starting at stage 
0 (basic, fundamental research) to stage V (implementation and dissemination). They 
argued that stage I (intervention development/refinement) and II (efficacy in research 
clinic). Many studies have investigated MBIs for an increasing variety of symptoms and 
populations using weak study designs and without proceeding to implementation. 
Stage III research is especially relevant for testing future improvements of MBI using 
web-based or other technology-based delivery tools without therapist guidance.[38] It 
is concluded that underpowered pilot trials (stage I and II are highly overrepresented. 
Future studies should focus on more on cost-effectiveness studies, and dissemination 
and implementation strategies.
With regard to Internet-based delivery of MBCT, the current thesis has generated food 
for thought. Internet-based MBCT has not yet met its full potential in its current format 
and needs to be improved to ensure patient-friendliness, accessibility and adherence. 
Poor intervention adherence is a common issue in Internet-based interventions that 
needs to be addressed.[17] Moreover, the Internet-based MBCT was resource intensive. 
This implies that adapted formats of Internet-based MBCT should be explored to 
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improve the adherence and scalability of the interventions. In line, we urge relevant 
parties such as healthcare insurance companies to provide financial support for the 
continuous development of e-health interventions beyond their initial conception.
As a possible solution, we envision two adapted Internet-based MBCT formats. First, 
as many patients mentioned disadvantages of online-only delivery in Internet-based 
MBCT, it seems useful to combine face-to-face group-MBCT sessions with additional 
Internet-based MBCT sessions in blended-MBCT. Blended-care interventions combine 
the advantages of face-to-face and Internet-based elements.[39] Second, as many 
cancer patients prefer self-help[11, 26] and unguided self-help interventions have 
previously demonstrated effectiveness for low-distressed cancer patients[40] the 
possibilities of unguided MBCT interventions should be explored. These interventions 
are extremely scalable with minimal costs. Although many unguided interventions 
show diminished user engagement, we know that technology itself can influence 
adherence and engagement to online interventions. Examples are the use of reminders 
that can help people to keep using an intervention[41] and gamification, i.e. the use 
of game design elements in non-game context, which has been shown to positive 
influence engagement.[42] Research has shown that an unguided intervention which 
leverages some of these technological features can be similarly effective as a guided 
online intervention.[43] Together, these interventions comprise the development of a 
mindfulness-based stepped-care programme with different levels of MBCT intensity 
corresponding with different patient needs and preferences.
Furthermore, we also need more research on long-term follow-up results. Long-term 
follow-up comparisons are often lacking in research on Internet-based interventions, 
impeding reliable long-term estimates.[13] Our follow-up study focused on the 
consolidation of the effectiveness of MBCT and eMBCT during the nine-month follow-up 
period. Findings suggested most improvements in cancer patients’ increase over time 
after both interventions. Interestingly, patients seemed to benefit more from therapist-
assisted Internet-based MBCT than MBCT based on psychological distress levels. Future 
RCTs should preferably include a longer comparison control group to determine long-
term cost-effectiveness results.
To be able to predict what treatment (Internet-based or group-based MBCT) works 
best for whom, future research also needs to tap into predictors and moderators.[44] 
In our follow-up study, psychological distress, rumination and neuroticism and more 
extraversion and agreeableness at baseline predicted a better outcome at the nine-
month follow-up after both interventions. Notably, less mindful and less conscientious 
patients at baseline benefited more from therapist-assisted Internet-based MBCT than 
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from MBCT. The individual therapist attention in Internet-based MBCT perhaps is of 
support to those patients who are less mindful and less conscientious. Furthermore, 
while patients in MBCT can refrain from discussing (the lack of ) home practice by letting 
others in the group share their experiences, patients in eMBCT are more acknowledged 
for their home practice as they receive weekly written feedback from their therapist. Thus, 
eMBCT might encourage the less conscientious and mindful patients to complete their 
homework.[10] Future studies should put these tentative predictors and moderators to 
test.
Moreover, in order to understand the processes which account for therapeutic change[45, 
46] , we should look into mediating variables, or intervening variables that tap into 
processes of change and which may serve a guide that points to possible mechanisms. 
A systematic review and meta-analysis of mediation studies in MBIs in various settings 
identified strong, consistent evidence for cognitive and emotional reactivity, moderate 
and consistent evidence for mindfulness, rumination, and worry, and preliminary but 
insufficient evidence for self-compassion and psychological flexibility as mechanisms 
underlying MBIs.[47]
With regard to comparing working mechanisms in group- and Internet-based MBCT, 
the concept of therapeutic alliance might be an important factor. Therapeutic alliance, 
or the achievement of collaborative, “work together” aspects of the of the therapeutic 
relationship between patient and therapist has shown to have a robust, albeit modest 
relation with treatment outcome across a broad spectrum of psychological treatments 
and client/problem contexts.[48] Research on the therapeutic alliance in Internet 
interventions exists but is still limited. A systematic review on the therapeutic alliance 
in Internet-based interventions indicated Internet-based interventions to be equivalent 
to face-to-face therapy in the development of therapeutic alliance. However, only a few 
studies have investigated this relationship.[49] It would be interesting in future trials in 
MBIs to examine if therapeutic alliance mediates the reduction of psychological distress 
or the increase of positive mental well-being after eMBCT compared to MBCT.
Although MBCT for distressed cancer patients is effective and saves money for distressed 
cancer patients, the reimbursement of MBCT in The Netherlands remains problematic. 
The Dutch National Health Insurance (Zorginstituut Nederland) advised the ministry 
to only reimburse MBCT for patients with psychiatric disorder. As only a minority of 
distressed cancer patients fulfil the diagnostic criteria for a psychiatric disorder, they 
cannot be offered MBCT. This implicates that an evidence based effective and cost-
effective treatment is not publicly accessible for this population and therefore creates 
inequality in access between those patients able to afford the treatment and those that 
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cannot afford it. Nevertheless, it must be noted that MBCT is provided for all cancer 
patients at several locations throughout The Netherlands, e.g. at the own Radboud 
University Medical Centre and at several psycho-oncological institutes such as the 
Helen Dowling Institute. Moreover, the Helen Dowling Institute provides nationwide 
and health-care reimbursed online cognitive behavioural therapy for cancer patients 
inspired by the current eMBCT.
Nevertheless, we should direct efforts to implementation of MBIs in daily clinical 
oncological care for all patients who wish to receive MBCT. As Greer mentioned in 
1994: “The most immediately important task of psycho-oncology is to close the yawning 
gap between current knowledge and actual clinical care of patients”.[50] This is easier said 
than done, as Rebecca Crane and Willem Kuyken, leading researchers in the field of MBIs 
eloquently illustrate [51]: “Even if a psychosocial intervention has compelling aims, has 
been shown to work, has a clear theory-driven mechanism of action, is cost-effective and 
is recommended by a government advisory body, its value is determined by how widely 
available it is in the health service.”
In order to improve availability of MBIs in the UK health service, Crane and Kuyken 
have formulated recommendations for successful implementation of MBIs.[42] Their 
recommendations are based on extensive review of the evidence of what contributes 
to the likelihood of evidenced-based practice flourishing. These recommendations 
include:
• Tailor and translate research findings to the local setting: base decisions on providing 
MBCT on both research evidence and local service priorities
• Engage in ownership of research or implementation process: to positively affect 
uptake, engage key stakeholders and develop local networks; refrain from top-
down forced research use in an organisation
• Use “champion” enthusiasts: e.g. former participants who are enthusiastic about the 
practice to promote new ideas, both within and outside a specific organisation
• Analyse the implementation context: we will need to explore factors that impede 
or facilitate implementation among local stakeholders by setting up an 
implementation steering group to ensure a tailored and systematic approach of 
local barriers and facilitators of implementation.
• Ensure credibility of the evidence: use of scientific results in clinical practice is 
enhanced by credible evidence, credible “champions” and a commitment to routine 
reporting of data to key stakeholders
• Provide leadership: Strong and facilitative leaders at project and organisational level 
can lend strategic support and authority to the process
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• Provide resources: Implementation needs adequate resources and support including 
financial, human (dedicated project leaders) and appropriate equipment.
This implementation framework with its recommendations may strongly facilitate the 
transfer of MBCT knowledge into action in the daily practice of oncological care.
Moreover, implementation of MBIs in clinical practice means that the therapist pool 
should be enlarged and more MBI therapists need be trained. But what does it mean 
to be a good Internet-based mindfulness-trainer? Clinician training is an important 
challenge in MBIs, especially since MBI therapists are required to have a personal 
practice in mindfulness in addition to professional training in the clinical approach. 
There is a paucity of knowledge on clinical training in Internet-based interventions in 
general. There are some examples of studies focusing on the training of therapists in 
online CBT, e.g.[52] In this training, online CBT skills were emphasized, such as writing 
motivational feedback messages. The training consisted of 1.5 days and covers the 
implementation domains “knowledge”, “skills”, “motivation”, and “organization”, by 
focusing on the therapy’s rationale, iCBT skills, and implementation strategies. Using 
an evaluation questionnaire, implementation determinants (therapist characteristics, 
e-health attitude, and implementation domains) and interventions acceptance were 
assessed among participants after training. The authors conclude that therapists’ 
positive training evaluations were promising regarding the dissemination of online CBT 
in daily practice, but that as well as training therapists, creating an open atmosphere 
among managers and colleagues is important to ensure that the new intervention 
becomes part of the regular treatment options. However, there is no standard available 
for determining instructor quality in Internet-based MBIs [38] and similar clinical training 
methods in improving online MBI teacher competency should be developed.
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EPILOGUE
More than ten years ago, the Helen Dowling Institute, as the oldest mental healthcare 
institute for cancer patients in The Netherlands, commenced to provide individual 
Internet-based MBCT (eMBCT) for cancer patients in clinical practice. This thesis was 
built upon this pioneering work.
The Dutch Cancer Foundation (KWF) has demonstrated willingness to cooperate in our 
mission to disseminate MBCT and Internet-based MBCT for cancer patients in clinical 
practice. Based on the results of this thesis, we conducted a budget-impact analysis 
together with KWF. The results of this budget-impact analysis were very positive, and 
the report was presented to the Secretary-General of the Dutch Ministry of Health in 
the Summer of 2018. With heartfelt dedication we trust that these efforts will contribute 
to future reimbursement of accessible and effective (Internet-based) psychological 
treatment for distressed cancer patients.
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Het aantal mensen dat moet leven met de gevolgen van kanker groeit
De incidentie en mortaliteit van kanker stijgt in rap tempo door veroudering en 
bevolkingsgroei. Dit fenomeen wordt ook wel double ageing genoemd. Mensen leven 
langer en het relatieve aandeel van mensen van 65 jaar en ouder neemt toe.[1] Ook 
worden er veranderingen verwacht in de prevalentie en de verdeling van de belangrijkste 
risicofactoren voor kanker.[2] De voorspelling is dat de incidentie van kankerpatiënten 
wereldwijd toeneemt van 12.7 miljoen gevallen in 2008 tot 22.2 miljoen in 2030.[3]
Mensen met kanker hebben vaak psychische klachten
Het is van groot belang dat patiënten met kanker worden gescreend op psychische 
klachten en psychisch welzijn.[4] Psychische klachten worden in het Engels vaak 
beschreven met  het begrip psychological distress. Dit begrip wordt door het National 
Comprehensive Cancer Network (NCCN) gedefinieerd als “een multi-factoriële 
onaangename emotionele ervaring van een psychologische (dat wil zeggen cognitieve, 
gedragsmatige, emotionele), sociale en / of spirituele aard die het vermogen om effectief 
om te gaan met de ziekte kanker en de fysieke symptomen en de behandeling ervan, 
beperken. De mate waarin er psychische klachten zijn, varieert van het hebben van normale 
gevoelens van kwetsbaarheid, verdriet en angsten tot problemen die invaliditeit kunnen 
veroorzaken, zoals depressie, angst, paniek, sociaal isolement en existentiële en spirituele 
crisis.” Het begrip psychological distress kan daarmee worden geconceptualiseerd als 
een dimensionele uitkomstmaat in termen van hoeveelheid psychische klachten of als 
een dichotome uitkomstmaat in termen van aan- of afwezigheid van een psychiatrische 
stoornis. In totaal hebben tussen één op drie [5] en één op twee patiënten met kanker 
[6] last van klinisch significante psychische klachten.
De screening op psychische klachten kan worden gebruikt als een behoeftebepaling 
en als een bron van informatie om te bepalen of verwijzing naar psychologische of 
psychiatrische zorg noodzakelijk is.[4] Enkel screenen is echter niet genoeg: informatie 
over de ernst van de klachten moet worden aangevuld met contextuele informatie om 
de klachten te kunnen duiden.[7] Een positieve screening op psychische klachten is 
enkel een indicatie dat verdere beoordeling van individuele behoeften en, eventueel, 
passende verwijzing en behandeling nodig is.[8] Niet alle patiënten met kanker en 
psychische klachten wensen psychologische behandeling: sommige patiënten hebben 
bijvoorbeeld voldoende steun van familie en vrienden of geven er de voorkeur aan niet 
over hun problemen te praten.[9] Wat er moet gebeuren na een positieve screening, 
blijft een onderzoeksvraag op zichzelf.[7]
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Bij het bepalen van de ernst van psychische klachten geldt het psychiatrisch interview 
overigens nog altijd als gouden standaard als het gaat om prognostische waarde, 
contextuele beoordeling van functionele beperkingen en om behoefteanalyse voor extra 
psychologische behandeling.[6] Uit een meta-analyse van 94 onderzoeken met bijna 
15000 deelnemers in oncologische, hematologische en palliatieve ziekenhuissettings 
werd geconcludeerd dat 30-40% van de kankerpatiënten last heeft van (een combinatie 
van) psychiatrische stoornissen.[10]
De gevolgen van psychische klachten bij kanker zijn groot
Het aanpakken van psychische klachten van kankerpatiënten is belangrijk omdat deze 
klachten ingrijpende gevolgen hebben voor de individuele patiënt en voor de samenleving 
als geheel. Psychologische comorbiditeit bij kanker wordt in verband gebracht met 
verminderde kwaliteit van leven, verminderde naleving van medische adviezen, 
langere ziekenhuisopname en toegenomen (oneigenlijk) gezondheidszorggebruik.[11-
13] Het bieden van psychosociale zorg aan kankerpatiënten kan op de lange termijn 
dus leiden tot kostenbesparingen, aangezien kankerpatiënten die baat hebben bij 
psychosociale zorg minder gebruik maken van andere gezondheidszorgdiensten.
[14] Dit fenomeen wordt cost-offset genoemd: verhoogd mentaal welbevinden zou 
moeten leiden tot een verhoogde therapietrouw in de behandeling tegen kanker en 
veranderingen in levensstijl (bijvoorbeeld stoppen met roken). Bovendien kunnen 
productiviteitsverliezen bij de werkende kankerpopulatie worden verminderd.[14]
Bewezen effectieve psychologische behandelingen voor kankerpatiënten 
zijn beschikbaar
Het aantal patiënten met kanker neemt toe in de komende jaren. Dat betekent dat er 
ook steeds meer mensen met kanker behoefte zullen hebben aan psychologische zorg.
In de afgelopen 30 jaar zijn er gelukkig steeds meer bewezen effectieve, ofwel "evidence 
based" psychologische behandelingen voor kankerpatiënten beschikbaar geworden. 
Onderzoek laat kleine tot middelgrote positieve effecten van psycho-oncologische 
interventies zien op emotionele stress, angst, depressie en gezondheidsgerelateerde 
kwaliteit van leven (QoL). Deze effecten blijven meestal op middellange en zelfs 
lange termijn gehandhaafd.[15] Daarnaast lijkt deze zorg een gunstige kosten-
batenverhouding te hebben. Een overzicht van 11 kosteneffectiviteitsstudies van 
psycho-oncologische interventies concludeerde dat psycho-oncologische zorg 
waarschijnlijk kosteneffectief is, afhankelijk van hoeveel de samenleving bereid 
is te betalen voor een toename van kwaliteit van leven.[16] Aangezien de mate van 
psychische klachten het hoogst is bij mensen met kanker op jonge leeftijd [6] die 
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nog een heel beroepsleven voor zich hebben, is er bovendien een potentieel groot 
economisch effect van vroege en effectieve psychologische interventies in termen van 
het verminderen van productiviteitsverlies.
Ondanks bewezen effectiviteit en kosteneffectiviteit zijn evidence-based 
psychologische behandelingen niet altijd toegankelijk voor kankerpatiënten vanwege 
stigma, terughoudendheid om weer naar het ziekenhuis of een andere zorginstelling te 
moeten afreizen en indirecte kosten zoals reis- en tijdinvesteringen.[17] Daarom worden 
deze interventies steeds vaker via internet aangeboden. Via internet aangeboden 
interventies zijn gemakkelijk toegankelijk, besparen reistijd en kunnen net zo effectief 
zijn als hun face-to-face tegenhangers.[18, 19]
Van alle evidence-based psychologische behandelingen in de psycho-oncologie is er het 
sterkste bewijs voor cognitieve gedragstherapie (CGT) en op mindfulness gebaseerde 
interventies (MBI’s).[20]
Cognitieve gedragstherapie
Cognitieve gedragstherapie (CGT) wordt beschouwd als de gouden standaard voor de 
behandeling van psychopathologie in het algemeen [21] en bij psychische klachten bij 
kanker.[20] CGT richt zich op het identificeren en uitdagen van irrationele negatieve 
automatische gedachten om deze in meer realistische of behulpzame gedachten 
te veranderen. Het is vervolgens gericht op het veranderen van maladaptief gedrag.
[22] Een Cochrane review uit 2015 gericht op psychologische interventies bij niet-
gemetastaseerde borstkankerpatiënten waaronder 24 gerandomiseerd gecontroleerde 
trials (RCT’s) naar CGT, liet een aanzienlijke vermindering van angst, depressie en 
stemmingsstoornissen zien.[23]
Daarnaast neemt het bewijs voor de werkzaamheid van via internet geleverde- CGT 
bij kankerpatiënten toe. Onbegeleide online CGT werd effectief bevonden in het 
verminderen van psychische stress en vermoeidheid [24-26] het verbeteren van QoL 
[25], het verbeteren van emotioneel en sociaal functioneren [26], en zelfredzaamheid.
[27]
Op mindfulness gebaseerde interventies
Naast CGT wordt er in de psycho-oncologie onderzoek gedaan naar op mindfulness 
gebaseerde interventies ("Mindfulness-based interventions", MBI’s), zoals Mindfulness-
gebaseerde Stress Reduction (MBSR) [28] en Mindfulness-based Cognitive Therapy 
(MBCT).[29] Mindfulness wordt vaak gedefinieerd als: “Het vermogen om aandacht 
te geven aan het huidige moment op een speciale manier: in het huidige moment, 
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open en onderzoekend met vriendelijke interesse en zonder te oordelen”.[28] Terwijl 
CGT zich richt op het identificeren en uitdagen van irrationele gedachten en gedrag, 
zijn veel kankergerelateerde gedachten en cognities niet irrationeel. Angst voor 
terugkeer van kanker is alles behalve irrationeel - het kan zelfs motiveren tot positief 
gezondheidsgedrag en daardoor de kans op terugkeer van kanker verkleinen.[30] In 
plaats van je te richten op de inhoud van cognities, kan het behulpzamer zijn om je 
bewust te worden van hoe je je verhoudt tot moeilijke gedachten, emoties of pijnlijke 
lichamelijke gewaarwordingen.
De beoefening van mindfulness stelt mensen in staat om een  radicale verandering 
te bewerkstelligen in hoe ze zich verhouden tot hun gedachten, gevoelens en 
lichaamssensaties, evenals hun omstandigheden. Zo kan je de gebruikelijke, 
geconditioneerde manieren om te reageren, die niet altijd behulpzaam zijn, leren 
herkennen. Dat stelt je in staat om bewuste keuzes te kunnen maken.[29] MBI’s richten 
zich zodoende op het vergroten van het vermogen om de ondubbelzinnige realiteit 
van het leven met kanker te omarmen, en het vermogen om vriendelijke aandacht te 
besteden en vrij en intentioneel te kiezen hoe je omgaat met het omgaan met deze 
gedachten, emoties en lichamelijke gewaarwordingen, zonder ze kwijt te hoeven raken.
Het bewijs voor de effectiviteit van MBI’s in de oncologie is de afgelopen twee decennia 
snel toegenomen. MBI’s hebben gunstige effecten op depressie, angst, angst voor 
terugkeer van kanker en vermoeidheid.[31] Hoewel de eerste resultaten aangeven 
dat MBI’s kosteneffectief zijn in de kankerzorg [32, 33], zijn de kosteneffectiviteits-
beoordelingen van MBI’s schaars.[34]
MBI’s worden ook via internet aangeboden, maar onderzoek naar internet-MBI’s (eMBI’s) 
is vooral gericht op de effectiviteit van eMBI’s in algemene (gezonde) populaties. 
Studies gericht op de effectiviteit van eMBI’s bij kankerpatiënten zijn schaars. Eén enkel 
gecontroleerd onderzoek (n=62) toonde de haalbaarheid aan van aangepaste MBSR 
voor kankerpatiënten via internet.[35] Een ander pilot-onderzoek bevestigde dat MBSR 
geleverd via een iPad mogelijk haalbaar en acceptabel is voor borstkankerpatiënten.[36] 
Hoewel MBI’s eerder hun potentie als aanvullende psychologische behandeling voor 
kankerpatiënten hebben aangetoond, is er nooit een goed ontworpen RCT uitgevoerd 
waarbij zowel internet-MBCT als groeps-MBCT voor kankerpatiënten werd vergeleken 
met gebruikelijke zorg.
Het BeMind onderzoek – een samenvatting van de bevindingen
In dit proefschrift is daarom onderzoek gedaan naar de effectiviteit en kosteneffectiviteit 
van Mindfulness-Based Cognitieve Therapie in groepsvorm (MBCT) en MBCT 
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aangeboden via internet (eMBCT) vergeleken met gebruikelijke zorg ("Treatment as 
Usual", afgekort als "TAU") in een steekproef van 245 patiënten met kanker die last 
hadden van psychische klachten.
In hoofdstuk 2 werd de hypothese onderzocht dat psychiatrische stoornissen en 
psychische klachten geassocieerd zijn met een toename in gebruik en kosten van de 
gezondheidszorg. De onderzoekspopulatie bestond uit 245 patiënten met op zijn minst 
milde psychische klachten. Patiënten werden beoordeeld met een gestructureerd 
psychiatrisch interview voor DSM-IV-TR-as-I-stoornissen op de aanwezigheid 
van depressieve stoornissen, angststoornissen en/of aanpassingsstoornissen. 
Psychische stress werd gemeten door de Hospital Anxiety and Depression Scale, een 
zelfinvulvragenlijst. Retrospectief gebruik van gezondheidszorg in de afgelopen 3 
maanden werd verzameld met behulp van de TiC-P, een zelfrapportagevragenlijst die 
samen met een van de onderzoekers in een interview werd ingevuld. In totaal had 36% 
van de patiënten een psychiatrische stoornis. Dit hield verband met gebruik en kosten 
van geestelijke gezondheidszorg en meer gebruik van complementaire zorg. Er werd 
daarnaast een trend van hoger gebruik van somatische gezondheidszorg bij patiënten 
met psychiatrische stoornissen geconstateerd. Psychische klachten bleken, in het kort, 
geassocieerd te zijn met een hoger gebruik van geestelijke gezondheidszorg en kosten.
De BeMind-studie, zoals beschreven in hoofdstuk 3 en 4, betrof een drie-armige 
multicentre RCT bij 245 patiënten met kanker en met op zijn minst milde psychische 
klachten die willekeurig werden toegewezen aan MBCT (n=77), eMBCT (n=90) of TAU 
(n=78). De primaire uitkomst betrof de mate van psychische klachten direct na de 
behandeling. De mate van voortijdige uitval was significant hoger in de eMBCT dan 
in de MBCT-groep. Patiënten rapporteerden significant minder psychische klachten na 
na beide MBCT-interventies vergeleken met TAU. Bovendien was de prevalentie van 
psychiatrische diagnoses lager in zowel MBCT (33%) als eMBCT (29%) in vergelijking 
met TAU  (16%), maar deze veranderingen waren niet significant. Beide interventies 
verminderden de angst voor recidief van kanker, rumineren en verbeterden 
geestelijke gezondheidsgerelateerde kwaliteit van leven, mindfulnessvaardigheden 
en positieve mentale gezondheid wel significant in vergelijking met TAU. De fysieke 
gezondheidsgerelateerde kwaliteit van leven verbeterde niet.
Hoofdstuk 5 was gericht op het verkennen van ervaren facilitators en barrières tijdens 
de eMBCT door zowel patiënten als therapeuten. In totaal namen 31 patiënten deel aan 
een individueel interview na de behandeling en werden acht therapeuten geïnterviewd 
in een focusgroepinterview. Er kwamen vier overkoepelende thema’s naar voren die 
grotendeels overeen kwamen tussen patiënten en therapeuten: behandelomgeving, 
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behandelvorm, rol van de therapeut en patiëntkenmerken. Met betrekking tot de 
behandeling gaven zowel patiënten als therapeuten aan dat ze veel flexibeler zijn in 
wanneer, waar en hoe ze zich bezighielden met eMBCT. Zowel patiënten als therapeuten 
meldden dat ze werden gefaciliteerd door dit gevoel van autonomie in de eMBCT. 
Patiënten gaven aan dat ze de verhalen van andere patiënten niet hoefden te verwerken. 
Therapeuten gaven aan dat ze de interventie beter konden afstemmen op individuele 
thema’s. Er waren ook verschillen tussen patiënten en therapeuten. Voor therapeuten 
leek de eMBCT een grotere tijdsinvestering te vereisen in vergelijking met MBCT. Met 
betrekking tot de behandelvorm noemden patiënten specifiek de asynchroniciteit 
als een barrière voor de rol van de therapeut omdat de asynchrone communicatie de 
dialoog belemmerde. Therapeuten waren meer bezig met het voorkomen van uitval. 
Ze noemden dat ze door het missen van non-verbale informatie niet in staat werden 
gesteld om het afhaken van patiënten in een vroeg stadium te herkennen.
Hoofdstuk 6 was gericht op de kosteneffectiviteit van beide MBCT-interventies in 
vergelijking met TAU. Dit kosteneffectiviteitsonderzoek werd parallel uitgevoerd aan 
de eerder beschreven RCT. Gezondheidszorgkosten en (informele) werkgerelateerde 
productiviteitsverlieskosten werden gemeten door middel van interviews. Uitkomsten 
werden uitgedrukt in termen van Quality Adjusted Life Years (QALY). Een economische 
evaluatie werd uitgevoerd vanuit een maatschappelijk perspectief met een 
tijdshorizon van 3 maanden. Betaalde werkgerelateerde productiviteitsverlieskosten 
en maatschappelijke kosten waren lager in beide MBCT’s in vergelijking met TAU. 
Bovendien verbeterde de kwaliteit van leven in eMBCT en MBCT vergeleken met TAU. 
De resultaten wijzen uit dat zowel eMBCT als MBCT kostenbesparende behandelingen 
zijn en tegelijkertijd de kwaliteit van leven verbeteren voor patiënten met kanker en 
psychische klachten. Een extrapolatie van de onderzoeksgegevens naar een tijdspad 
van 9 maanden liet daarnaast een vergelijkbaar patroon zien van superioriteit van 
beide interventies ten opzichte van TAU. Verbeteringen van kwaliteit van leven na 9 
maanden follow-up bleven stabiel in beide experimentele interventies vergeleken met 
de uitkomst na drie maanden.
Discussie
Het onderzoek in dit proefschrift illustreert op een robuuste manier dat MBCT en eMBCT 
effectieve alternatieven zijn voor gebruikelijke zorg, met minder psychische klachten tot 
gevolg, minder angst voor terugkeer van kanker, minder rumineren en meer positieve 
mentale gezondheid en welzijn en een hogere kwaliteit van leven. Bovendien toonde 
ons kosteneffectiviteitsonderzoek de dominantie van beide interventies in vergelijking 
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met TAU: MBCT leidt in deze populatie zelfgeselecteerde patiënten met kanker en 
psychische klachten tot lagere maatschappelijke kosten en een hogere kwaliteit van 
leven.
De resultaten van de RCT zijn in overeenstemming met meta-analyses van eerdere 
RCT’s op MBI’s voor het verminderen van psychische klachten bij kankerpatiënten.[31, 
37] Deze effecten bleken meestal stabiel op de middellange en zelfs lange termijn. 
[15] In het verlengde hiervan toonde de vervolgstudie van het BeMind-project (niet 
opgenomen in het huidige proefschrift) ook een consolidatie van het behandelresultaat 
tijdens de follow-upperiode van negen maanden. Interessant is dat de resultaten na 
verloop van tijd zelfs positiever werden, vooral in eMBCT.[38]
Bovendien laten deze resultaten overtuigend zien dat het internet MBCT veel 
toegankelijker maakt voor kankerpatiënten zonder extra kosten en zonder de 
effectiviteit van de interventie in gevaar te brengen. Omdat veel kankerpatiënten 
obstakels ervaren in het deelnemen aan face-to-face psychologische interventies [17, 
39], kan het via internet aanbieden van psychologische interventies bijzonder krachtig 
zijn in de oncologische context, wanneer patiënten worden gehinderd door fysieke (bijv. 
reisafstand) of mentale barrières (bijv. niet opnieuw het ziekenhuis willen bezoeken).
[40] Het huidige onderzoek draagt  in hoge mate bij tot het nauwelijks beschikbare 
bewijs voor MBI's via internet in de oncologie.
Niettemin gaf ons kwalitatief onderzoek in hoofdstuk 5 wel aan dat er nog veel te 
verbeteren valt in het ontwerp en de aanbiedingsvorm van eMBCT. Dit impliceert 
dat technische verbetering noodzakelijk is en dat nieuwe behandelmethoden nader 
moeten worden onderzocht in toekomstig onderzoek.
De resultaten van onze kosteneffectiviteitsanalyse in hoofdstuk 6 laten zien dat 
zowel MBCT als eMBCT de potentie hebben om de maatschappelijke kosten al 
tijdens de interventieperiode te verminderen. Dit is een geweldige prestatie en 
het is belangrijke informatie, aangezien evaluaties van de kosteneffectiviteit van 
psychologische behandelingen hard nodig zijn in de psychosociale oncologie.[16] De 
huidige resultaten zijn gedeeltelijk in overeenstemming met eerdere bevindingen 
over de kosteneffectiviteit van MBI’s voor kankerpatiënten.[32, 33, 41] Het feit dat onze 
resultaten wijzen op een kostenbesparing na MBCT is hoogstwaarschijnlijk het resultaat 
van de zelfgeselecteerde aard van de huidige steekproef.
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Kortom, onze studie naar MBCT bij kankerpatiënten is de eerste studie die aangeeft dat 
MBCT, zowel in een groep als via internet, minder psychische klachten en een hogere 
kwaliteit van leven oplevert, terwijl tegelijkertijd maatschappelijke kosten worden 
bespaard.
Sterke punten van dit proefschrift
Dit proefschrift bevat de eerste grootschalige RCT van eMBCT en MBCT bij 
kankerpatiënten in Nederland met behulp van een grote, klinisch representatieve 
en heterogene steekproef van kankerpatiënten met verschillende tumortypen in 
verschillende stadia van de ziekte. Dit is een sterk punt, aangezien borstkankerpatiënten 
tot dusverre oververtegenwoordigd zijn in studies over MBI’s bij kankerpatiënten [42] en 
uitbreiding van de evidence-base van psycho-oncologische interventies in bijvoorbeeld 
palliatieve populaties noodzakelijk is.[20]
Bovendien hebben we een patiëntgerichte wervingsmethode gebruikt. In de BeMind-
studie slaagden we erin meer dan 500 patiënten te werven en 245 patiënten te includeren 
in een periode van ongeveer 20 maanden. Werven door middel van zelfselectie was snel 
en effectief.[43]
Bovendien werd deze studie uitgevoerd in verschillende klinische settings, wederom 
ten voordele van de klinische representativiteit.
Het MBCT protocol is gevolgd in zowel de MBCT als in de eMBCT en onze mindfulness-
trainers voldeden aan de criteria van de Vereniging van Mindfulness-Based Trainers in 
Nederland en Vlaanderen. Bovendien hadden alle betrokken trainers eerdere ervaring 
met het verlenen van psychologische zorg aan kankerpatiënten.
Beperkingen van dit proefschrift
Naast de sterke punten van het huidige proefschrift, moeten enkele beperkingen 
worden genoemd. Ons onderzoeksdesign liet niet toe om te bepalen of consolidatie 
van de behandelingseffecten het gevolg is van de MBCT-interventies of van natuurlijk 
herstel of regressie naar het gemiddelde (hoewel opgemerkt moet worden dat we 
deze trend in de gebruikelijke zorg-groep gedurende de drie maanden niet hebben 
waargenomen).
Daarnaast liet het design niet toe om te bepalen of de nieuwe interventie (eMBCT) 
slechter presteerde dan de interventie die al ontwikkeld was (MBCT) middels een 
zogeheten non-inferiority analyse.
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MBCT en eMBCT verschilden niet alleen in het online versus face-to-face aspect, maar 
ook of ze individueel of met groepsgenoten deelnamen. Dit impliceert dat de effecten 
van verschillende aanbiedingsvormen en die van lotgenotencontact in de huidige 
studie niet kunnen worden onderscheiden.
Onze RCT bevatte geen actieve maar een gebruikelijke-zorg conditie. De 
meeste mindfulness-onderzoeken die zijn uitgevoerd in de oncologie hebben 
wachtlijstcontrolegroepen gebruikt in plaats van actieve interventies.[44] Hoewel 
dit onderzoeksontwerp passend is in deze fase van onderzoek, hebben toekomstige 
studies over MBCT op internet meer rigoureuze designs nodig met bijvoorbeeld actieve 
controlegroepen.[44, 45] Met deze studie kunnen we niet concluderen of MBCT en 
eMBCT effectiever zijn dan andere evidence-based benaderingen voor psychische 
klachten bij patiënten met kanker, zoals cognitieve gedragstherapie.
Aanbevelingen voor vervolgonderzoek
Het huidige proefschrift heeft, zoals het een proefschrift betaamt, stof tot nadenken 
gegegeven. De eMBCT heeft nog niet zijn volledige potentie benut in zijn huidige 
vorm en moet worden verbeterd om patiëntvriendelijkheid, toegankelijkheid en 
therapietrouw te waarborgen. Bovendien was de eMBCT in zijn huidige vorm redelijk 
bewerkelijk. Andere vormen van eMBCT zouden moeten worden onderzocht om de 
therapietrouw en mogelijkheid tot schaalvergroting van de interventies te verbeteren. 
In het verlengde daarvan dringen we er bij relevante partijen, zoals zorgverzekeraars, 
op aan om financiële ondersteuning te bieden voor de doorontwikkeling van 
e-healthinterventies.
We stellen ons twee aangepaste eMBCT-vormen voor. Ten eerste lijkt het interessant 
om face-to-face groep-MBCT-sessies te combineren met extra internetsessies in een 
zogeheten blended-MBCT. Ten tweede geven veel patiënten met kanker de voorkeur aan 
zelfhulp.[9, 17] Daarom moeten de mogelijkheden van onbegeleide MBCT-interventies 
worden onderzocht. Zelfhulpinterventies zijn makkelijk op grote schaal aan te bieden 
tegen minimale kosten. Samen omvatten deze interventies de ontwikkeling van een 
op mindfulness gebaseerd stepped-care-programma met verschillende niveaus van 
MBCT-intensiteit overeenkomstig met de verschillende behoeften en voorkeuren van 
verschillende patiënten.
Verder hebben we ook meer onderzoek nodig naar de langetermijnresultaten van 
de follow-up. Lange-termijn follow-up vergelijkingen ontbreken vaak in onderzoek 
naar internet- interventies. Interessant genoeg leken patiënten meer baat te hebben 
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bij eMBCT dan MBCT op langere termijn. Toekomstige RCT’s zouden bij voorkeur een 
langere vergelijkingscontrolegroep moeten bevatten om de resultaten op de lange 
termijn voor de te bepalen.
Om te kunnen voorspellen welke behandeling (internet- of groeps-MBCT) het beste 
werkt voor wie, moet toekomstig onderzoek daarnaast ook meer licht schijnen op 
predictoren en moderatoren van het interventie-effect in MBCT.[46] Daarnaast moeten 
we kijken naar mediërende variabelen om onderliggende processen te vangen die 
verantwoordelijk zijn voor therapeutische verandering.[47, 48]
Klinische implicaties
De bevindingen in dit proefschrift leiden tot een aantal aanbevelingen voor de klinische 
praktijk. Ten eerste zouden we er verstandig aan doen om MBCT voor patiënten met 
kanker en psychische klachten te vergoeden. Hoewel MBCT voor patiënten met 
kanker en psychische klachten effectief is en geld bespaart, adviseert het college van 
Zorgverzekeringen aan de minister om MBCT alleen te vergoeden voor patiënten met 
een psychiatrische stoornis. Aangezien slechts een minderheid van patiënten met 
kanker voldoet aan de diagnostische criteria voor een psychiatrische stoornis, kan MBCT 
lang niet aan alle patiënten met kanker worden aangeboden. Dit creëert ongelijkheid 
tussen patiënten die de behandeling kunnen betalen en diegenen die het niet kunnen 
betalen.
Daarnaast moeten we ons inspannen om MBCT te implementeren in de dagdagelijkse 
klinische praktijk. Zoals Greer in 1994 al zei: “De meest urgente taak van psycho-
oncologie is het dichten van de gapende kloof tussen huidige kennis en klinische zorg 
in de praktijk”.[49]
Bovendien betekent de implementatie van eMBIs in de klinische praktijk dat de pool 
van trainers moet worden vergroot en dat meer online MBI-therapeuten moeten 
worden opgeleid. Maar wat betekent het om een  goede online mindfulness-trainer te 
zijn? Er is geen standaard beschikbaar voor het bepalen van de kwaliteit van online 
trainers. Trainingsmethoden zullen moeten worden ontwikkeld om bekwame online 
mindfulness-trainers op te leiden.
Conclusie
Samenvattend biedt dit proefschrift overtuigend bewijs voor de effectiviteit van zowel 
individuele MBCT via internet als voor MBCT in groepsvorm voor patiënten met kanker 
die last hebben van psychische klachten. Tegelijkertijd genereerde dit proefschrift ook 
belangrijke vragen voor vervolgonderzoek. Hopelijk moedigen deze resultaten andere 
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onderzoekers aan om het onderzoek naar MBCT voor patiënten met kanker, voort te 
zetten, om zo een optimale vorm van MBCT voor de groep patiënten met kanker te 
ontwikkelen. Daar waar patiënten behoeftes hebben die verder reiken dan gangbare 
psychologische interventies zoals cognitieve gedragstherapie, kan MBCT een optie zijn. 
Voor de steeds groter wordende groep patiënten met kanker, waarvan een aanzienlijke 
minderheid psychische klachten heeft, is MBCT in ieder geval een belangrijke effectieve 
én kosteneffectieve aanvulling op het bestaande psychologische behandelaanbod.
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te benaderen en je bent altijd bereid om het een en ander met enthousiasme uit te 
leggen. Merci!
De afdeling Psychiatrie wil ik bedanken voor het faciliteren van mijn ontwikkeling 
als wetenschapper, psycholoog en Radboudiaan. Geert, bedankt voor al je werk met 
onze Teleformulieren en onze wijdlopige gesprekken over onderzoek, vrachtwagens, 
klassieke muziek en je vleugel, en tennis. Na een gesprek met jou heb je altijd weer een 
fris perspectief op het leven.
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Beste Roy, als mentor van mijn promotietraject heb je een kleine maar niet onbelangrijke 
rol gespeeld. Je hebt net nog even het zetje te geven om mijn klinische ontwikkeling 
aan te zwengelen en daar kan ik nu de vruchten van plukken. Samen konden we verder 
kijken dan mijn promotietraject reikte en dat is heel erg fijn! Gérard, jij bent toch ook 
een soort mentor van me geweest. Je bent een aardige, slimme jongeman en het 
was fijn om af en toe met je te kunnen lunchen en ervaringen uit te wisselen over het 
onderzoekersbestaan. Ik hoop dat we elkaar nog blijven zien.
Er zijn een aantal collega’s die nauwer betrokken zijn geweest bij mijn ontwikkeling 
tot mindfulness-trainer. Nicole, als hoofddocent van de opleiding beschik je over een 
onuitputtelijke bron van niet-aflatend enthousiasme voor alles wat met mindfulness 
te maken heeft, en vooral voor het doceren over het trainersschap. Ik ben je dankbaar 
voor je kennis en de training die we samen hebben kunnen doen. Renée, bedankt 
voor je begeleiding tijdens mijn opleiding. Hiske, bedankt voor je supervisie zowel als 
psychiater en als mindfulness-trainer. Als geen ander belichaam je voor mij op een zeer 
overtuigende manier de vriendelijke interesse, nieuwsgierigheid en open blik die ons 
zo veel kan brengen.
Collega’s, ik heb veel aan jullie gehad. Tussen het werken door was er gelukkig ook 
ruimte om te ouwehoeren. Melanie, onze wegen zijn inmiddels gescheiden, maar je 
bent tijdens het grootste deel van mijn promotietraject erg belangrijk voor me geweest. 
Ook al hebben we nu andere keuzes gemaakt, dat doet voor mij niets af aan “onze tijd” 
op de onderzoekerskamer. Hanne, Mira, Rhoda, Lotte, Carolien, Marloes, Linda, Imke, 
Marleen, Ellen, Rinie, Tjipco, Ineke, Inge, Hetty, en Wendy heel hartelijk dank voor onze 
fijne samenwerking!
Ook onderzoeksassistenten Heidi, Eva, Merel, David en Marieke mogen zeker niet 
vergeten worden. Bedankt voor jullie inzet. Het was gezellig om met jullie samen te 
werken.
Irma, Ramona en Kelly, jullie verdienen een aparte alinea. Ik mag enkel hopen dat ik de 
rest van mijn leven ooit nog ergens kom te werken waar ze zo’n secretariaat hebben 
als dat ik hier heb gehad. Ik zou zelf bijna secretaresse willen worden om met jullie 
te kunnen blijven samenwerken. Jullie vormen de ruggengraat van het Centrum en 
zonder deze drie gezusters loopt alles in de soep. Jullie regelen niet alleen alles tot in de 
puntjes, jullie bieden ook een luisterend oor en brengen ook wat lucht in al het serieuze 
werk door af en toe ook gewoon vieze grapjes (garagegrappen) te kunnen maken. 
Zonder jullie had ik het echt niet volgehouden. Toppers!
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Dirk, jij verdient ook een aparte alinea. De laatste twee jaar ben je eigenhandig 
verantwoordelijk geweest voor een groot deel van mijn werkplezier. Je bent de 
vleesgeworden homo universalis: de nieuwsgierige integere wetenschapper, de 
empathische clinicus, de slimme boer en bovenal de familieman. Echt, wat kan jij niet? 
Je bent op veel fronten een voorbeeld voor mij en mijn collega’s en samen met jou kan 
altijd nét een stapje verder worden gezet. Eruit halen wat erin zit wordt met jou erbij 
makkelijker én veel leuker. Ik wil je bedanken voor je supervisie en onze samenwerking. 
Tot het volgende ronde tafel-etentje bij jullie thuis.
Ik wil ook de collega’s van de Medische Psychologie en de Gammaraad bedanken voor 
de samenwerking, de prettige overleggen en de interessante journal clubs. Judith, 
bedankt voor alles wat je doet om de psychologische zorg voor kankerpatiënten naar 
een hoger plan te trekken op nationaal en internationaal niveau. Sanne, Marieke vdW, 
Marieke G, José, Annemiek, Marlies, Sarah, Nelleke, Floor, Marlies, Harriët en Juliane wil 
ook in mijn dankbetuiging betrekken.
De leden van de Vedetteteam in ruste-groep mogen ook zeker niet vergeten worden. 
In het bijzonder Dave, Jos, Mathijs, Pim en Thijs hebben de nodige steun, toeverlaat en 
afleiding geboden de afgelopen jaren. Dat onze vriendschap nog lang mag voortduren.
Bram, jou wil ik ook graag bedanken voor al die keren dat we samen hebben gegeten in 
de afgelopen jaren (heb je al 5 euro overgemaakt?) en al die keren dat je mij belachelijk 
heb mogen maken (krijg jij je overuren wel betaald?). Je bent een goeie vriend en ook 
al pakken we niet altijd alles hetzelfde aan, het is heel erg fijn om samen met jou te 
kunnen reflecteren op de zin en onzin van het leven. Je enthousiasme voor het werk 
van GZ-psycholoog werkte aanstekelijk en dat heeft in grote mate bijgedragen aan mijn 
klinische aspiraties. En nog sorry van je matras.
Sander en Anke, en tegenwoordig Evi, altijd fijn om bij jullie langs te gaan. Mark en 
Lieve, jullie zijn in korte tijd toch wel matties geworden van mij en Angela. Dat de drank 
nog maar vaak rijkelijk mag vloeien. Roy, we zien elkaar te weinig maar als ik er ben is 
het altijd goed. Manon, ik ben dankbaar dat we elkaar af en toe nog mogen zien en onze 
koffiemomenten zijn altijd gezellig. En ook Margreet, die OOK al aan het promoveren is, 
wat heb ik toch slimme vrienden! Ooit kom ik ook in Leuth wonen (Angela heeft toch 
niks te vertellen). Jennifer en Nanne, tot de volgende borrel in Lent!
Het nevenclubje waar Teun, Stef, Berend, Sytze, Hein en Manu deel van uitmaken: 
bedankt voor het ware familiegevoel, wat op een of andere manier toch altijd het beste 
naar boven komt na een aantal speciaalbiertjes. Dat we nog maar vele Flaming Ass Owls 
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mogen nuttigen samen in Amsterdam, Rosmalen of Arnhem. En dat ik er nog maar vaak 
af gefietst mag worden door André en Jilles. Lieve Anneloes en Marianne, jullie worden 
gemist. We waren uit hetzelfde hout gesneden en bij jullie zijn was thuiskomen. Frank, 
Marij, Kim, Renée en Hein, ik voel me altijd welkom in Budel. Dank daarvoor. Gert-Jan, er 
is niemand met wie ik zo lekker kan ouwehoeren over auto’s en gadgets. Gaby en gezin, 
bedankt voor het meeleven en de lieve kaartjes. Oma Silvia en Hub, voor jullie staat de 
deur in Arnhem altijd open! Ook de Verhooles, Van Waarts, en de Van 't Hofs mogen 
natuurlijk niet ontbreken. Rommert, Jeanette, Ramon, Leendert, Marleen, Mart, Isa, Wim 
en Pie, bedankt voor jullie gezelligheid en de hartelijkheid waarmee ik in de familie ben 
verwelkomd.
Else, jij hebt vier levens geleefd aan life-events in de tijd dat wij hebben samengewerkt. 
Wat ben jij een taaie tante. Jij bent een wervelwind, waar jij binnenkomt waait het stof 
op! Maar wat er ook gebeurt, op Else kun je rekenen. Het project is in de beginfase uit 
het slop getrokken bij gratie van jouw ondernemende houding, doorzettingsvermogen 
en levenservaring. Ik ben blij dat we dit samen hebben mogen doen. Ik ben er trots op 
dat jij mijn paranimf bent en naast me staat bij de verdediging, want naast een fijne 
collega ben je gewoon een heel fijn mens. Je staat met beide benen op de grond – je 
reed weliswaar in een directeuren-Volvo en je bekleedt een vooraanstaande positie als 
ziekenhuispsychiater, met jou kun je ook naar de Dag van het Levenslied. Wat wil je nog 
meer in een collega? Gaan we nou eindelijk eens samen eten trouwens?
Manu, mijn kleine broertje is zo klein niet meer. Ik kijk met bewondering naar hoe jij met 
een enorme drive en doorzettingsvermogen door je moeilijke studie bent gekomen. 
Dat maakt me trots en blij. Het duurt niet lang meer en ik sta in jouw schaduw. Je bent 
een lieve, integere en sportieve jonge vent en de wereld ligt aan je voeten. Het is heel 
prettig en verfrissend dat we erg verschillend, maar toch ook weer erg hetzelfde zijn. Ik 
hoop dat je niet de rest van je leven in New York gaat wonen en dat ik gewoon af en toe 
bij je op de koffie kan. Fijn dat je nu naast me staat.
Pap en mam, wie had dit gedacht in 1989? Dankzij jullie sta ik nu vol in het leven en ik 
prijs me gelukkig met jullie onvoorwaardelijke steun en liefde. Ook al zijn jullie soms (en 
met name papa) veeleisend geweest (lees de ergotherapie-verslagen van toen ik 4 was 
er maar op na), dat maakt ook dat ik sta waar ik nu mag staan. Ik had me geen betere 
ouders kunnen wensen. In de loop der jaren ben ik vooral gaan zien dat jullie op je 
eigen manier boeddhisten zijn. Mam, jij kan zo heerlijk genieten van een rondje fietsen 
en een beschuit met aardbeien. Pap, jij hebt mij als geen ander meegegeven dat het 
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plezier hem zit in de kleine dingen van het leven. Daarnaast kan je eigenlijk alles. Een 
appartement verbouwen met mijn pa? Geen probleem. Ik kan niet op papier zetten in 
deze paar zinnen wat jullie voor me betekenen, ik hou van jullie.
Angela, wat hebben we het goed samen. Ik vind het heel fijn om samen met jou door 
het leven mogen te gaan. Samen kunnen we genieten van burgerlijke kneuterigheid 
maar we maken ook grootse plannen. Je brengt heel veel humor, frisheid en plezier 
in mijn leven. Ik ben gek op jou en kijk heel erg uit naar nog heel vaak wakker worden 
naast jouw guitige lachje.  
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PHD PORTFOLIO
Activities Hours
Supervisor Master Thesis students Gezondheidszorgpsychologie 50
Tutor Cancer Research 5DIF1 30
Trainer Mindfulness-based Stress Reduction 108
Supervisor Research Internship HAN Toegepaste Psychologie 50
Member Gammaraad psychosociale oncologie 30
Attendee and presenter Grand Round Radboudumc Psychiatrie 60
Journal Club psychosociale oncologie 60
Tutor Mindfulness for (bio)medical professionals 90
Reviewer for journals Journal of Supportive Care in Cancer, BMC Cancer, Trials, Palliative 
Medicine, Psycho-Oncology, JMIR, Behaviour Research and Therapy,
30
Redactielid Tijdschrift Nederlandse Vereniging Psychosociale Oncologie 60
Member research meetings / journal club Centre for Mindfulness 60
Netherlands Society for Research on Internet Interventions congress 2013 10-11-2013  8
Vereniging Gedragstherapie en Cognitieve Therapie najaarscongres 2013 15-11-2013  8
Landelijk Mindfulness Symposium 2014 22-5-2014  8
Presentation “Mindfulness in medicine” at Zorginstituut Nederland 2-12-2015  4
Open Huis Centrum voor Mindfulness 2015 15-9-2015  8
Landelijk Mindfulness Symposium 2016 21-5-2016 8
International Congress on Behavioural Medicine 2016 Melbourne 12-10-2016  32
Loopbaanmanagement voor promovendi 2-1-2017  20
International Psycho-Oncology Society congress 2017 Berlin 16-8-2017  24
Verenging cognitieve gedragstherapie najaarscongres 2017 11-9-2017 8
International Conference on Mindfulness 2018 Amsterdam 13-7-2018  24
NVvP voorjaarscongres Maastricht 2019 4-3-2019  4
Courses ECTS
Management voor Promovendi 2-1-2014 3
RIHS introduction course 25-3-2014 1.8
Presentation Skills 3-1-2015 1.5
Opfriscursus statistiek voor promovendi 11-1-2015 1.5
Psychodiagnostiek MPSGP14a 2-2-2016 8
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Courses ECTS
Wetenschapsjournalistiek 4-1-2016 3
NIHES CE08 Repeated Measurements 22-4-2016 1.7
Donders PhD intro meeting for RIHS switchers 9-12-2016 0.3
Post-academische opleiding tot mindfulness trainer 30-6-2017  
Basiscursus Regelgeving en Organisatie voor Klinisch onderzoekers (BROK) 6-5-2018 1.8
Psychopathologie MPSGP12 11-5-2018 8
Psychologische Interventies MPSGP11 29-1-2019 8
Vaardigheidstraining Neuropsychologische Revalidatie MPSGP13d 2-1-2019 3
Vaardigheidstraining Klachtgerichte Interventies MPSGP13c 2-1-2019 3
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DATA MANAGEMENT STATEMENT
This thesis is based on the results of human studies, which were conducted in accordance 
with the principles of the Declaration of Helsinki. The medical and ethical review 
board Committee on Research Involving Human Subjects Region Arnhem Nijmegen, 
Nijmegen, The Netherlands has given approval to conduct these studies (CMO Arnhem 
– Nijmegen 2013/542).
 This project is stored on the Radboudumc, department server: (H:)PSYdata$ in the 
folder: H:\Research\BeMind. The patient data for the analyses of the studies as presented 
in chapter 2, 4, 5, and 6 is stored on this departments’ H-drive in a secured folder 
specifically for this project to which access is only granted to authorized personnel, as 
to be determined by the management of the department of Psychiatry.
All paper informed consent forms are stored in a locked cabinet at the Centre for 
Mindfulness. Data management and monitoring were performed using a Microsoft 
Excel file which is also stored in the secured folder on the department server. An audit 
trail was incorporated to provide evidence of the activities that has altered the original 
data. The privacy of the participants in this study is warranted by use of encrypted 
and unique individual subject codes. This code correspondents with the code used 
in the patient report forms. The code was stored separately from the study data in a 
separate folder on the department server. Patient report forms were converged from 
Surveymonkey to SPSS (SPSS Inc., Chicago, Illinois, USA). The original Surveymonkey 
files are also available.
 The data will be saved for 15 years after termination of the study (December 21, 2015). 
Using these patient data in future research is only possible after a renewed permission 
by the patient as recorded in the informed consent. The datasets analyzed during these 
studies are available from the corresponding author on reasonable request. 
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DONDERS GRADUATE SCHOOL FOR COGNITIVE NEUROSCIENCE
For a successful research Institute, it is vital to train the next generation of young 
scientists. To achieve this goal, the Donders Institute for Brain, Cognition and Behaviour 
established the Donders Graduate School for Cognitive Neuroscience (DGCN), which 
was officially recognised as a national graduate school in 2009. The Graduate School 
covers training at both Master’s and PhD level and provides an excellent educational 
context fully aligned with the research programme of the Donders Institute.
The school successfully attracts highly talented national and international students in 
biology, physics, psycholinguistics, psychology, behavioral science, medicine and related 
disciplines. Selective admission and assessment centers guarantee the enrolment of the 
best and most motivated students.
The DGCN tracks the career of PhD graduates carefully. More than 50% of PhD alumni 
show a continuation in academia with postdoc positions at top institutes worldwide, 
e.g. Stanford University, University of Oxford, University of Cambridge, UCL London, MPI 
Leipzig, Hanyang University in South Korea, NTNU Norway, University of Illinois, North 
Western University, Northeastern University in Boston, ETH Zürich, University of Vienna 
etc..
Positions outside academia spread among the following sectors: specialists in a medical 
environment, mainly in genetics, geriatrics, psychiatry and neurology. Specialists in 
a psychological environment, e.g. as specialist in neuropsychology, psychological 
diagnostics or therapy. Positions in higher education as coordinators or lecturers. A 
smaller percentage enters business as research consultants, analysts or head of research 
and development. Fewer graduates stay in a research environment as lab coordinators, 
technical support or policy advisors. Upcoming possibilities are positions in the IT sector 
and management position in pharmaceutical industry. In general, the PhDs graduates 
almost invariably continue with high-quality positions that play an important role in our 
knowledge economy.
For more information on the DGCN as well as past and upcoming defenses please visit:
http://www.ru.nl/donders/graduate-school/phd/
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